rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCCTGGACTAGCGGCTACACCGGGGAGCTGTTTTTTGGAGAA	CASSSWTSGYTGELFF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	48	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	1	5	3	3	2	18	31	44	34	46						01,02								CASSSWTSGYTGELFF+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCGCAACAGGGAGGGGGGCCAACGTCCTGACTTTCGGGGCC	CASSATGRGANVLTF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	45	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-06	01	5	3	3	4	3	3	18	30	39	33	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSATGRGANVLTF+TCRBV07-06+TCRBJ02-06	TCRBV07-06*01		TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCGAACGACGGACCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	20	1.8205982485844849E-4		43	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-05	01	5	1	7	1	8	0	18	30	-1	38	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01		TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCAGGGAAGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSPGKGTGELFF	In	VDJ	1	25	2.275747810730606E-4	2.7475848728967237E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	3	5	1	6	18	30	36	31	42														CASSPGKGTGELFF+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCACAAGCCACCCTACTAGCGGGGGGGCCGACAGATACGCAGTATTTTGGCCCA	CASSSQATLLAGGPTDTQYF	In	VDJ	1	25	2.275747810730606E-4	2.7475848728967237E-4	60	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	3	0	3	13	3	18	31	57	44	60														CASSSQATLLAGGPTDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAACGGGGGCAGGAGCTAATGAAAAACTGTTTTTTGGCAGT	CASSLTGAGANEKLFF	In	VDJ	1	25	2.275747810730606E-4	2.7475848728967237E-4	48	TCRBV07	TCRBV07-06	01				TCRBJ01	TCRBJ01-04	01	2	6	0	3	2	5	18	33	41	35	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTGAGANEKLFF+TCRBV07-06+TCRBJ01-04	TCRBV07-06*01		TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGTCCTCCGCGGGGGGGTAACGCAGATACGCAGTATTTTGGCCCA	CASSPPRGGNADTQYF	In	VDJ	1	32	2.912957197735176E-4	3.516908637307806E-4	48	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	7	0	4	6	5	18	29	44	35	49														CASSPPRGGNADTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCGGGGGGCTGGGGGACGGAACCTACGAGCAGTACTTCGGGCCG	CASSGGLGDGTYEQYF	In	VDJ	1	45	4.096346059315091E-4	4.945652771214103E-4	48	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-07	01	5	6	0	2	1	12	18	30	37	31	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGGLGDGTYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCCCAGAGGAATGGAAACACCATATATTTTGGAGAG	CASSSQRNGNTIYF	In	VDJ	1	46	4.187375971744315E-4	5.055556166129972E-4	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	4	11	1	3	4	2	18	31	39	35	41														CASSSQRNGNTIYF+TCRBV07-06+TCRBJ01-03	TCRBV07-06*01	TCRBD02-01*02	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCACACAGGGGTAGATACGAGCAGTACTTCGGGCCG		Out	VDJ	1	14	1.2744187740091394E-4		40	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	2	4	2	4	19	31	40	33	44														X+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCAGGACAACGTTACCCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	15	1.3654486864383636E-4		50	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	6	4	1	16	19	31	37	32	53														X+TCRBV07-05+TCRBJ01-02	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCGTAAGTCACCGGGACAGGGGGTCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	15	1.3654486864383636E-4		52	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	1	2	10	2	19	31	52	41	54														X+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGCCTCTCAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	15	1.3654486864383636E-4		40	TCRBV07	TCRBV07-05	01				TCRBJ02	TCRBJ02-01	01	0	4	6	5	5	0	19	35	-1	40	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01		TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTCCTGAGGGTCAGGGGGTGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	17	1.5475085112968121E-4		49	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	1	1	9	2	19	32	48	41	50														X+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAAACACGGGAGACACCGGGGAGCTGTTTTTTGGAGAA	CASSLNTGDTGELFF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	45	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	8	2	3	4	0	19	34	-1	38	44														CASSLNTGDTGELFF+TCRBV07-05+TCRBJ02-02	TCRBV07-05*01	TCRBD02-01*02	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGGCGAGACCAGCAGAACTCCTACGAGCAGTACTTCGGGCCG	CASRRDQQNSYEQYF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	45	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	4	4	0	0	14	19	-1	31	27	45														CASRRDQQNSYEQYF+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCGCCAACCGACAGGGGGCGAGCTTAGAGACCCAGTACTTCGGGCCA	CASSANRQGASLETQYF	In	VDJ	1	26	2.3667777231598303E-4	2.857488267812593E-4	51	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	2	0	4	7	6	19	31	48	38	54														CASSANRQGASLETQYF+TCRBV07-05+TCRBJ02-05	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCGACAGGTCACTAGCACAGATACGCAGTATTTTGGCCCA	CASSRQVTSTDTQYF	In	VDJ	1	33	3.0039871101644E-4	3.6268120322236754E-4	45	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	4	0	1	5	19	31	38	32	43														CASSRQVTSTDTQYF+TCRBV07-05+TCRBJ02-03	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGTCCCTCCCAAGTCACCGGGGAGCTGTTTTTTGGAGAA	CASSPSQVTGELFF	In	VDJ	1	45	4.096346059315091E-4	4.945652771214103E-4	42	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	4	5	4	0	12	19	-1	30	27	42														CASSPSQVTGELFF+TCRBV07-05+TCRBJ02-02	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCGGACTATGGTAATACGCAGTATTTTGGCCCA	CASSADYGNTQYF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	1	9	7	1	5	23	36	43	37	48			01,02			01,02							Vb 1	CASSADYGNTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGATTCAGCGGGAGAATTAGGGCAGTACTTCGGGCCG	CASSVDSAGELGQYF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	6	2	9	4	7	23	39	51	43	58			01,02										Vb 1	CASSVDSAGELGQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTGGGACAGGGTCACTACAATGAGCAGTTCTTCGGGCCA	CASSVGQGHYNEQFF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	3	3	0	3	23	-1	46	37	49			01,02										Vb 1	CASSVGQGHYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGAGGATACTACGAGCAGTACTTCGGGCCG	CASSVGGYYEQYF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	11	1	3	0	3	23	-1	43	39	46			01,02										Vb 1	CASSVGGYYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGGGCGACGGTGAAAAACTGTTTTTTGGCAGT	CASSVGGDGEKLFF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	7	0	7	0	5	23	-1	44	39	49			01,02										Vb 1	CASSVGGDGEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCGGGGGTTCCTACGAGCAGTACTTCGGGCCG	CASSPGGSYEQYF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	8	2	1	2	1	23	35	43	37	44			01,02										Vb 1	CASSPGGSYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTGGACCCCGGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSVDPGGTGELFF	In	VDJ	1	21	1.911628161013709E-4	2.307971293233248E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	8	2	4	6	0	23	37	-1	43	49			01,02										Vb 1	CASSVDPGGTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAAGGCGGGAGGGACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	22	2.0026580734429334E-4		46	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	7	0	2	3	1	23	39	51	42	52			01,02										Vb 1	X+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGAGAGTTGGAAGCGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	24	2.1847178983013817E-4		40	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	6	6	6	9	0	23	36	-1	45	49			01,02			01,02							Vb 1	X+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCTATGCCCGCCTACAATGAGCAGTTCTTCGGGCCA	CASSVAMPAYNEQFF	In	VDJ	1	25	2.275747810730606E-4	2.7475848728967237E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	9	2	0	6	23	-1	42	39	48			01,02			01,02							Vb 1	CASSVAMPAYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTTTCGTGGGCTATACGCAGTATTTTGGCCCA		Out	VDJ	1	30	2.730897372876727E-4		37	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	8	0	7	6	1	23	35	45	41	46			01,02										Vb 1	X+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGGGGACAGGGGAATGTCTGGAAACACCATATATTTTGGAGAG	CASSGDRGMSGNTIYF	In	VDJ	1	45	4.096346059315091E-4	4.945652771214103E-4	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	2	1	2	4	23	34	46	36	50			01,02										Vb 1	CASSGDRGMSGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCTCGGCGGGACAGGGCCTCTCCTACGAGCAGTACTTCGGGCCG	CASSAGQGLSYEQYF	In	VDJ	7	280	0.0025488375480182787	0.0030772950576443306	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	3	0	5	3	23	32	46	37	49			01,02										Vb 1	CASSAGQGLSYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCAAGAAACAGACAGGGCCTAATGAAAAACTGTTTTTTGGCAGT	CASSKKQTGPNEKLFF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	48	TCRBV11	TCRBV11-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	3	3	8	1	19	31	46	39	47														CASSKKQTGPNEKLFF+TCRBV11-01+TCRBJ01-04	TCRBV11-01*01	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCCTAAGGGAATTTGGCTATGGCTACACCTTCGGTTCG	CASSLREFGYGYTF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	42	TCRBV11	TCRBV11-01	01				TCRBJ01	TCRBJ01-02	01	5	0	8	4	4	6	19	31	39	35	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLREFGYGYTF+TCRBV11-01+TCRBJ01-02	TCRBV11-01*01		TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCCCCGTAGCGGGAGGGCCTGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	35	3.1860469350228484E-4		46	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	0	7	4	4	19	31	46	35	50														X+TCRBV11-01+TCRBJ02-01	TCRBV11-01*01	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAGAGGGGATGGAACACTGAAGCTTTCTTTGGACAA	CASSQERGWNTEAFF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	45	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-01	01	0	5	2	1	1	3	29	46	52	47	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQERGWNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCCACGTTTGGTGGCAGAACTGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCGACAGCCCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	14	1.2744187740091394E-4		38	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	5	4	1	3	43	56	62	57	65													Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAAGAGGGCCGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSQRGPGSYEQYF	In	VDJ	1	21	1.911628161013709E-4	2.307971293233248E-4	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	11	0	0	1	5	29	44	50	45	55													Vb 16	CASSQRGPGSYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TTTGGTGGCAGAACTGGAGGATTCTGGAGTTWWTTCTGTGCCAGCAGCCCGACAGCCCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	24	2.1847178983013817E-4		37	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	23	2	5	4	19	3	37	31	55	50	58													Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTACTCTGGGACAGTGATACGAGCAGTACTTCGGGCCG		Out	VDJ	1	26	2.3667777231598303E-4		47	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	5	4	6	3	29	45	58	51	61													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGTAGCCCGGACAGGGTAACCACTGAAGCTTTCTTTGGACAA	CASSPDRVTTEAFF	In	VDJ	1	26	2.3667777231598303E-4	2.857488267812593E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	3	4	1	4	29	42	51	43	55													Vb 16	CASSPDRVTTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAACTATTAGGACAGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSQLLGQGTGELFF	In	VDJ	1	27	2.4578076355890547E-4	2.9673916627284615E-4	48	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	1	2	5	6	0	29	44	-1	50	59													Vb 16	CASSQLLGQGTGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGGATCCCGGGGAACTGTTTTTTGGAGAA	CASSQGDPGELFF	In	VDJ	1	33	3.0039871101644E-4	3.6268120322236754E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	8	3	14	7	2	29	45	57	52	59													Vb 16	CASSQGDPGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGTTCCCCCTGTAAGGGAGACCCTAAAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	33	3.0039871101644E-4		50	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	9	2	7	12	7	29	40	57	52	64													Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAGGAGGGAGGACATCAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	35	3.1860469350228484E-4		49	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	9	1	2	3	5	29	46	55	49	60													Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD02-01*02	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGTGGCAGAACTGGAGGATTCTGGAGTTWWTTCTGTGCCAGCAGTCCTTGGACAGGGTAGACCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	48	4.3694357966027634E-4		47	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	19	1	3	2	17	4	34	32	57	49	61													Vb 16	X+TCRBV14-01+TCRBJ02-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCCAGGGTCTCGTCGCAAGAGACCCAGTACTTCGGGCCA	CASSPRVSSQETQYF	In	VDJ	1	49	4.460465709031988E-4	5.385266350877579E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	3	2	1	8	29	42	48	43	56													Vb 16	CASSPRVSSQETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TTTATTTCTGTGCCAGCGAACCCCCCTTTCCAGGTCAGCGGGGCAGACCCCGTTGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	50	4.551495621461212E-4		62	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	6	3	7	19	12	8	17	43	36	55													Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCCGGGAATCTACGAGCAGTACTTCGGGCCG	CASSQDPGIYEQYF	In	VDJ	1	52	4.7335554463196606E-4	5.714976535625186E-4	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	8	3	3	2	2	29	46	53	48	55													Vb 16	CASSQDPGIYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCTTCCGGGCCTTTAGGATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	69	6.281063957616473E-4		44	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-04	01	5	8	0	6	4	7	29	41	49	45	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01		TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGATGGTGTGCGGGAGGGCTGTTCTACGAGCAGTACTTCGGGCCG	CASRWCAGGLFYEQYF	In	VDJ	2	73	6.64518360733337E-4	8.022947828858433E-4	48	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	7	0	3	7	5	29	40	56	47	61													Vb 16	CASRWCAGGLFYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAATGACGGCTCTACGAGCAGTACTTCGGGCCG	CASSQ*RLYEQYF	Stop	VDJ	2	79	7.191363081908715E-4		39	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	2	2	7	3	1	4	29	44	48	45	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQ*RLYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAATCTCAGCAGTCTGAAGCTTTCTTTGGACAA	CASSQSQQSEAFF	In	VDJ	2	97	8.829901505634752E-4	0.0010660629306839288	39	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-01	01	2	4	5	6	3	4	29	44	50	47	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQSQQSEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAACACTGAAGCTTTCTTTGGACAA		Out	VJ	3	120	0.0010923589491506909		34	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-01	01	2	0	0	1	0	0	29	-1	-1	-1	44													Vb 16	X+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGCCCGGACAGGGGGACGCTGAAGCTTTCTTTGGACAA		Out	VDJ	4	153	0.001392757660167131		46	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	1	6	3	3	29	45	58	48	61													Vb 16	X+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATGATGGTCGGAGGGTACCGTTCTTCGGGCCA	CASSQDDGRRVPFF	In	VDJ	9	391	0.0035592695759826677	0.004297222741210476	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	10	0	15	8	4	29	46	60	54	64													Vb 16	CASSQDDGRRVPFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCGACAGCCCCTATGGCTACACCTTCGGTTCG		Out	VDJ	45	1940	0.017659803011269504		38	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	5	4	1	3	29	42	48	43	51													Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGTCCTTGGACAGGGTAGACCAAAAACATTCAGTACTTCGGCGCC	CASSPWTG*TKNIQYF	Stop	VDJ	64	2769	0.025206182751652192		48	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	1	3	2	5	4	29	40	53	45	57													Vb 16	CASSPWTG*TKNIQYF+TCRBV14-01+TCRBJ02-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GAGACACAGCACGGTATTTCTGTGCCAGCAGCGTACCCTCGGACAGGTTAGAGCTTAGCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	12	1.0923589491506909E-4		61	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	4	2	8	11	20	32	47	40	58														X+TCRBV21-or09_02+TCRBJ02-06	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGGGGGATCGGGTGCCACTGAAGCTTTCTTTGGACAA	CASSGGSGATEAFF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	6	6	1	4	1	9	24	35	41	36	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGGSGATEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCACCAAGGGGGCGAGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASTKGARGNQPQHF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	6	0	2	0	5	24	-1	44	38	49														CASTKGARGNQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCTACAGGGGTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSPTGVAKNIQYF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	3	2	0	3	1	24	36	46	39	47														CASSPTGVAKNIQYF+TCRBV21-or09_02+TCRBJ02-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGACCCGGGACAGGGGTGGATACGCAGTATTTTGGCCCA	CASSVGPGTGVDTQYF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	2	6	9	2	24	36	55	45	57														CASSVGPGTGVDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTACGTGGGCTCTCTGGAAACACCATATATTTTGGAGAG	CASSLRGLSGNTIYF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	8	0	0	6	1	24	36	46	42	47														CASSLRGLSGNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGAATTGGAGAACACTGAAGCTTTCTTTGGACAA	CASSELENTEAFF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	6	1	8	1	6	0	24	35	-1	41	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSELENTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGAGGGGACCTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSEGTYSNQPQHF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-05	01	6	0	7	0	4	3	24	35	44	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGTYSNQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01		TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGAACCAACTTGGAGACCCAGTACTTCGGGCCA	CASRTNLETQYF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	36	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	3	10	5	5	2	24	35	43	40	45						01,02								CASRTNLETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCGATACGGGGTTCATGGCTACACCTTCGGTTCG	CASSRYGVHGYTF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	3	6	5	3	24	36	46	41	49														CASSRYGVHGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCGGACCACAGGGGGGGGACTGAAGCTTTCTTTGGACAA	CASSADHRGGTEAFF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	1	5	7	3	24	36	51	43	54														CASSADHRGGTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGCCCGGACAGGGCCATTAGCACAGATACGCAGTATTTTGGCCCA	CASSGPDRAISTDTQYF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	51	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	3	0	5	5	24	36	49	41	54														CASSGPDRAISTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTATTGACAGGTCAGATCAGCCCCAGCATTTTGGTGAT	CASSIDRSDQPQHF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	4	5	4	4	24	35	45	39	49														CASSIDRSDQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAAAACCTTTGGGGGAGGGGAATTCAGTACTTCGGCGCC	CASSKNLWGRGIQYF	In	VDJ	1	20	1.8205982485844849E-4	2.198067898317379E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	2	9	0	10	9	2	24	39	55	48	57														CASSKNLWGRGIQYF+TCRBV21-or09_02+TCRBJ02-04	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCACACACCCCGGGCTGGGCACTGAAGCTTTCTTTGGACAA	CATHPGLGTEAFF	In	VDJ	1	21	1.911628161013709E-4	2.307971293233248E-4	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	10	8	0	4	8	4	24	31	43	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATHPGLGTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGCAGTAGCAGGGACGCATGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	21	1.911628161013709E-4		56	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	6	0	7	4	9	15	24	35	49	44	64				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGGACAGGGAGTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVGTGSNTGELFF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	3	2	3	3	24	36	48	39	51														CASSVGTGSNTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCGCGCCGACTAGGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	26	2.3667777231598303E-4		41	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	8	7	6	2	24	36	48	42	50						01,02								X+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTATAACACGGGGAGCTGTTTTTTGGAGAA	CASSV*HGELFF	Stop	VDJ	1	26	2.3667777231598303E-4		36	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	6	7	5	0	24	36	-1	41	44														CASSV*HGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTCGTAGCGGGAGGGTACACAGATACGCAGTATTTTGGCCCA	CASSVVAGGYTDTQYF	In	VDJ	1	27	2.4578076355890547E-4	2.9673916627284615E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	5	0	2	4	2	24	36	51	40	53														CASSVVAGGYTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTGGGGACAATACCTAACTATGGCTACACCTTCGGTTCG	CASSVGTIPNYGYTF	In	VDJ	1	27	2.4578076355890547E-4	2.9673916627284615E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	6	0	3	4	24	36	45	39	49														CASSVGTIPNYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAAAACAGGAGGGCGGGACGGCCGCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	28	2.548837548018279E-4		59	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	7	3	0	9	6	22	37	52	46	58														X+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGCGACGGACTAGCGGGAGGGAGGTGGGCCAAAAACATTCAGTACTTCGGCGCC	CASSGDGLAGGRWAKNIQYF	In	VDJ	1	34	3.0950170225936243E-4	3.7367154271395446E-4	60	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	5	1	0	1	6	6	21	33	54	39	60														CASSGDGLAGGRWAKNIQYF+TCRBV21-or09_02+TCRBJ02-04	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCGTAGGTGGGAGGATACGCAGTATTTTGGCCCA	CASSRRWEDTQYF	In	VDJ	1	37	3.368106759881297E-4	4.066425611887151E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	9	2	6	7	0	24	36	-1	43	48														CASSRRWEDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCAGGGGGCCGGGATAACACCATATATTTTGGAGAG	CASSPGGRDNTIYF	In	VDJ	1	38	3.4591366723105214E-4	4.17632900680302E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	4	0	7	1	6	24	36	45	37	51														CASSPGGRDNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCATCTCCTTACAGCAGCTCACGAACGAGCAGTACTTCGGGCCG	CASISLQQLTNEQYF	In	VDJ	1	38	3.4591366723105214E-4	4.17632900680302E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	3	5	5	10	10	24	31	45	41	55														CASISLQQLTNEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGAATACCGGACTGCTAACTATGGCTACACCTTCGGTTCG	CASSEYRTANYGYTF	In	VDJ	1	41	3.732226409598194E-4	4.506039191550627E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	1	10	0	8	1	24	35	48	43	49						01,02								CASSEYRTANYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCAACATACCCTCCGGGACAGGCACCGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	50	4.551495621461212E-4		53	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	4	4	13	5	24	36	57	49	62														X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCCGCTACAGGGGAGGTATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	51	4.6425255338904364E-4		46	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	2	5	6	4	24	36	49	42	53														X+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGAGGGTATGGTCAGCCCCAGCATTTTGGTGAT	CASSVGGYGQPQHF	In	VDJ	1	55	5.006645183607333E-4	6.044686720372793E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	10	0	6	3	5	24	36	45	39	50														CASSVGGYGQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAGGTTCTCAGTTGGTGAAGCTTTCTTTGGACAA		Out	VDJ	1	57	5.188705008465782E-4		40	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	5	7	6	4	24	38	47	44	51														X+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCACGCCGGGACAGGGGAATGAGCAGTTCTTCGGGCCA	CASSTPGQGNEQFF	In	VDJ	2	77	7.009303257050266E-4	8.462561408521909E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	2	7	4	0	24	37	-1	41	51														CASSTPGQGNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGGTAGGGGGGGCTGCTCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	89	8.101662206200957E-4		41	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	10	9	0	2	4	6	24	31	42	35	48														X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAAGGGGTAGGGGAGTGTACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	97	8.829901505634752E-4		49	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-05	01	1	5	2	2	4	6	24	40	49	44	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01		TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGTAGACAGTACAGATACGCAGTATTTTGGCCCA	CASSVVDSTDTQYF	In	VDJ	3	110	0.0010013290367214666	0.0012089373440745585	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	5	3	6	1	24	36	47	42	48														CASSVVDSTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGACAGGTCGGCCCACACTGAAGCTTTCTTTGGACAA	CASSVDRSAHTEAFF	In	VDJ	3	127	0.0011560798878511478	0.0013957731154315357	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	4	3	3	7	24	36	45	39	52														CASSVDRSAHTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCGATAGGGGACAGGCAAACTATGGCTACACCTTCGGTTCG	CASDRGQANYGYTF	In	VDJ	4	166	0.0015110965463251225	0.0018243963556034246	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	0	4	2	7	2	24	31	46	38	48														CASDRGQANYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCGGAGGGGGGACAGGGTCCTACGAGCAGTACTTCGGGCCG	CASGGGTGSYEQYF	In	VDJ	4	175	0.0015930234675114242	0.0019233094110277067	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	0	3	1	8	0	24	31	-1	39	48														CASGGGTGSYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGACAGGGTAAGAATGAGCAGTTCTTCGGGCCA	CASSVGQGKNEQFF	In	VDJ	6	268	0.0024396016531032095	0.002945410983745288	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	3	7	3	4	24	36	47	39	51														CASSVGQGKNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCTCAGGGATGGGATACGCAGTATTTTGGCCCA	CASSEAQGWDTQYF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	42	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	3	6	1	4	23	40	46	41	50														CASSEAQGWDTQYF+TCRBV06-01+TCRBJ02-03	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGGCCGGCGTGAACACTGAAGCTTTCTTTGGACAA	CASSEAAGVNTEAFF	In	VDJ	1	31	2.8219272853059513E-4	3.4070052423919376E-4	45	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-01	01	0	9	0	0	0	5	23	-1	43	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEAAGVNTEAFF+TCRBV06-01+TCRBJ01-01	TCRBV06-01*01		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAATGATGAACACTGAAGCTTTCTTTGGACAA	CAWSVMMNTEAFF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	39	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-01	01	0	2	8	0	3	0	26	40	-1	43	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVMMNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAGGGCTATGGCTACACCTTCGGTTCG	CAWSEGYGYTF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	33	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	1	5	3	4	0	0	26	-1	-1	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSEGYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAGGGGGCAGGATCCAACAACTACGAGCAGTACTTCGGGCCG	CAWKGAGSNNYEQYF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	5	0	3	0	12	26	-1	43	36	55													Vb 20	CAWKGAGSNNYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCCAGTGGTACCCCTACGAGCAGTACTTCGGGCCG	CAWSPQWYPYEQYF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	5	2	3	7	26	38	44	41	51			unresolved										Vb 20	CAWSPQWYPYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCGGGCAGGGGGCGGCACCGGGGAGCTGTTTTTTGGAGAA	CAWSRAGGGTGELFF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	0	4	4	2	26	38	50	42	52													Vb 20	CAWSRAGGGTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTATGGGGAGGGTTGGGCTACACCTTCGGTTCG	CAWSVWGGLGYTF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	9	0	8	3	3	26	40	50	43	53			unresolved										Vb 20	CAWSVWGGLGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGAGGACAGGCCCTACGGAGGAAGGGAGCAGTTCTTCGGGCCA		Out	VDJ	1	16	1.456478598867588E-4		50	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	4	10	2	15	26	40	49	42	64													Vb 20	X+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAGTCGAGGGGTTCCTACGAAAAACTGTTTTTTGGCAGT	CAWKSRGSYEKLFF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	42	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-04	01	4	5	2	8	5	7	26	36	46	41	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWKSRGSYEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*02		TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAAAACAGTTTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	19	1.7295683361552607E-4		44	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	3	5	1	3	2	26	40	47	43	49													Vb 20	X+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTTCGGGGCGCCGGGCACTGAAGCTTTCTTTGGACAA	CAWSFGAPGTEAFF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	2	7	0	4	3	6	26	38	46	41	52			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSFGAPGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATGGAACCAGGGATTGAAGCTTTCTTTGGACAA	CAWMEPGIEAFF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	3	7	6	2	26	36	47	42	49													Vb 20	CAWMEPGIEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAAAAGAGACCCAGTACTTCGGGCCA	CAWSVKETQYF	In	VJ	1	34	3.0950170225936243E-4	3.7367154271395446E-4	33	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-05	01	0	0	0	3	0	2	26	-1	40	-1	42													Vb 20	CAWSVKETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01		TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCCCTGTCGGGGGGGGCCCCAGCATTTTGGTGAT		Out	VDJ	1	35	3.1860469350228484E-4		34	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	7	8	0	9	6	0	26	33	-1	39	47													Vb 20	X+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCGAAGGGGATCAGCCCCAGCATTTTGGTGAT	CAWSVEGDQPQHF	In	VDJ	1	39	3.5501665847397456E-4	4.2862324017188893E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	5	2	5	3	0	26	40	-1	43	48			unresolved										Vb 20	CAWSVEGDQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACTAGCGGGAATACGCAGTATTTTGGCCCA	CAWTSGNTQYF	In	VDJ	1	45	4.096346059315091E-4	4.945652771214103E-4	33	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	4	3	7	0	0	26	-1	-1	36	45													Vb 20	CAWTSGNTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGACCCTCGACGGTAGCGGGGTCCTCGTGGACGAGCAGTACTTCGGGCCG	CAWRTLDGSGVLVDEQYF	In	VDJ	1	46	4.187375971744315E-4	5.055556166129972E-4	54	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	5	3	5	12	9	26	37	57	49	66													Vb 20	CAWRTLDGSGVLVDEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTATGGGCCAGGGGATGTCTGAAGCTTTCTTTGGACAA	CAWSMGQGMSEAFF	In	VDJ	1	48	4.3694357966027634E-4	5.275362955961709E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	2	6	6	4	26	38	50	44	54													Vb 20	CAWSMGQGMSEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTATACTAGCACCTCGGAAGAATGAGCAGTTCTTCGGGCCA	CAWSILAPRKNEQFF	In	VDJ	1	49	4.460465709031988E-4	5.385266350877579E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	3	7	7	2	10	26	38	46	40	56			unresolved			01,02							Vb 20	CAWSILAPRKNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGTCTGGAGACCGGGACAGGGGGTTTACGAGCAGTACTTCGGGCCG	CVWRPGQGVYEQYF	In	VDJ	1	51	4.6425255338904364E-4	5.605073140709316E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	1	4	3	2	26	37	51	40	53													Vb 20	CVWRPGQGVYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TATCTCTGTGCCTGGAGTCTCATCGGCGCTCTCCAGTTCGGGACTAGCGGGAGATATTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CAWSLIGALQFGTSGRYSGANVLTF	In	VDJ	2	70	6.372093870045697E-4	7.693237644110826E-4	75	TCRBV30	TCRBV30-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	2	0	2	1	21	4	6	18	53	39	57			01,02										Vb 20	CAWSLIGALQFGTSGRYSGANVLTF+TCRBV30-01+TCRBJ02-06	TCRBV30-01	TCRBD02-01*02	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGTTGGGGCTAAACACTGAAGCTTTCTTTGGACAA	CAWRLGLNTEAFF	In	VDJ	2	87	7.919602381342509E-4	9.561595357680598E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	7	0	2	3	2	26	37	45	40	47			unresolved										Vb 20	CAWRLGLNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGTCAGAGAGGATCTACCTACGAGCAGTACTTCGGGCCG	CACQRGSTYEQYF	In	VDJ	3	112	0.0010195350192073115	0.0012309180230577323	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	11	1	2	5	5	26	34	43	39	48													Vb 20	CACQRGSTYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCCGGGACAGGGGAATGGAACTATGGCTACACCTTCGGTTCG	CAWAGTGEWNYGYTF	In	VDJ	4	188	0.0017113623536694157	0.002066183824418336	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	2	2	3	5	26	35	48	38	53													Vb 20	CAWAGTGEWNYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGACCGGGACAGGGGGTCTACGAGCAGTACTTCGGGCCG	CAWRPGQGVYEQYF	In	VDJ	20	871	0.007928705372585432	0.009572585697172186	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	1	3	3	1	26	37	51	40	52			unresolved										Vb 20	CAWRPGQGVYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGAATAGCATCACCGGGGAGCTGTTTTTTGGAGAA	CASSQGNSITGELFF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	5	7	4	4	2	23	39	47	43	49						01,02								CASSQGNSITGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCATAATATGGGGGCCTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	15	1.3654486864383636E-4		47	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	6	0	3	6	2	23	37	49	43	51														X+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATCGAACTAGCGGGGCCCGTAGCACAGATACGCAGTATTTTGGCCCA	CASSQDRTSGARSTDTQYF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	57	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	3	3	0	4	5	23	40	54	44	59														CASSQDRTSGARSTDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATTTCAGGGGGCTTAACGAGCAGTACTTCGGGCCG	CASSQDFRGLNEQYF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	0	5	3	3	23	40	51	43	54														CASSQDFRGLNEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCGGGACACCCTAACTATGGCTACACCTTCGGTTCG	CASSPGHPNYGYTF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	6	0	1	2	23	36	43	37	45														CASSPGHPNYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCACATCGGGGTAGTCGCGAGCAGTACTTCGGGCCG	CASSPHRGSREQYF	In	VDJ	1	21	1.911628161013709E-4	2.307971293233248E-4	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	8	3	6	5	6	23	36	46	41	52														CASSPHRGSREQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGATGGACAGTGGGGGAGCTGGGCTTCGGGCCG		Out	VDJ	1	24	2.1847178983013817E-4		41	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	5	15	1	13	23	40	47	41	60														X+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCATCCCGGACCCAAACTCCAACTATGGCTACACCTTCGGTTCG	CASIPDPNSNYGYTF	In	VDJ	1	27	2.4578076355890547E-4	2.9673916627284615E-4	45	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-02	01	7	1	7	2	4	9	23	33	41	37	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASIPDPNSNYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01		TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCGAGGCAGATAAGTTAGGCCGACAGTACTTCGGGCCG		Out	VDJ	1	28	2.548837548018279E-4		43	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	11	1	10	0	17	23	-1	40	36	57														X+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCGCGTTAAGACAGGGGAATGGGGTGTGTACGAGACCCAGTACTTCGGGCCA	CASSRVKTGEWGVYETQYF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	57	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	2	2	5	7	14	23	36	51	43	65														CASSRVKTGEWGVYETQYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAGGACAGGGGGCGCAGTTATGAGCAGTTCTTCGGGCCA	CASSQEDRGRSYEQFF	In	VDJ	1	32	2.912957197735176E-4	3.516908637307806E-4	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	0	8	0	6	23	-1	51	40	57														CASSQEDRGRSYEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGAGAACGAGAGGGCCGCTTGAAGCTTTCTTTGGACAA	CASSQGRTRGPLEAFF	In	VDJ	1	35	3.1860469350228484E-4	3.846618822055413E-4	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	11	0	7	9	5	23	39	53	48	58														CASSQGRTRGPLEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD02-01*02	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATCCCGGACACCGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQDPGHRSYNEQFF	In	VDJ	1	48	4.3694357966027634E-4	5.275362955961709E-4	51	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	6	0	4	3	23	40	49	44	52														CASSQDPGHRSYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCACGGACAGGGTACGCAGTATTTTGGCCCA	CASSHGQGTQYF	In	VDJ	1	61	5.552824658182679E-4	6.704107089868006E-4	36	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	1	3	8	1	0	23	37	-1	38	46														CASSHGQGTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAGATAGGGGCGGCCAACTATGGCTACACCTTCGGTTCG	CASSQEIGAANYGYTF	In	VDJ	2	81	7.373422906767164E-4	8.902174988185385E-4	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	2	2	3	5	23	40	48	43	53														CASSQEIGAANYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAGGGAGCCACAGATACGCAGTATTTTGGCCCA	CASSQEGATDTQYF	In	VDJ	4	154	0.0014018606514100533	0.0016925122817043818	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	9	2	2	0	1	23	-1	45	40	46														CASSQEGATDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCACCCTGGGACTAGCGGGGTCATACAATGAGCAGTTCTTCGGGCCA	CASTLGLAGSYNEQFF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	4	4	3	19	29	46	33	49													Vb 5.1	CASTLGLAGSYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCAGGAACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSRNSGANVLTF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-06	01	4	1	8	0	1	1	19	31	35	32	36				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSRNSGANVLTF+TCRBV05-01+TCRBJ02-06	TCRBV05-01*01		TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCCAGACAGGGCTAAACTATGGCTACACCTTCGGTTCG	CASSPQTGLNYGYTF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	3	2	5	3	19	31	43	36	46													Vb 5.1	CASSPQTGLNYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCGGGACAGGGGAGCTACGAGCAGTACTTCGGGCCG	CASSSGQGSYEQYF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	2	3	1	2	19	32	43	33	45													Vb 5.1	CASSSGQGSYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTGACAGTAGCACAGATACGCAGTATTTTGGCCCA	CASSFDSSTDTQYF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	2	5	0	1	1	19	33	39	34	40													Vb 5.1	CASSFDSSTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCCCTTTATCACAGGGGACGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	13	1.1833888615799151E-4		50	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	2	4	11	2	19	31	49	42	51													Vb 5.1	X+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCGGGACAGGGGGACGAGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	13	1.1833888615799151E-4		53	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	1	0	2	5	19	32	45	34	50													Vb 5.1	X+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAACAGGGGGTGTACGAGCAGTACTTCGGGCCG	CASSLEQGVYEQYF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	1	4	1	2	19	35	44	36	46													Vb 5.1	CASSLEQGVYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCAATGGACAGGGGGTGACACTGAAGCTTTCTTTGGACAA	CASSQWTGGDTEAFF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	1	3	4	2	19	31	45	35	47													Vb 5.1	CASSQWTGGDTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAATCCCCCAGGGACACTGAAGCTTTCTTTGGACAA	CASSLESPRDTEAFF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	3	3	7	0	19	35	-1	42	47													Vb 5.1	CASSLESPRDTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGTGGGACTAGCGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSLGGTSASTDTQYF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	0	6	0	2	2	19	35	47	37	49						01,02							Vb 5.1	CASSLGGTSASTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCATCCGGGACAAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSIRDKNTGELFF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	6	1	4	1	19	31	41	35	42													Vb 5.1	CASSIRDKNTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTTTCAGCGGGGGTTACGGGGAGCTGTTTTTTGGAGAA	CASSFSGGYGELFF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	6	2	7	4	3	19	30	42	34	45													Vb 5.1	CASSFSGGYGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCTGGACAGCCGAACACTGAAGCTTTCTTTGGACAA	CASSSGQPNTEAFF	In	VDJ	1	27	2.4578076355890547E-4	2.9673916627284615E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	5	1	2	2	19	32	40	34	42													Vb 5.1	CASSSGQPNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTCGAGGGGGCGCCCACCGGGGAGCTGTTTTTTGGAGAA	CASSFEGAPTGELFF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	5	0	4	2	3	19	33	42	35	45													Vb 5.1	CASSFEGAPTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCAGGCCACAGGGTCCCCCTACGAGCAGTACTTCGGGCCG	CASSQATGSPYEQYF	In	VDJ	1	32	2.912957197735176E-4	3.516908637307806E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	3	2	6	4	19	31	43	37	47													Vb 5.1	CASSQATGSPYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCGGGACAGAGAGGCGATGAGCAGTTCTTCGGGCCA	CASSSGQRGDEQFF	In	VDJ	1	61	5.552824658182679E-4	6.704107089868006E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	5	8	1	7	19	32	40	33	47													Vb 5.1	CASSSGQRGDEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTACTAGCGGGAGGGAAGTTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLLAGGKLNTGELFF	In	VDJ	4	170	0.0015475085112968121	0.0018683577135697722	54	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	3	0	1	0	5	19	-1	46	33	51													Vb 5.1	CASSLLAGGKLNTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGACCGGGACACCAACGGGTGAGCAGTTCTTCGGGCCA	CASSWTGTPTGEQFF	In	VDJ	5	202	0.0018388042310703296	0.002220048577300553	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	6	9	5	8	19	32	43	37	51													Vb 5.1	CASSWTGTPTGEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GAGGGACTCAGCCGTGTATCTCTACAGTAGCTTCCTCCATATTCTGGACAAAGCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	14	1.2744187740091394E-4		52	TCRBV17	TCRBV17-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	6	5	14	4	22	31	50	45	54														X+TCRBV17-01+TCRBJ02-06	TCRBV17-01*01	TCRBD01-01*01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCCGACCCACCCGGGTATCACCCCTCCACTTTGGGAAC	CASSPRPTRVSPLHF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	6	8	4	10	13	2	25	36	53	49	55						01,02							Vb 3	CASSPRPTRVSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD02-01	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCGGGACAGAGTCCTACGAGCAGTACTTCGGGCCG	CASSGTESYEQYF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	5	1	1	2	25	36	44	37	46													Vb 3	CASSGTESYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCGGGACAGGGGGCTATTCCTACGAGCAGTACTTCGGGCCG	CASSPGTGGYSYEQYF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	0	1	4	3	25	36	52	40	55													Vb 3	CASSPGTGGYSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCAACAGGGGGCGGGCGGGTCAGCCCCAGCATTTTGGTGAT	CASSPNRGRAGQPQHF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	0	6	4	7	25	37	50	41	57													Vb 3	CASSPNRGRAGQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGGCCCGAGGGGGGGGAACCGAGCAGTACTTCGGGCCG		Out	VDJ	1	13	1.1833888615799151E-4		46	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	9	0	6	8	4	25	39	54	47	58													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCGGGACAGGGCTGGTCAGCCCCAGCATTTTGGTGAT	CASSFRDRAGQPQHF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	3	6	2	4	25	39	50	41	54													Vb 3	CASSFRDRAGQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCAGGACAGGGTTTTTTGGCTACACCTTCGGTTCG	CASSRTGFFGYTF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	3	7	2	5	25	36	46	38	51													Vb 3	CASSRTGFFGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCGCAGGGGGCATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	14	1.2744187740091394E-4		38	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	0	5	2	0	25	36	-1	38	46													Vb 3	X+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTACCAGCAGGGGGACTAGCGGGGGAACAGATACGCAGTATTTTGGCCCA	CTSRGTSGGTDTQYF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	0	2	3	1	1	25	36	51	37	52													Vb 3	CTSRGTSGGTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCCGCGGACAGGGTCCCCGTTATCTGGAAACACCATATATTTTGGAGAG	CASTPRTGSPLSGNTIYF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	54	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	1	3	1	6	9	25	35	49	41	58													Vb 3	CASTPRTGSPLSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCTACAGGGGGCCCTAGCACAGATACGCAGTATTTTGGCCCA	CASSPTGGPSTDTQYF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	0	0	3	3	25	37	49	40	52													Vb 3	CASSPTGGPSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTTCTGTATAATTCACCCCTCCACTTTGGGAAC	CASSLFLYNSPLHF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	1	4	10	4	2	1	25	41	45	43	46						01,02							Vb 3	CASSLFLYNSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD02-01	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCAGACAGGGGGGTTAGGGAACACTGAAGCTTTCTTTGGACAA	CASSQTGGLGNTEAFF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	1	1	3	6	25	36	48	39	54													Vb 3	CASSQTGGLGNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCAGAGGACCCAAGAGACCCAGTACTTCGGGCCA	CASSPQRTQETQYF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	5	1	7	1	7	0	25	37	-1	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPQRTQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCTAGGGGGCGCGACCGAAGCTTTCTTTGGACAA	CASSPLGGATEAFF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	0	8	5	6	25	37	49	42	55													Vb 3	CASSPLGGATEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGTTCGGCAATCAGCCCCAGCATTTTGGTGAT	CASRFGNQPQHF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	8	6	2	3	0	25	36	-1	39	41						01,02							Vb 3	CASRFGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACCGACGGGCAAACGCGAGCAGTACTTCGGGCCG	CASSLPTGKREQYF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	2	8	0	6	5	5	25	40	49	45	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLPTGKREQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGCGGGGCACAAGAGACCCAGTACTTCGGGCCA	CASSRGAQETQYF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	7	3	2	2	2	25	36	44	38	46													Vb 3	CASSRGAQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCCACAGATACGCAGTATTTTGGCCCA		Out	VJ	1	19	1.7295683361552607E-4		35	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	5	0	0	2	0	4	25	-1	37	-1	41													Vb 3	X+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGGACTAGCGGGATGACAGATACGCAGTATTTTGGCCCA	CASSRTSGMTDTQYF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	1	3	3	1	2	25	37	50	38	52													Vb 3	CASSRTSGMTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCTCCAGCTAACTCCTACGAGCAGTACTTCGGGCCG	CASSLSPANSYEQYF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	1	4	5	0	3	4	25	41	47	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLSPANSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCTCGGGCAGGAACAATCAGCCCCAGCATTTTGGTGAT	CATSGRNNQPQHF	In	VDJ	1	20	1.8205982485844849E-4	2.198067898317379E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	10	4	4	3	7	2	25	32	43	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CATSGRNNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGCGACTAGTGAGGACATTCAGTACTTCGGCGCC	CASSATSEDIQYF	In	VDJ	1	21	1.911628161013709E-4	2.307971293233248E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	2	8	8	2	5	25	37	45	39	50						01,02							Vb 3	CASSATSEDIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD02-01	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACCTAGGGGGCGAGGGGCTTTCTTTGGACAA	CASSLPRGRGAFF	In	VDJ	1	21	1.911628161013709E-4	2.307971293233248E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	5	0	11	3	5	25	40	50	43	55													Vb 3	CASSLPRGRGAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGCGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSLRGSTDTQYF	In	VDJ	1	21	1.911628161013709E-4	2.307971293233248E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	7	2	0	0	0	25	-1	-1	39	46													Vb 3	CASSLRGSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTCCCCGGACAGGGGGTATAATTCACCCCTCCACTTTGGGAAC	CASSSPDRGYNSPLHF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	1	1	4	6	0	25	36	-1	42	52													Vb 3	CASSSPDRGYNSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGGGGCAAAGAGATGGGATACGCAGTATTTTGGCCCA	CASRGAKRWDTQYF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	6	0	6	0	10	25	-1	42	36	52													Vb 3	CASRGAKRWDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGGGGAACACAGATACGCAGTATTTTGGCCCA	CASSLGGNTDTQYF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	9	1	2	0	2	25	-1	46	40	48													Vb 3	CASSLGGNTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCAAGCGGGGGGGCGAACGGGGAGCTGTTTTTTGGAGAA	CASSPSGGANGELFF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	6	0	7	3	4	25	37	50	40	54													Vb 3	CASSPSGGANGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCTAGCGGGAGGGCCTCGCTACAATGAGCAGTTCTTCGGGCCA	CASSFLAGGPRYNEQFF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	4	0	3	1	5	25	39	52	40	57													Vb 3	CASSFLAGGPRYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCCGAGCGGCAATCAGCCCCAGCATTTTGGTGAT	CASTPSGNQPQHF	In	VDJ	1	25	2.275747810730606E-4	2.7475848728967237E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	7	6	6	2	5	0	25	35	-1	40	44						01,02							Vb 3	CASTPSGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTATGCCAGGGTGGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	26	2.3667777231598303E-4		44	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	3	5	5	3	25	39	49	44	52													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCTCCCGGCTGCCCTCCTACGAGCAGTACTTCGGGCCG	CASTSRLPSYEQYF	In	VDJ	1	27	2.4578076355890547E-4	2.9673916627284615E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	7	9	0	0	6	4	25	35	44	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASTSRLPSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAAGCAGGACCGACCCAAAACCGGGGAGCTGTTTTTTGGAGAA	CAKQDRPKTGELFF	In	VDJ	1	28	2.548837548018279E-4	3.0772950576443307E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-02	01	10	1	7	5	4	9	25	32	40	36	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CAKQDRPKTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01		TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCCACAGGGGTATTCACAGAATTCACCCCTCCACTTTGGGAAC	CASTPQGYSQNSPLHF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	7	3	2	7	4	9	25	35	46	39	55													Vb 3	CASTPQGYSQNSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCTGTGGGACAAGCTTTGAATACGCAGTATTTTGGCCCA	CASSPVGQALNTQYF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	6	7	6	8	25	36	48	42	56													Vb 3	CASSPVGQALNTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTCCGCTCCTACGAGCAGTACTTCGGGCCG	CASSLRSYEQYF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	4	10	0	0	3	25	-1	39	37	42						01,02							Vb 3	CASSLRSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCATCTTCCGGGGGCGCGGGAGCAGTACTTCGGGCCG	CASHLPGAREQYF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	8	6	0	7	8	4	25	34	48	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASHLPGAREQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGGGACTAGCGGGAGGTCCCGCAATGAGCAGTTCTTCGGGCCA	CASGTSGRSRNEQFF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	0	1	6	0	5	25	-1	49	34	54													Vb 3	CASGTSGRSRNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCTAGGGGACAGGTTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	30	2.730897372876727E-4		43	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	0	4	4	5	1	25	35	48	40	49													Vb 3	X+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAGAGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSRDSNQPQHF	In	VDJ	1	30	2.730897372876727E-4	3.2971018474760685E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	11	2	0	1	1	25	37	41	38	42													Vb 3	CASSRDSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGGGACTAGCGGGAGTGAGGAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	30	2.730897372876727E-4		56	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	1	2	0	0	7	25	-1	55	42	62													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGGACAGAAATCAAAGAGACCCAGTACTTCGGGCCA	CARTEIKETQYF	In	VDJ	1	30	2.730897372876727E-4	3.2971018474760685E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	9	2	5	3	0	6	25	-1	38	33	44													Vb 3	CARTEIKETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCAGACATCTATGTACCTCTGTGCCAGCATCCCCCGGGGCCGTAAAAAGGGACAGGGGAGCCAAGAGACCCAGTACTTCGGGCCA	CASIPRGRKKGQGSQETQYF	In	VDJ	1	31	2.8219272853059513E-4	3.4070052423919376E-4	60	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	0	2	1	19	2	21	31	60	50	62													Vb 3	CASIPRGRKKGQGSQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCTGGACAGGCAACCGTTTATGGACCCCTCCACTTTGGGAAC	CASSPGQATVYGPLHF	In	VDJ	1	31	2.8219272853059513E-4	3.4070052423919376E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	4	12	3	13	25	37	47	40	60													Vb 3	CASSPGQATVYGPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGGGGCAGATACGCAGTATTTTGGCCCA	CASSFGADTQYF	In	VDJ	1	31	2.8219272853059513E-4	3.4070052423919376E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	8	3	4	0	0	25	-1	-1	39	44													Vb 3	CASSFGADTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGCGGTTCCTACGAGCAGTACTTCGGGCCG	CASSGGSYEQYF	In	VDJ	1	32	2.912957197735176E-4	3.516908637307806E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	7	5	1	1	1	25	37	42	38	43						01,02							Vb 3	CASSGGSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGCCGGGACAGGGGGCCGAGACCCAGTACTTCGGGCCA	CASSSPGQGAETQYF	In	VDJ	1	32	2.912957197735176E-4	3.516908637307806E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	0	5	4	1	25	38	54	42	55													Vb 3	CASSSPGQGAETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGGGACAAGACTAGCGGGAGGGCCGCCAAAAACATTCAGTACTTCGGCGCC	CASSWDKTSGRAAKNIQYF	In	VDJ	1	33	3.0039871101644E-4	3.6268120322236754E-4	57	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	4	2	0	1	7	2	24	37	58	44	60													Vb 3	CASSWDKTSGRAAKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAACAATAGAAGGTATGCCAGATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	34	3.0950170225936243E-4		46	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-06	01	7	3	6	8	0	16	25	-1	38	35	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01		TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCGGCTAGCGGGGGGTGATGAGCAGTTCTTCGGGCCA	CASSFRLAGGDEQFF	In	VDJ	1	34	3.0950170225936243E-4	3.7367154271395446E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	4	1	8	4	2	25	39	54	43	56													Vb 3	CASSFRLAGGDEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGCCCCGGGACAAAGGGGAACCGGGGAGCTGTTTTTTGGAGAA	CASSAPGQRGTGELFF	In	VDJ	1	35	3.1860469350228484E-4	3.846618822055413E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	6	5	5	7	25	37	48	42	55													Vb 3	CASSAPGQRGTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGCCCTAATGAAAAACTGTTTTTTGGCAGT	CASSRPNEKLFF	In	VDJ	1	37	3.368106759881297E-4	4.066425611887151E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-04	01	5	10	0	3	1	1	25	37	40	38	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSRPNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01		TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTATCCCACCTAGGACAGGGGCGCCACAATGAGCAGTTCTTCGGGCCA	CASSLSHLGQGRHNEQFF	In	VDJ	1	37	3.368106759881297E-4	4.066425611887151E-4	54	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	1	2	5	8	4	25	41	58	49	62													Vb 3	CASSLSHLGQGRHNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCGATCGGGGGCTGAGCACTGAAGCTTTCTTTGGACAA	CASSDRGLSTEAFF	In	VDJ	1	39	3.5501665847397456E-4	4.2862324017188893E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	6	6	0	4	5	4	25	36	47	41	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSDRGLSTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCAGCGGGAGGGCCATACAGATACGCAGTATTTTGGCCCA	CASSQREGHTDTQYF	In	VDJ	1	42	3.823256322027418E-4	4.615942586466496E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	6	0	3	1	4	25	37	48	38	52													Vb 3	CASSQREGHTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGGATTACAGGGGTCGAACACTGAAGCTTTCTTTGGACAA	CASGLQGSNTEAFF	In	VDJ	1	42	3.823256322027418E-4	4.615942586466496E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	3	2	1	5	2	25	34	46	39	48													Vb 3	CASGLQGSNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCCCGGACTAGCGGTCACCGGGGAGCTGTTTTTTGGAGAA	CASTPGLAVTGELFF	In	VDJ	1	46	4.187375971744315E-4	5.055556166129972E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	1	5	4	5	1	25	35	50	40	51						01,02							Vb 3	CASTPGLAVTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCTCGAAACAGGCTACACCTTCGGTTCG	CASSPLETGYTF	In	VDJ	1	46	4.187375971744315E-4	5.055556166129972E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	6	8	9	0	25	37	-1	46	49													Vb 3	CASSPLETGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACTATCATACGAGCAGTACTTCGGGCCG	CASSLLSYEQYF	In	VDJ	1	47	4.2784058841735393E-4	5.16545956104584E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	4	9	4	0	3	25	-1	43	40	46						01,02							Vb 3	CASSLLSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGCCCGAGAGGGTGCACAATGAGCAGTTCTTCGGGCCA	CASSLPERVHNEQFF	In	VDJ	1	48	4.3694357966027634E-4	5.275362955961709E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	11	0	5	6	3	25	39	50	45	53													Vb 3	CASSLPERVHNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCATTGGGACAGGGGAAGCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	50	4.551495621461212E-4		47	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	2	1	4	3	25	36	50	40	53													Vb 3	X+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACTACCCGGACAGCGTATGGCTACACCTTCGGTTCG	CASSTTRTAYGYTF	In	VDJ	1	51	4.6425255338904364E-4	5.605073140709316E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	5	5	7	2	25	37	50	44	52													Vb 3	CASSTTRTAYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCTCTTTCGGTAACAATCAGCCCCAGCATTTTGGTGAT	CASSPSFGNNQPQHF	In	VDJ	1	58	5.279734920895006E-4	6.3743969051204E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	8	5	3	8	3	25	37	48	45	51						01,02							Vb 3	CASSPSFGNNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGCAGCTCGATGAACACCATATATTTTGGAGAG	CASSLGSSMNTIYF	In	VDJ	1	58	5.279734920895006E-4	6.3743969051204E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	8	0	7	0	9	25	-1	43	39	52													Vb 3	CASSLGSSMNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCGAACTCCAGGGGGCTTAACACCATATATTTTGGAGAG	CASSPNSRGLNTIYF	In	VDJ	2	67	6.099004132758024E-4	7.36352745936322E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	4	0	7	8	2	25	37	53	45	55													Vb 3	CASSPNSRGLNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAAATCAACAGGGTGAGTTCCTACGAGCAGTACTTCGGGCCG	CASKINRVSSYEQYF	In	VDJ	2	69	6.281063957616473E-4	7.583334249194958E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	3	3	1	6	5	25	35	47	41	52													Vb 3	CASKINRVSSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGGGGGACAGGTGGGCATCCAACTATGGCTACACCTTCGGTTCG	CASSSGDRWASNYGYTF	In	VDJ	2	69	6.281063957616473E-4	7.583334249194958E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	4	2	3	9	25	38	49	41	58													Vb 3	CASSSGDRWASNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGCTGAGGGTAGCGGAAGGGGAGAGACCCAGTACTTCGGGCCA	CASSFAEGSGRGETQYF	In	VDJ	2	70	6.372093870045697E-4	7.693237644110826E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	5	5	4	9	6	25	39	54	48	60						01,02							Vb 3	CASSFAEGSGRGETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGTGGTTACAGGGGAACTAATGAAAAACTGTTTTTTGGCAGT	CASGYRGTNEKLFF	In	VDJ	2	75	6.827243432191818E-4	8.242754618690172E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	9	3	2	1	5	0	25	33	-1	38	45													Vb 3	CASGYRGTNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGAGGGCAGGTCTCACAGATACGCAGTATTTTGGCCCA	CASRRAGLTDTQYF	In	VDJ	2	79	7.191363081908715E-4	8.682368198353647E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	11	0	2	0	7	25	-1	41	36	48													Vb 3	CASRRAGLTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGCCTAGCGGGGGTTATAGATACGCAGTATTTTGGCCCA	CASSLGLAGVIDTQYF	In	VDJ	2	81	7.373422906767164E-4	8.902174988185385E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	4	2	5	3	4	25	40	53	43	57													Vb 3	CASSLGLAGVIDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATATGCAGTGAACACTGAAGCTTTCTTTGGACAA	CASSLYAVNTEAFF	In	VDJ	2	81	7.373422906767164E-4	8.902174988185385E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	5	0	3	0	25	41	-1	44	47													Vb 3	CASSLYAVNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGACCGGGACACCCTTCAAGAGACCCAGTACTTCGGGCCA	CASSDRDTLQETQYF	In	VDJ	2	84	7.646512644054836E-4	9.231885172932991E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	6	2	4	5	25	37	47	41	52													Vb 3	CASSDRDTLQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCAGACAGGGAGATCCTCTGGAAACACCATATATTTTGGAGAG	CASSFQTGRSSGNTIYF	In	VDJ	2	87	7.919602381342509E-4	9.561595357680598E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	2	3	0	3	5	25	39	49	42	54													Vb 3	CASSFQTGRSSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCAGGGCGACTATGGCTACACCTTCGGTTCG	CASSSQGDYGYTF	In	VDJ	2	95	8.647841680776303E-4	0.001044082251700755	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	3	3	2	2	25	38	45	40	47													Vb 3	CASSSQGDYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTTTCCCTTTGAGTAGCGGGGAGCTGTTTTTTGGAGAA	CASSSFPLSSGELFF	In	VDJ	2	105	9.558140805068546E-4	0.001153985646616624	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	5	8	7	13	0	25	38	-1	51	54						01,02							Vb 3	CASSSFPLSSGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGCCACCGGGCCCTACTTGAGCAGTACTTCGGGCCG		Out	VDJ	3	120	0.0010923589491506909		38	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	8	8	0	7	6	7	25	34	44	40	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACCGGAGTATAGGACTAGCGGATCCTACGAGCAGTACTTCGGGCCG	CASRPEYRTSGSYEQYF	In	VDJ	3	133	0.0012106978353086824	0.0014617151523810571	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	1	5	1	11	1	25	36	57	47	58						01,02							Vb 3	CASRPEYRTSGSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACGGGGGGCGCAGACTGAAGCTTTCTTTGGACAA	CASSLRGAQTEAFF	In	VDJ	3	141	0.0012835217652520617	0.0015496378683137523	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	1	5	0	5	25	-1	47	40	52													Vb 3	CASSLRGAQTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAATCGGGGCGGGGAAACTAATGAAAAACTGTTTTTTGGCAGT	CASNRGGETNEKLFF	In	VDJ	4	158	0.001438272616381743	0.0017364736396707295	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	7	7	3	1	6	1	25	35	47	41	48													Vb 3	CASNRGGETNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTACACTAGTCGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFTLVGNTGELFF	In	VDJ	4	170	0.0015475085112968121	0.0018683577135697722	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	3	8	2	3	5	25	39	47	42	52						01,02							Vb 3	CASSFTLVGNTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGTCCGGACTAGGAGGCGAGACCCAGTACTTCGGGCCA		Out	VDJ	4	172	0.001565714493782657		43	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	1	8	5	4	5	25	37	48	41	53						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGGCTTAGCGGGGGGGCCCATGAGCAGTTCTTCGGGCCA	CASSLWLSGGAHEQFF	In	VDJ	5	222	0.0020208640559287784	0.0024398553671322906	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	0	8	3	3	25	42	56	45	59													Vb 3	CASSLWLSGGAHEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCCTGCTTCTGGGCGAGTCCTACGAGCAGTACTTCGGGCCG	CASSPLLLGESYEQYF	In	VDJ	6	266	0.002421395670617365	0.0029234303047621143	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	8	0	1	12	3	25	36	52	48	55													Vb 3	CASSPLLLGESYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGTCGCAGGGGCCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	6	276	0.0025124255830465893		44	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	2	0	4	1	25	39	49	43	50													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCAGGACCTTAGCTCCTACGAGCAGTACTTCGGGCCG	CASSFQDLSSYEQYF	In	VDJ	8	327	0.0029766781364356327	0.0035938410137489147	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	3	1	7	0	3	5	25	39	46	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFQDLSSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGACAGGGGGCGGGTAATGAAAAACTGTTTTTTGGCAGT	CASSLGQGAGNEKLFF	In	VDJ	10	440	0.004005316146885866	0.004835749376298234	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	0	4	0	3	25	-1	51	39	54													Vb 3	CASSLGQGAGNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTCTGGGTCAGGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLWVRATNEKLFF	In	VDJ	15	645	0.005871429351684963	0.007088768972073547	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	3	0	8	0	25	37	-1	45	50													Vb 3	CASSLWVRATNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCCTCCGGTTCACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRLRFTNTGELFF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	45	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	8	5	0	3	4	18	30	36	33	40						01,02								CASRLRFTNTGELFF+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGTTTAACTAGCGGGCTCACAGATACGCAGTATTTTGGCCCA	CASLTSGLTDTQYF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	42	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	3	4	2	3	2	18	27	39	30	41						01,02								CASLTSGLTDTQYF+TCRBV12-02+TCRBJ02-03	TCRBV12-02*01	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCACCCCCCAGCGGCCCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CATPQRPSSYNEQFF	In	VDJ	1	34	3.0950170225936243E-4	3.7367154271395446E-4	45	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	12	6	5	0	8	5	18	23	36	31	41						01,02								CATPQRPSSYNEQFF+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGACGTGGGACAGCCGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	51	4.6425255338904364E-4		41	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	5	4	4	3	18	29	40	33	43														X+TCRBV12-02+TCRBJ01-01	TCRBV12-02*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTGTTCAGAAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	12	1.0923589491506909E-4		43	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	5	2	3	2	23	37	43	40	45													Vb 14	X+TCRBV27-01+TCRBJ02-02	TCRBV27-01*01	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCAACCAGACCTCTCTGTACTTCTGTGTAGTTGGCAGGGGATTCTATGAGCAGTTCTTCGGGCCA	CVVGRGFYEQFF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	36	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	13	4	2	8	7	5	23	27	40	34	45													Vb 14	CVVGRGFYEQFF+TCRBV27-01+TCRBJ02-01	TCRBV27-01*01	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCACCTGTGCGGGAGGGGGATCACCCCTCCACTTTGGGAAC	CATCAGGGSPLHF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	39	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	10	7	0	10	5	3	23	30	44	35	47													Vb 14	CATCAGGGSPLHF+TCRBV27-01+TCRBJ01-06	TCRBV27-01*01	TCRBD02-01*02	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGACTCGGCACAGGGGGCAGGCAACTATGGCTACACCTTCGGTTCG	CSDSAQGAGNYGYTF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	3	0	2	7	4	25	32	48	39	52													Vb 4	CSDSAQGAGNYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CTGGCAAGCCACGTTTGGTGGCCCTGAAGACAGCAGCWATATCTCTGCAGCGGGTGGACAGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	16	1.456478598867588E-4		35	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	23	1	5	1	18	0	46	37	-1	55	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATAAGGCGGGGGCCGGGGAGCTGTTTTTTGGAGAA	CSVDKAGAGELFF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	7	2	6	4	0	25	36	-1	40	47													Vb 4	CSVDKAGAGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCGTATGAGTGGGCCAGAGACCCAGTACTTCGGGCCA	CSVRMSGPETQYF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	8	0	4	10	1	25	33	47	43	48													Vb 4	CSVRMSGPETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGCCGGGACATGTTATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	19	1.7295683361552607E-4		38	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	6	8	3	4	25	33	42	36	46													Vb 4	X+TCRBV29-01+TCRBJ01-06	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTGGACAGATTCTGGAAACACCATATATTTTGGAGAG	CSVWTDSGNTIYF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	1	5	1	1	2	25	34	41	35	43													Vb 4	CSVWTDSGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATAGGCTCAGCTACGAGCAGTACTTCGGGCCG	CSVEDRLSYEQYF	In	VDJ	1	25	2.275747810730606E-4	2.7475848728967237E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-07	01	0	4	5	3	6	0	25	39	-1	45	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEDRLSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGACGCAGGTGGGGACAGGGGCGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	26	2.3667777231598303E-4		46	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	0	2	5	10	3	25	32	52	42	55													Vb 4	X+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCGGGCCGGGAGGGCGCCGACACCGGGGAGCTGTTTTTTGGAGAA	CSVAGREGADTGELFF	In	VDJ	1	26	2.3667777231598303E-4	2.857488267812593E-4	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	8	0	3	5	5	25	35	48	40	53													Vb 4	CSVAGREGADTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGAGCAGGGGAGCACTGAAGCTTTCTTTGGACAA	CSVEQGSTEAFF	In	VDJ	1	27	2.4578076355890547E-4	2.9673916627284615E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	2	4	4	2	25	33	43	37	45													Vb 4	CSVEQGSTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAGCCCAGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	28	2.548837548018279E-4		37	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	5	3	3	0	25	39	-1	42	45													Vb 4	X+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATGTGGGGCAGGGACGTGGCTACACCTTCGGTTCG	CSVDVGQGRGYTF	In	VDJ	1	31	2.8219272853059513E-4	3.4070052423919376E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	3	0	7	7	9	1	25	36	50	45	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVDVGQGRGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTCAACAGGGGGCATCATGAACACTGAAGCTTTTTTTGGACAA	CSVSTGGIMNTEAFF	In	VDJ	1	33	3.0039871101644E-4	3.6268120322236754E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	0	17	3	21	25	34	46	37	67													Vb 4	CSVSTGGIMNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCCACGAGGGACAGGGTCTGGCGCAGATACGCAGTATTTTGGCCCA	CSVPRGTGSGADTQYF	In	VDJ	1	34	3.0950170225936243E-4	3.7367154271395446E-4	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	3	4	7	7	25	33	49	40	56													Vb 4	CSVPRGTGSGADTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCACAGGTCCCGGGGGCCATGCCGGGGAGCTGTTTTTTGGAGAA	CSATGPGGHAGELFF	In	VDJ	1	35	3.1860469350228484E-4	3.846618822055413E-4	45	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-02	01	7	6	0	6	11	4	25	32	49	43	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSATGPGGHAGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01		TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGACAGGGGGGACCTACGAGCAGTACTTCGGGCCG	CSVETGGTYEQYF	In	VDJ	1	35	3.1860469350228484E-4	3.846618822055413E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	1	2	0	2	25	-1	45	36	47													Vb 4	CSVETGGTYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGAAACTAGCGGGAGTGCCAAAAACATTCAGTACTTCGGCGCC	CSVETSGSAKNIQYF	In	VDJ	1	37	3.368106759881297E-4	4.066425611887151E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	2	3	2	1	0	1	25	-1	48	37	49													Vb 4	CSVETSGSAKNIQYF+TCRBV29-01+TCRBJ02-04	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAATTGGACAGGGGCGAGCAGTACTTCGGGCCG	CSVELDRGEQYF	In	VDJ	1	40	3.6411964971689697E-4	4.396135796634758E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	2	6	2	0	25	37	-1	39	48													Vb 4	CSVELDRGEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAAATTCCCGGGACAGAGAACCGGGGAGCTGTTTTTTGGAGAA	CSVKFPGQRTGELFF	In	VDJ	1	41	3.732226409598194E-4	4.506039191550627E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	5	5	8	3	25	34	49	42	52													Vb 4	CSVKFPGQRTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGTCGGGACAGGGCGTGGGAATGAGCAGTTCTTCGGGCCA	CSVGVGTGRGNEQFF	In	VDJ	1	41	3.732226409598194E-4	4.506039191550627E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	3	7	5	6	25	35	49	40	55													Vb 4	CSVGVGTGRGNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCCCGCGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSPRSSYNEQFF	In	VDJ	1	45	4.096346059315091E-4	4.945652771214103E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	7	5	0	2	2	25	31	37	33	39						01,02							Vb 4	CSPRSSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCCAAAGCTCTGGAAACACCATATATTTTGGAGAG	CSVVQSSGNTIYF	In	VDJ	1	51	4.6425255338904364E-4	5.605073140709316E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-03	01	4	4	6	0	2	3	25	35	39	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVVQSSGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01		TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATGTACAGACAGAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	106	9.649170717497769E-4		46	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	2	5	1	6	0	25	39	-1	45	50													Vb 4	X+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAATTTGTCGTAGGGCGGGACGACTACACCTTCGGTTCG	CSVEFVVGRDDYTF	In	VDJ	3	121	0.0011014619403936134	0.0013298310784820144	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	7	3	10	11	3	25	37	54	48	57													Vb 4	CSVEFVVGRDDYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCTCCGGGGAGTTTTTGAACACTGAAGCTTTCTTTGGACAA	CSSGEFLNTEAFF	In	VDJ	5	221	0.0020117610646858556	0.0024288650276407036	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	8	8	3	0	2	6	25	31	38	33	44						01,02							Vb 4	CSSGEFLNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACGGTAGGTACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	17	728	0.006626977624847525		37	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-02	01	3	5	4	5	4	1	25	36	43	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01		TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGTGGACAGGCACAGATACGCAGTATTTTGGCCCA	CSGWTGTDTQYF	In	VDJ	20	838	0.007628306661568992	0.009209904493949818	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	1	5	1	3	0	25	32	-1	35	41													Vb 4	CSGWTGTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAGGGGGGGGGCGAGCAGTACTTCGGGCCG	CASSEGGGEQYF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	36	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	9	0	6	0	2	23	-1	44	37	46													Vb 22	CASSEGGGEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGTGCCACAGGGGGGAACTATGGCTACACCTTCGGTTCG	CASATGGNYGYTF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	3	1	2	4	1	23	31	43	35	44													Vb 22	CASATGGNYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGTCGGAGGGAGCACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVGGSTNTGELFF	In	VDJ	1	20	1.8205982485844849E-4	2.198067898317379E-4	48	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	10	0	0	2	4	23	36	44	38	48													Vb 22	CASSVGGSTNTGELFF+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTTACCAGATGAACACTGAAGCTTTCTTTGGACAA	CASSYQMNTEAFF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	5	0	3	1	23	35	41	38	42													Vb 22	CASSYQMNTEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCGTCCGCGGGAGTAGCGGGGCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVRGSSGASYNEQFF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	54	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	5	3	0	12	1	23	34	54	46	55													Vb 22	CASSVRGSSGASYNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGAATAACGAGCTCTGGAAACACCATATATTTTGGAGAG	CASRITSSGNTIYF	In	VDJ	1	33	3.0039871101644E-4	3.6268120322236754E-4	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	6	11	2	0	6	0	23	34	-1	40	43													Vb 22	CASRITSSGNTIYF+TCRBV02-01+TCRBJ01-03	TCRBV02-01*01	TCRBD02-01*02	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCCGACGGGAGGCTTCTTCCTACGAGCAGTACTTCGGGCCG	CASRREASSYEQYF	In	VDJ	1	41	3.732226409598194E-4	4.506039191550627E-4	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	8	1	1	3	5	23	32	42	35	47													Vb 22	CASRREASSYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGCGACACCGAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSEATPSSGANVLTF	In	VDJ	3	147	0.0013381397127095963	0.0016155799052632736	51	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	2	6	0	0	5	23	-1	44	40	49													Vb 22	CASSEATPSSGANVLTF+TCRBV02-01+TCRBJ02-06	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGACATCTGTGTACTTCTGTGCCAGCAGCCTCCTTTGGGACAGGGGATCGTGTTCTGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	16	1.456478598867588E-4		59	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	2	1	8	10	19	30	48	38	58			01,02											X+TCRBV06-04+TCRBJ02-03	TCRBV06-04	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGAACGGCTCTACAATGAGCAGTTCTTCGGGCCA	CASSERLYNEQFF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	39	TCRBV06	TCRBV06-04					TCRBJ02	TCRBJ02-01	01	3	9	0	3	2	1	28	42	47	44	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSERLYNEQFF+TCRBV06-04+TCRBJ02-01	TCRBV06-04		TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGCAGGGGACGAGCAGTACTTCGGGCCG	CASSAGDEQYF	In	VDJ	1	54	4.915615271178109E-4	5.934783325456923E-4	33	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	2	5	0	0	28	-1	-1	41	47			01,02											CASSAGDEQYF+TCRBV06-04+TCRBJ02-07	TCRBV06-04	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAGAGGCGGGAGGGCCGGACGAGCAGTACTTCGGGCCG	CASSEEAGGPDEQYF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	45	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	7	0	5	6	4	26	38	53	44	57														CASSEEAGGPDEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTCTGCGGGAGAAACAGATACGCAGTATTTTGGCCCA	CASSYSAGETDTQYF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	45	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	7	2	3	1	2	26	43	51	44	53														CASSYSAGETDTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTATATGCCAGGGGCTATGTGGAACACTGAAGCTTTCTTTGGACAA	CASSYMPGAMWNTEAFF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	51	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	1	5	7	26	40	51	45	58														CASSYMPGAMWNTEAFF+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAAACCAAAATTATGGCTACACCTTCGGTTCG	CASSENQNYGYTF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	39	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-02	01	5	2	8	5	0	10	26	-1	40	38	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSENQNYGYTF+TCRBV06-07+TCRBJ01-02	TCRBV06-07*01		TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCGTGGCCCCAGCGGGAGAGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	22	2.0026580734429334E-4		40	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	11	6	2	5	8	3	26	32	48	40	51														X+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTCAGGGATTGAAGCTTTCTTTGGACAA	CASSSGIEAFF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	33	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	3	7	0	2	26	-1	44	39	46														CASSSGIEAFF+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGACGGGACAGGGGGCACTGAAGCTTTCTTTGGACAA	CASSDGTGGTEAFF	In	VDJ	1	25	2.275747810730606E-4	2.7475848728967237E-4	42	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	1	4	3	0	26	38	-1	41	52														CASSDGTGGTEAFF+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGCGGTAGACACTAGCACAGATACGCAGTATTTTGGCCCA	CASSAVDTSTDTQYF	In	VDJ	1	27	2.4578076355890547E-4	2.9673916627284615E-4	45	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-03	01	5	2	6	0	6	2	26	38	48	44	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAVDTSTDTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCCGCCAGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSRQGSGANVLTF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	45	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	4	3	0	4	0	26	37	-1	41	46														CASSRQGSGANVLTF+TCRBV06-07+TCRBJ02-06	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCCGGGGGGCCTATGGACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	31	2.8219272853059513E-4		46	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	8	1	3	1	7	26	37	45	38	52														X+TCRBV06-07+TCRBJ02-02	TCRBV06-07*01	TCRBD02-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCCCCCCCGCGGAAGAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	35	3.1860469350228484E-4		40	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	11	7	5	1	6	3	26	32	42	38	45						01,02								X+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01	TCRBD02-01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACGTCCCTCAGGACAGGCAAGAGACCCAGTACTTCGGGCCA	CASSYVPQDRQETQYF	In	VDJ	1	36	3.2770768474520726E-4	3.9565222169712824E-4	48	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	1	4	2	8	0	26	41	-1	49	56														CASSYVPQDRQETQYF+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGATGGGACTAACGGGAGGCAGACCCAGTACTTCGGGCCA	CASSDGTNGRQTQYF	In	VDJ	1	39	3.5501665847397456E-4	4.2862324017188893E-4	45	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	9	6	3	9	26	38	48	41	57						01,02								CASSDGTNGRQTQYF+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01	TCRBD02-01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCCGCCGATCGGGGGGCGGTGAAAAACTGTTTTTTGGCAGT	CASRRSGGGEKLFF	In	VDJ	1	61	5.552824658182679E-4	6.704107089868006E-4	42	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	8	8	1	7	7	3	26	35	49	42	52														CASRRSGGGEKLFF+TCRBV06-07+TCRBJ01-04	TCRBV06-07*01	TCRBD02-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCAGCCATGTATCGCTGTGCCAGAAGCTTGGTGAAGGGGGAGGTTTGGACAGATACGCAGTATTTTGGCCCA	CARSLVKGEVWTDTQYF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	51	TCRBV07	TCRBV07-07	01				TCRBJ02	TCRBJ02-03	01	3	5	1	3	5	8	19	33	44	38	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CARSLVKGEVWTDTQYF+TCRBV07-07+TCRBJ02-03	TCRBV07-07*01		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTCGCCCCCGGACAGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSSPPDRGNTEAFF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	48	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	2	1	7	0	19	32	-1	39	48														CASSSPPDRGNTEAFF+TCRBV07-07+TCRBJ01-01	TCRBV07-07*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCAACCTAGAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASSQPRSRANVLTF	In	VDJ	1	30	2.730897372876727E-4	3.2971018474760685E-4	45	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	4	8	5	4	5	19	31	39	35	44						01,02								CASSQPRSRANVLTF+TCRBV07-07+TCRBJ02-06	TCRBV07-07*01	TCRBD02-01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTACAGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSLQGSGNTIYF	In	VDJ	1	30	2.730897372876727E-4	3.2971018474760685E-4	42	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	4	3	0	0	0	19	-1	-1	34	39														CASSLQGSGNTIYF+TCRBV07-07+TCRBJ01-03	TCRBV07-07*01	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGGTATAGTCAGGGGGCTGCGCAGTATTTTGGCCCA	CASRYSQGAAQYF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	39	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	0	10	7	2	22	33	48	40	50														CASRYSQGAAQYF+TCRBV07-01+TCRBJ02-03	TCRBV07-01*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTACCCTAGCGGGAGAGGGTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	13	1.1833888615799151E-4		46	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	4	2	4	3	5	22	35	48	38	53														X+TCRBV07-01+TCRBJ02-07	TCRBV07-01*01	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTCGATTAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSSISTGELFF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	39	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	5	8	4	3	0	22	36	-1	39	42						01,02								CASSSISTGELFF+TCRBV07-01+TCRBJ02-02	TCRBV07-01*01	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCAGCCGGGCCGCTTACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	38	3.4591366723105214E-4		53	TCRBV07	TCRBV07-01	01				TCRBJ02	TCRBJ02-06	01	5	8	0	5	4	13	22	34	42	38	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-01+TCRBJ02-06	TCRBV07-01*01		TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGGACTTGGCTGTGTATCTCTGTGCCAGCAGCCATTAAGGGCAGTGACTAGCGGGAGGGCCTTGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	4	186	0.001693156371183571		61	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	2	0	4	13	5	20	32	59	45	64														X+TCRBV07-01+TCRBJ02-03	TCRBV07-01*01	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAGCCACGTTTGGTGGGACTCGCCGTGTATGTCTGTGCCAGCAGCTCTACGGGACAGGTCCCTGGAAACACCATATATTTTGGAGAG	CASSSTGQVPGNTIYF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	48	TCRBV07	TCRBV07-08		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	0	4	2	4	3	33	46	58	50	61			01,02											CASSSTGQVPGNTIYF+TCRBV07-08+TCRBJ01-03	TCRBV07-08	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGCTTGGAATCCTCTACGACAGGGGCGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	19	1.7295683361552607E-4		50	TCRBV07	TCRBV07-08		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	2	2	5	12	1	20	34	54	46	55			01,02											X+TCRBV07-08+TCRBJ02-05	TCRBV07-08	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGATCGGACAGGGCGAACCTACGAGCAGTACTTCGGGCCG	CASSDRTGRTYEQYF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	3	2	2	4	23	37	47	39	51													Vb 12	CASSDRTGRTYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGGGTTTTTAACAGTAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	18	1.6385384237260363E-4		50	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	5	0	9	3	23	38	51	47	54													Vb 12	X+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGAAAGACTGGGTACCGCTTTCTTTGGACAA		Out	VDJ	1	20	1.8205982485844849E-4		37	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	2	10	11	4	7	23	36	44	40	51						01,02							Vb 12	X+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD02-01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAAGCGGCGGGAGGTGGTACAGATACGCAGTATTTTGGCCCA	CASSEAAGGGTDTQYF	In	VDJ	1	30	2.730897372876727E-4	3.2971018474760685E-4	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	7	1	3	4	4	23	37	49	41	53													Vb 12	CASSEAAGGGTDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGCCCGGGAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSESPGNSNQPQHF	In	VDJ	1	41	3.732226409598194E-4	4.506039191550627E-4	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	0	8	3	0	3	1	23	40	48	43	49													Vb 12	CASSESPGNSNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD02-01*02	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTTTAAGGGCCCAAGACTGTGGAAACACCATATATTTTGGAGAG	CASSLRAQDCGNTIYF	In	VDJ	1	42	3.823256322027418E-4	4.615942586466496E-4	48	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-03	01	5	5	3	3	3	10	23	35	42	38	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSLRAQDCGNTIYF+TCRBV10-02+TCRBJ01-03	TCRBV10-02*01		TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCTCCAGGGAACAGCAATCAGCCCCAGCATTTTGGTGAT	CASSESPGNSNQPQHF	In	VDJ	1	43	3.9142862344566427E-4	4.725845981382365E-4	48	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	3	1	2	3	23	40	47	42	50													Vb 12	CASSESPGNSNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCCCCGTGACAGGGGAACCGGGGAGCTGTTTTTTGGAGAA	CASSPRDRGTGELFF	In	VDJ	2	73	6.64518360733337E-4	8.022947828858433E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	2	5	6	1	23	35	49	41	50													Vb 12	CASSPRDRGTGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGAGCCATCTCTGGAAACACCATATATTTTGGAGAG	CAIRAISGNTIYF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	39	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	6	6	7	0	0	3	24	-1	38	35	41						01,02							Vb 12	CAIRAISGNTIYF+TCRBV10-03+TCRBJ01-03	TCRBV10-03*01	TCRBD02-01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCGGCCGGGGGGCTGCTAGGCACTGAAGCTTTCTTTGGACAA	CAAGGLLGTEAFF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	39	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	12	8	1	4	3	8	24	29	39	32	47													Vb 12	CAAGGLLGTEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01	TCRBD02-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGGACAGGGCCGTGGCTACACCTTCGGTTCG		Out	VDJ	1	14	1.2744187740091394E-4		38	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	3	7	0	3	23	-1	45	38	48													Vb 12	X+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCAACCCCGGATAGCGGGGAGGAAGGTGAGCAGTTCTTCGGGCCA	CAISESTPDSGEEGEQFF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	54	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	3	9	9	7	23	40	57	49	64													Vb 12	CAISESTPDSGEEGEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD02-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGAGCGGGAGCAGATAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	22	2.0026580734429334E-4		43	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	6	2	7	0	5	23	-1	46	38	51													Vb 12	X+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGAGACAGGGGGTGACACTGAAGCTTTCTTTGGACAA	CAISETGGDTEAFF	In	VDJ	1	25	2.275747810730606E-4	2.7475848728967237E-4	42	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	1	3	0	2	24	-1	47	39	49													Vb 12	CAISETGGDTEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCCAAAGGGACACCAGCAATCAGCCCCAGCATTTTGGTGAT	CASQRDTSNQPQHF	In	VDJ	1	28	2.548837548018279E-4	3.0772950576443307E-4	42	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	0	6	1	6	2	24	31	43	37	45													Vb 12	CASQRDTSNQPQHF+TCRBV10-03+TCRBJ01-05	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGAGTCCGGACAGACCTACGAGCAGTACTTCGGGCCG	CAISESGQTYEQYF	In	VDJ	1	28	2.548837548018279E-4	3.0772950576443307E-4	42	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	5	2	1	1	24	41	48	42	49													Vb 12	CAISESGQTYEQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGGAGGGACTAGCGGGGGGCTACGAGCAGTACTTCGGGCCG	CAISEEGLAGGYEQYF	In	VDJ	1	28	2.548837548018279E-4	3.0772950576443307E-4	48	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	0	1	3	2	0	23	38	-1	40	55													Vb 12	CAISEEGLAGGYEQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCCCTATCTCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	35	3.1860469350228484E-4		35	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	10	4	9	4	3	3	24	31	37	34	40						01,02							Vb 12	X+TCRBV10-03+TCRBJ02-02	TCRBV10-03*01	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGACAGGCTATGGCTACACCTTCGGTTCG	CAISETGYGYTF	In	VDJ	1	35	3.1860469350228484E-4	3.846618822055413E-4	36	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	4	4	0	0	23	-1	-1	38	43													Vb 12	CAISETGYGYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGGGGACCGATTTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CAISESGTDFSGANVLTF	In	VDJ	1	42	3.823256322027418E-4	4.615942586466496E-4	54	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-06	01	0	0	7	0	1	6	23	40	46	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESGTDFSGANVLTF+TCRBV10-03+TCRBJ02-06	TCRBV10-03*01		TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGCGGGAGAACAGATACGCAGTATTTTGGCCCA	CASSSGRTDTQYF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	7	2	3	0	1	27	-1	47	40	48			01,02										Vb 17	CASSSGRTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGCCTAGCGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSIGLAGSYNEQFF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	4	3	1	2	0	27	43	-1	45	54			01,02										Vb 17	CASSIGLAGSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGAAGCTTCCGATACGCAGTATTTTGGCCCA	CASEASDTQYF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	33	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	6	7	6	2	4	27	36	41	38	45			01,02			01,02							Vb 17	CASEASDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCGGGACAGTCTTCAAGAGACCCAGTACTTCGGGCCA	CASRDSLQETQYF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	9	0	5	2	2	4	27	35	44	37	48			01,02										Vb 17	CASRDSLQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCGCCGGGACAGAATATCAGCCCCAGCATTTTGGTGAT	CASAGTEYQPQHF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	9	0	5	5	4	3	27	35	46	39	49			01,02										Vb 17	CASAGTEYQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCAGGCCGGGGAGACCCAGTACTTCGGGCCA	CASRQAGETQYF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	6	4	4	5	1	5	27	38	43	39	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRQAGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACTCCGGGACAGTCGAATGGCTACACCTTCGGTTCG	CASSTPGQSNGYTF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	5	6	4	4	27	40	51	44	55			01,02										Vb 17	CASSTPGQSNGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTCCCAGGGCACACCGGGGAGCTGTTTTTTGGAGAA	CASSIVPGHTGELFF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	4	3	3	3	1	27	43	51	46	52			01,02										Vb 17	CASSIVPGHTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTTCTTCACCACCGGGTCAAATCAGCCCCAGCATTTTGGTGAT	CASSIFFTTGSNQPQHF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	8	4	4	12	3	27	41	57	53	60			01,02			01,02							Vb 17	CASSIFFTTGSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAACAGGGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	17	1.5475085112968121E-4		34	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	3	2	3	0	0	27	-1	-1	37	44			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCGCAGACAGGTTTGGGCGAAAAACTGTTTTTTGGCAGT	CASSAQTGLGEKLFF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	4	8	5	7	27	39	50	44	57			01,02										Vb 17	CASSAQTGLGEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGGGATCAGGATAGGCGAGACCCAGTACTTCGGGCCA	CASSGIRIGETQYF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	8	3	5	0	11	27	-1	43	38	54			01,02										Vb 17	CASSGIRIGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*02	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAACGAAGAACACTGAAGCTTTCTTTGGACAA	CASSITKNTEAFF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	2	2	8	1	2	1	27	42	46	44	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSITKNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGACACTAGAAACTATGGCTACACCTTCGGTTCG	CASSIDTRNYGYTF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	3	8	2	4	1	27	41	50	45	51			01,02			01,02							Vb 17	CASSIDTRNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCAGGGGGCGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	20	1.8205982485844849E-4		38	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	0	3	1	1	27	38	47	39	48			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAAGGGGTTCAGCCCCAGCATTTTGGTGAT	CASSIEGVQPQHF	In	VDJ	1	20	1.8205982485844849E-4	2.198067898317379E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	5	2	6	0	1	27	-1	49	44	50			01,02										Vb 17	CASSIEGVQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCGGTCCACTTCCATGAACACTGAAGCTTTCTTTGGACAA	CASRSTSMNTEAFF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	9	3	10	0	7	4	27	35	45	42	49			01,02			01,02							Vb 17	CASRSTSMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGCCAGGGAGGGGGAACCTACGAGCAGTACTTCGGGCCG	CASSSQGGGTYEQYF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	9	0	2	4	4	27	40	51	44	55			01,02										Vb 17	CASSSQGGGTYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCATGGGACGGATATTCACCCCTCCACTTTGGGAAC	CASSIAWDGYSPLHF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-06	01	1	0	7	8	3	4	27	43	51	46	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIAWDGYSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01		TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCTTCGGATAAGCTTTCTTTGGACAA		Out	VDJ	1	22	2.0026580734429334E-4		34	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	1	8	9	5	1	27	41	49	46	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAACTCACTTACTAGCGGGAGGCAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	24	2.1847178983013817E-4		56	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	3	1	0	8	2	25	38	58	46	60			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGACAGAGAACTATGGCTACACCTTCGGTTCG	CASSMGTENYGYTF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	5	2	1	2	27	41	49	42	51			01,02										Vb 17	CASSMGTENYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GCTTTCTATCTCTGTGCCAGTAGTATATGGACGTCATTGGGGCAGGTCCCGCATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	24	2.1847178983013817E-4		61	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	7	0	0	11	10	12	27	43	38	53			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGACCGTGATGGGGACCAAAAACATTCAGTACTTCGGCGCC	CASSTTVMGTKNIQYF	In	VDJ	1	25	2.275747810730606E-4	2.7475848728967237E-4	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-04	01	4	0	8	2	11	0	27	40	-1	51	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTTVMGTKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01		TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGACTAGCGGGACAGCAGTACTTCGGGCCG	CASSIGLAGQQYF	In	VDJ	1	25	2.275747810730606E-4	2.7475848728967237E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	2	3	8	0	1	27	-1	54	43	55			01,02										Vb 17	CASSIGLAGQQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACACAACTAGCGGGAGATTTTGGAGAGACCCAGTACTTCGGGCCA	CATQLAGDFGETQYF	In	VDJ	1	27	2.4578076355890547E-4	2.9673916627284615E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	10	3	2	4	4	7	27	34	49	38	56			01,02										Vb 17	CATQLAGDFGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*02	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAAATCATCGGGGGCGGTAATCAGCCCCAGCATTTTGGTGAT	CASKIIGGGNQPQHF	In	VDJ	1	27	2.4578076355890547E-4	2.9673916627284615E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	7	6	0	4	8	3	27	37	51	45	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASKIIGGGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAGGGGCCCCAAAACATTCAGTACTTCGGCGCC	CASSIEGPQNIQYF	In	VDJ	1	27	2.4578076355890547E-4	2.9673916627284615E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	7	0	5	0	3	27	-1	49	44	52			01,02										Vb 17	CASSIEGPQNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGATGGGGGTAGGGAGAGACACTGAAGCTTTCTTTGGACAA	CASSPMGVGRDTEAFF	In	VDJ	1	28	2.548837548018279E-4	3.0772950576443307E-4	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	6	1	3	5	9	27	39	49	44	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPMGVGRDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGACAGGGGGCCGGAACTGAAGCTTTCTTTGGACAA	CASSRQGAGTEAFF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	0	5	0	4	27	-1	50	40	54			01,02										Vb 17	CASSRQGAGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGAGGGATTGCAGCCCCAGCATTTTGGTGAT	CASSIEGLQPQHF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	11	0	7	1	4	27	41	47	42	51			01,02										Vb 17	CASSIEGLQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCTAGGGGACGTGAACACTGAAGCTTTCTTTGGACAA	CASSTLGDVNTEAFF	In	VDJ	1	30	2.730897372876727E-4	3.2971018474760685E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	4	0	7	0	6	1	27	40	51	46	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTLGDVNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGTCTAGCAGATACGCAGTATTTTGGCCCA	CASSIGLADTQYF	In	VDJ	1	30	2.730897372876727E-4	3.2971018474760685E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	4	8	4	2	0	27	43	-1	45	49			01,02			01,02							Vb 17	CASSIGLADTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGCCTAGCGGGAGTGGGGATACGCAGTATTTTGGCCCA	CASSMPSGSGDTQYF	In	VDJ	1	30	2.730897372876727E-4	3.2971018474760685E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	4	2	6	2	4	27	41	53	43	57			01,02										Vb 17	CASSMPSGSGDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCAATCTGGGGATCCAGATTACTTATGGCTACACCTTCGGTTCG	CASNLGIQITYGYTF	In	VDJ	1	31	2.8219272853059513E-4	3.4070052423919376E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	9	0	8	5	7	11	27	35	46	42	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASNLGIQITYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACCCCTCGCATCCGGGGAGCTGTTTTTTGGAGAA	CASRPLASGELFF	In	VDJ	1	32	2.912957197735176E-4	3.516908637307806E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	6	3	7	6	0	9	27	-1	40	38	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRPLASGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGGGCCCCAGATACGCAGTATTTTGGCCCA	CASSMRAPDTQYF	In	VDJ	1	32	2.912957197735176E-4	3.516908637307806E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	11	0	4	0	3	27	-1	46	41	49			01,02										Vb 17	CASSMRAPDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGGGACTAGCTGATACGCAGTATTTTGGCCCA	CASSTGLADTQYF	In	VDJ	1	33	3.0039871101644E-4	3.6268120322236754E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	7	6	1	1	27	40	50	41	51			01,02			01,02							Vb 17	CASSTGLADTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCACCCTGGGGGGACCCCGCGTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASTLGGPRVSNQPQHF	In	VDJ	1	34	3.0950170225936243E-4	3.7367154271395446E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	9	9	1	0	6	9	27	35	47	41	56			01,02										Vb 17	CASTLGGPRVSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACAAGCAGGCTACTATGGCTACACCTTCGGTTCG	CASRQAGYYGYTF	In	VDJ	1	34	3.0950170225936243E-4	3.7367154271395446E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	4	3	5	2	27	38	47	43	49			01,02										Vb 17	CASRQAGYYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGCTAGCGGGGACCACCGGGGAGCTGTTTTTTGGAGAA	CASSRLAGTTGELFF	In	VDJ	1	34	3.0950170225936243E-4	3.7367154271395446E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	4	3	4	2	2	27	40	51	42	53			01,02										Vb 17	CASSRLAGTTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCGCGGGGGCCTGGAAACACCATATATTTTGGAGAG	CASSSRGPGNTIYF	In	VDJ	1	34	3.0950170225936243E-4	3.7367154271395446E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	5	7	2	2	2	1	27	39	48	41	49			01,02										Vb 17	CASSSRGPGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD02-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCAGGGGTTTGGACAGGAGATCTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	35	3.1860469350228484E-4		52	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	4	4	10	6	27	41	58	51	64			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGCCTATGGCTACACCTTCGGTTCG	CASSIAYGYTF	In	VDJ	1	36	3.2770768474520726E-4	3.9565222169712824E-4	33	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	3	10	0	4	1	0	27	41	-1	42	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIAYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATACCCTAGCGGGAGGTCGTGGAGATACGCAGTATTTTGGCCCA	CASNTLAGGRGDTQYF	In	VDJ	1	37	3.368106759881297E-4	4.066425611887151E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	4	1	5	5	6	27	37	53	42	59			01,02										Vb 17	CASNTLAGGRGDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGAAGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSIEDSNQPQHF	In	VDJ	1	37	3.368106759881297E-4	4.066425611887151E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	3	2	8	0	1	3	27	41	44	42	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIEDSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGGCCAGACCCCGGGGAGCTGTTTTTTGGAGAA	CASSRPDPGELFF	In	VDJ	1	37	3.368106759881297E-4	4.066425611887151E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	5	2	7	6	6	1	27	39	48	45	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSRPDPGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGAGGACAGGGGGGCCTATAATTCACCCCTCCACTTTGGGAAC	CASREDRGAYNSPLHF	In	VDJ	1	39	3.5501665847397456E-4	4.2862324017188893E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	1	1	2	3	1	27	38	51	41	52			01,02										Vb 17	CASREDRGAYNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATGACGGGGCTAACACCGGGGAGCTGTTTTTTGGAGAA	CASNDGANTGELFF	In	VDJ	1	40	3.6411964971689697E-4	4.396135796634758E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	7	7	0	2	5	1	27	37	47	42	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASNDGANTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TATCTCTGTGCCAGTAGTATAGACGTCAGGGGCCAACGTCGAAACCTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	40	3.6411964971689697E-4		64	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	2	0	3	16	6	23	32	26	48			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGTTCCAGGGTTCTAATGAAAAACTGTTTTTTGGCAGT	CASSMFQGSNEKLFF	In	VDJ	1	41	3.732226409598194E-4	4.506039191550627E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	3	3	4	2	27	41	50	45	52			01,02										Vb 17	CASSMFQGSNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCGGACTTTACGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSGLYGANVLTF	In	VDJ	1	41	3.732226409598194E-4	4.506039191550627E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	1	10	4	3	4	27	39	47	42	51			01,02			01,02							Vb 17	CASSSGLYGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD02-01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACGCCTAGCGGGAGGGCCGGGATCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	42	3.823256322027418E-4		55	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	4	0	2	3	7	26	41	56	44	63			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*02	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGCGGACAGGCCCAAATCAGCCCCAGCATTTTGGTGAT	CASSRRTGPNQPQHF	In	VDJ	1	43	3.9142862344566427E-4	4.725845981382365E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	4	4	3	4	27	40	50	43	54			01,02										Vb 17	CASSRRTGPNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAACGCACTAGGGGGTCCGGTCGATACGCAGTATTTTGGCCCA	CASSNALGGPVDTQYF	In	VDJ	1	44	4.005316146885867E-4	4.835749376298234E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	5	1	6	7	7	27	40	53	47	60			01,02										Vb 17	CASSNALGGPVDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGAGGGACAGGGGAACTATGGCTACACCTTCGGTTCG	CASSEGQGNYGYTF	In	VDJ	1	44	4.005316146885867E-4	4.835749376298234E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	2	2	2	0	27	39	-1	41	51			01,02										Vb 17	CASSEGQGNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGTTCGTCACCGGGGAGCTGTTTTTTGGAGAA	CASRFVTGELFF	In	VDJ	1	45	4.096346059315091E-4	4.945652771214103E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	8	6	4	3	1	27	38	43	41	44			01,02			01,02							Vb 17	CASRFVTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCAGGGCCGCTGAAGCTTTCTTTGGACAA	CASSTRAAEAFF	In	VDJ	1	45	4.096346059315091E-4	4.945652771214103E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	3	6	1	3	27	40	46	41	49			01,02										Vb 17	CASSTRAAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGGACAGCTTTATGAAAAACTGTTTTTTGGCAGT	CASSIGGQLYEKLFF	In	VDJ	1	45	4.096346059315091E-4	4.945652771214103E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	0	5	6	1	4	27	43	51	44	55			01,02										Vb 17	CASSIGGQLYEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCGACATCTTACAATGAGCAGTTCTTCGGGCCA	CASSSTSYNEQFF	In	VDJ	1	45	4.096346059315091E-4	4.945652771214103E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	6	4	2	3	27	39	45	41	48			01,02										Vb 17	CASSSTSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGTCTTCTCCCGGACAATCGGTGGCTACACCTTCGGTTCG	CASVFSRTIGGYTF	In	VDJ	1	47	4.2784058841735393E-4	5.16545956104584E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	1	6	7	10	5	27	36	51	46	56			01,02										Vb 17	CASVFSRTIGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGCGGAGGACAGGCTGAAGCTTTCTTTGGACAA	CASSSGGQAEAFF	In	VDJ	1	49	4.460465709031988E-4	5.385266350877579E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	4	6	5	0	27	40	-1	45	52			01,02										Vb 17	CASSSGGQAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCGGACAGGGTCGGCGAAATTCACCCCTCCACTTTGGGAAC	CASSTGQGRRNSPLHF	In	VDJ	1	52	4.7335554463196606E-4	5.714976535625186E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	1	3	7	2	7	27	40	50	42	57			01,02										Vb 17	CASSTGQGRRNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGAATCCCGGGGGGTACAATGAGCAGTTCTTCGGGCCA	CASRNPGGYNEQFF	In	VDJ	1	54	4.915615271178109E-4	5.934783325456923E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	1	4	6	0	27	38	-1	44	51			01,02										Vb 17	CASRNPGGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGGGACTAGCGGGAGGAAAGGAACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	55	5.006645183607333E-4		53	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	0	1	3	1	6	27	40	56	41	62			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTTTTGGGGATCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSIFWGSGANVLTF	In	VDJ	1	55	5.006645183607333E-4	6.044686720372793E-4	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-06	01	3	0	8	1	6	0	27	41	-1	47	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIFWGSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01		TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCTACAGGGAGGGCCCTGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSSTGRALGTGELFF	In	VDJ	1	57	5.188705008465782E-4	6.26449351020453E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	9	0	4	6	7	27	39	52	45	59			01,02										Vb 17	CASSSTGRALGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGCCGGTACCCTACGAGCAGTACTTCGGGCCG	CASSIGPVPYEQYF	In	VDJ	1	62	5.643854570611903E-4	6.814010484783875E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	1	9	0	2	0	6	27	-1	46	43	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGPVPYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGGAATTCACCCCTCCACTTTGGGAAC	CASSIGNSPLHF	In	VDJ	1	64	5.825914395470352E-4	7.033817274615613E-4	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-06	01	3	0	9	7	1	0	27	41	-1	42	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01		TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACCTGAACAGGGCCACCAGCCCCAGCATTTTGGTGAT	CASSIPEQGHQPQHF	In	VDJ	2	66	6.0079742203288E-4	7.253624064447351E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	3	7	5	4	27	42	53	47	57			01,02										Vb 17	CASSIPEQGHQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACTTTCTACGAGCAGTACTTCGGGCCG	CASSTFYEQYF	In	VDJ	2	68	6.190034045187249E-4	7.473430854279089E-4	33	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	4	10	3	0	2	27	-1	42	40	44			01,02			01,02							Vb 17	CASSTFYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACCAGGGGGCGACACCGGGGAGCTGTTTTTTGGAGAA	CASRPGGDTGELFF	In	VDJ	2	70	6.372093870045697E-4	7.693237644110826E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	0	3	2	1	27	38	48	40	49			01,02										Vb 17	CASRPGGDTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGCGGGGACAGCATATTCACCCCTCCACTTTGGGAAC	CASAGTAYSPLHF	In	VDJ	2	70	6.372093870045697E-4	7.693237644110826E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	8	0	5	8	3	3	27	36	46	39	49			01,02										Vb 17	CASAGTAYSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCGGGACGTAAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASTRDVNSNQPQHF	In	VDJ	2	72	6.554153694904145E-4	7.913044433942565E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	7	0	7	0	3	5	27	37	45	40	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTRDVNSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGTGGGCTCTCTGGAAACACCATATATTTTGGAGAG	CASSRGLSGNTIYF	In	VDJ	2	73	6.64518360733337E-4	8.022947828858433E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	8	0	0	3	1	27	39	46	42	47			01,02										Vb 17	CASSRGLSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCAAGACTAGCGAAAACACAGATACGCAGTATTTTGGCCCA	CASSLKTSENTDTQYF	In	VDJ	2	73	6.64518360733337E-4	8.022947828858433E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	2	6	2	5	4	27	39	52	44	56			01,02			01,02							Vb 17	CASSLKTSENTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGCGGCGGGACTCCTCAGTTCTTCGGGCCA	CASSGGGTPQFF	In	VDJ	2	74	6.736213519762595E-4	8.132851223774302E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	13	6	3	27	39	51	45	54			01,02			01,02							Vb 17	CASSGGGTPQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGCGTTTATGAACACTGAAGCTTTCTTTGGACAA	CASSAFMNTEAFF	In	VDJ	2	75	6.827243432191818E-4	8.242754618690172E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	7	6	0	1	4	27	38	42	39	46			01,02			01,02							Vb 17	CASSAFMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTCTCGATCGGACAGGTCGGTGCACCCCTCCACTTTGGGAAC	CASSFSIGQVGAPLHF	In	VDJ	2	75	6.827243432191818E-4	8.242754618690172E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	4	11	9	6	27	39	55	48	61			01,02										Vb 17	CASSFSIGQVGAPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCGCCGGGACAGGGAGCTATGGCTACACCTTCGGTTCG		Out	VDJ	2	76	6.918273344621043E-4		40	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	0	3	4	6	2	27	34	49	40	51			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGGCTGAGGGGGGTTTCACCGGGGAGCTGTTTTTTGGAGAA	CASTAEGGFTGELFF	In	VDJ	2	76	6.918273344621043E-4	8.35265801360604E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	7	5	1	4	6	4	27	37	49	43	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTAEGGFTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTGGACGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVDGSSYNEQFF	In	VDJ	2	77	7.009303257050266E-4	8.462561408521909E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	8	2	0	5	0	27	39	-1	44	50			01,02										Vb 17	CASSVDGSSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCGACAGGGGGCCGGCACTGAAGCTTTCTTTGGACAA	CASSRQGAGTEAFF	In	VDJ	2	86	7.828572468913285E-4	9.45169196276473E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	0	4	2	3	27	38	50	40	53			01,02										Vb 17	CASSRQGAGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCAGTTCGCCTACGAGCAGTACTTCGGGCCG	CASSIQFAYEQYF	In	VDJ	2	87	7.919602381342509E-4	9.561595357680598E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	5	2	1	4	27	41	45	42	49			01,02										Vb 17	CASSIQFAYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGTCGAGGGTCGGGAGTGGTTGGCAATGAGCAGTTCTTCGGGCCA	CASSRRGSGVVGNEQFF	In	VDJ	2	99	9.0119613304932E-4	0.0010880436096671025	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	8	2	6	10	7	27	39	55	49	62			01,02										Vb 17	CASSRRGSGVVGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGCTGACAGCTACTCTGGAAACACCATATATTTTGGAGAG	CASSADSYSGNTIYF	In	VDJ	3	117	0.0010650499754219236	0.0012858697205156667	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	2	5	0	4	3	27	38	47	42	50			01,02										Vb 17	CASSADSYSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTATCGACAGCATTTATGAAAAACTGTTTTTTGGCAGT	CASSIIDSIYEKLFF	In	VDJ	3	123	0.0011196679228794582	0.001351811757465188	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	2	5	6	4	5	27	41	50	45	55			01,02										Vb 17	CASSIIDSIYEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGAGGGAGGGGTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASEGGVSNQPQHF	In	VDJ	4	158	0.001438272616381743	0.0017364736396707295	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	8	9	0	0	2	2	27	36	45	38	47			01,02										Vb 17	CASEGGVSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGGCTACTAGCGGGGACACTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	7	284	0.0025852495129899686		43	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	9	3	3	3	3	3	27	35	48	38	51			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCACAAAGACAGGGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	18	1.6385384237260363E-4		41	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	2	1	4	0	23	33	-1	37	45													Vb 11	X+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGTAAGATTGTGCGGTATGGCTACACCTTCGGTTCG	CASKIVRYGYTF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	36	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	9	7	5	5	9	0	23	31	-1	40	44						01,02							Vb 11	CASKIVRYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD02-01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAACGGGCCTTGCCGAAGCTTTCTTTGGACAA	CASSETGLAEAFF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	39	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-01	01	2	8	0	8	2	6	23	38	44	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSETGLAEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAACGGCCAGGGAGGTGAAAAACTGTTTTTTGGCAGT	CASNGQGGEKLFF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	39	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	7	9	1	7	7	0	23	33	-1	40	46													Vb 11	CASNGQGGEKLFF+TCRBV25-01+TCRBJ01-04	TCRBV25-01*01	TCRBD02-01*02	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGGAAGACTAGCGGACATACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	27	2.4578076355890547E-4		47	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	2	5	3	3	4	23	34	46	37	50						01,02							Vb 11	X+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCACATACCTCTCAGTACCTCTGTGCCGGGATGGGTACAGGGAAAAACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	29	2.639867460447503E-4		40	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	11	3	3	5	9	4	23	29	44	38	48													Vb 11	X+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCACATACCTCTCAGTACCTCTGTGCCACCTTAGACATAATAGCCAAAAACATTCAGTACTTCGGCGCC	CATLDIIAKNIQYF	In	VDJ	1	33	3.0039871101644E-4	3.6268120322236754E-4	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	10	2	6	0	5	4	23	30	39	35	43													Vb 11	CATLDIIAKNIQYF+TCRBV25-01+TCRBJ02-04	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAGGGTCAGGGAGGAACAATGAGCAGTTCTTCGGGCCA	CASSEGSGRNNEQFF	In	VDJ	1	44	4.005316146885867E-4	4.835749376298234E-4	45	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	9	1	5	6	1	23	38	50	44	51													Vb 11	CASSEGSGRNNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAGGGAGCGGGGCAAATTCACCCCTCCACTTTGGGAAC	CASSEGSGANSPLHF	In	VDJ	1	56	5.097675096036558E-4	6.154590115288661E-4	45	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	2	6	3	7	3	2	23	38	48	41	50													Vb 11	CASSEGSGANSPLHF+TCRBV25-01+TCRBJ01-06	TCRBV25-01*01	TCRBD02-01*01	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCACCAACCAGACATCTGTGTATCTCTATGCCAGCTCCCGGACCGTCGAGCAGTACTTCGGGCCG	YASSRTVEQYF	In	VDJ	1	21	1.911628161013709E-4	2.307971293233248E-4	33	TCRBV26	TCRBV26-01	01				TCRBJ02	TCRBJ02-07	01	8	1	7	6	4	3	27	36	44	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									YASSRTVEQYF+TCRBV26-01+TCRBJ02-07	TCRBV26-01*01		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCACCAACCAGACATCTGTGTATCTCTATGCCAGCAGTGGACGGACGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	33	3.0039871101644E-4		49	TCRBV26	TCRBV26-01	01				TCRBJ02	TCRBJ02-06	01	5	1	7	5	0	13	27	-1	43	39	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV26-01+TCRBJ02-06	TCRBV26-01*01		TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCRGCCRTGTATCKCTGTGCCAGCAGCCCCCTTGGAGGGGGGGCAAGAACAGATACGCAGTATTTTGGCCCA	CASSPLGGGARTDTQYF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	51	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	9	0	3	9	5	18	30	46	39	51		TCRBV07-02,TCRBV07-07												CASSPLGGGARTDTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCRGCCRTGTATCKCTGTGCCAGCAGCGCGGCTAGCGGGGGCTCGGCCGGGGAGCTGTTTTTTGGAGAA	CASSAASGGSAGELFF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	48	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	4	2	6	4	5	19	31	45	35	50		TCRBV07-02,TCRBV07-07												CASSAASGGSAGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCACCGACAGGGGGGCTTCCTACGAGCAGTACTTCGGGCCG	CASTDRGASYEQYF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	42	TCRBV05	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	1	1	2	3	19	29	40	31	43		TCRBV05-05,TCRBV05-06,TCRBV05-07												CASTDRGASYEQYF+TCRBV05-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTTTTATACAGCGCCAGGGGAGACCCAGTACTTCGGGCCA	CASSFYTAPGETQYF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	45	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	3	5	12	0	22	35	-1	47	52		TCRBV07-01,TCRBV07-04												CASSFYTAPGETQYF+TCRBV07-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTGACTCCAGGATCTACACCTTCGGTTCG	CASSDSRIYTF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	33	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	4	10	0	2	28	-1	49	45	51		TCRBV06-04,TCRBV06-07												CASSDSRIYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTYRGSYSTRTATTTYTGTGCCAGCAGCCCAAGAACAGCGCTTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	14	1.2744187740091394E-4		50	TCRBV12	unresolved					TCRBJ01	TCRBJ01-02	01	5	3	5	4	6	12	22	34	44	40	56		TCRBV12-01,TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCTTACATCATTCAGGACAGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	14	1.2744187740091394E-4		47	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	5	2	9	0	18	33	-1	42	48		TCRBV07-01,TCRBV07-02												X+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCTCACAATCGCGGACTCCCACAGATATGCAGTATTTTGGCCCA	CASSSQSRTPTDMQYF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	48	TCRBV05	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	1	10	11	9	11	19	32	46	41	57		TCRBV05-05,TCRBV05-06,TCRBV05-07				01,02								CASSSQSRTPTDMQYF+TCRBV05-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTGAACTCTACGAGCAGTACTTCGGGCCG	CASSELYEQYF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	33	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	3	10	3	0	0	28	-1	-1	42	45		TCRBV06-04,TCRBV06-07				01,02								CASSELYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCATCAGGACTAGCGGGGCTAGCACAGATACGCAGTATTTTGGCCCA	CAIRTSGASTDTQYF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	2	3	0	0	2	26	-1	48	37	50		TCRBV06-07,TCRBV06-08												CAIRTSGASTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
SGACTCRGCYRTGTATCKCTGTGCAAGTCGAGTCGGGGCTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	16	1.456478598867588E-4		40	TCRBV07	unresolved					TCRBJ01	TCRBJ01-01	01	12	7	0	0	10	0	19	24	-1	34	39		TCRBV07-05,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCATGGGACAGGGACTCTATGGCTACACCTTCGGTTCG	CASSMGQGLYGYTF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	42	TCRBV05	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	3	4	0	3	19	-1	42	35	45		TCRBV05-05,TCRBV05-06,TCRBV05-07												CASSMGQGLYGYTF+TCRBV05-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGGGGACTYRGCYRTGTATCKCTGTGCCAGCAGCTTGGGACTGAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGLRNTGELFF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	45	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	0	10	1	1	3	22	35	42	36	45		TCRBV07-01,TCRBV07-07				01,02								CASSLGLRNTGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCCCGGGGGGTTCTGGAAACACCATATATTTTGGAGAG	CASSPGGSGNTIYF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	5	8	1	1	1	1	19	31	39	32	40		TCRBV07-05,TCRBV07-07												CASSPGGSGNTIYF+TCRBV07-X+TCRBJ01-03	unresolved	TCRBD02-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGGACTCMGCCRTGTATCKCTGTGCCAGCAGCTTGATTTAGGTGACACATTATCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	20	1.8205982485844849E-4		58	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	2	6	0	9	6	20	34	47	43	53		TCRBV07-07,TCRBV07-08												X+TCRBV07-X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTACTCCGGGACAATAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	20	1.8205982485844849E-4		44	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	0	6	4	1	1	23	40	47	41	48		TCRBV06-04,TCRBV06-08												X+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCTTCAGCGGGGATACAGATACGCAGTATTTTGGCCCA	CASSFSGDTDTQYF	In	VDJ	1	20	1.8205982485844849E-4	2.198067898317379E-4	42	TCRBV05	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	6	3	3	1	2	19	33	41	34	43		TCRBV05-05,TCRBV05-06,TCRBV05-07												CASSFSGDTDTQYF+TCRBV05-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCACCTCCAGGGCGGGTAACAACAATGAGCAGTTCTTCGGGCCA	CATSRAGNNNEQFF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	42	TCRBV06	unresolved					TCRBJ02	TCRBJ02-01	01	10	4	3	5	4	9	23	30	39	34	48		TCRBV06-08,TCRBV06-09		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRAGNNNEQFF+TCRBV06-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAAGGACTAGCGGGGGTTTACGAGCAGTACTTCGGGCCG	CASSEGLAGVYEQYF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	1	2	4	3	2	26	38	54	41	56		TCRBV06-01,TCRBV06-07												CASSEGLAGVYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCCCGACTGCGGTCAATCAGCCCCAGCATTTTGGTGAT	CASSPTAVNQPQHF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	2	10	3	2	5	19	31	37	33	42		TCRBV07-06,TCRBV07-07				01,02								CASSPTAVNQPQHF+TCRBV07-X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGACTCGGCCGGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSDSAGGSTDTQYF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	8	1	0	3	0	28	45	-1	48	55		TCRBV06-04,TCRBV06-08												CASSDSAGGSTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CTCCCTCYCAGACWTCTGTWTACTTCTGTGCCAGCAGGGGAGCATCTGAAGCTTTCTTTGGACAA	CASRGASEAFF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	33	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	9	2	6	0	3	26	-1	42	37	45		TCRBV06-07,TCRBV06-09												CASRGASEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCTGGGAGACAGACCAGAACACTGAAGCTTTCTTTGGACAA	CASSWETDQNTEAFF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	45	TCRBV07	unresolved					TCRBJ01	TCRBJ01-01	01	4	2	5	1	4	4	18	31	40	35	44		TCRBV07-06,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWETDQNTEAFF+TCRBV07-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCAAGGCTAGCGGGGGGGAGTAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	24	2.1847178983013817E-4		53	TCRBV10	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	4	0	3	4	3	23	40	56	44	59		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTCCCGGACAGGCTACGAGCAGTACTTCGGGCCG	CASSSRTGYEQYF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	4	3	2	0	22	36	-1	38	45		TCRBV07-01,TCRBV07-04												CASSSRTGYEQYF+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTCCCCTTACCAAGAGACCCAGTACTTCGGGCCA	CASSSPYQETQYF	In	VDJ	1	26	2.3667777231598303E-4	2.857488267812593E-4	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	4	10	0	3	1	23	36	41	39	42		TCRBV06-05,TCRBV06-06,TCRBV06-08				01,02								CASSSPYQETQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCAGGACTAGCGCGACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSRTSATNTGELFF	In	VDJ	1	30	2.730897372876727E-4	3.2971018474760685E-4	48	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	1	6	0	1	3	19	31	41	32	44		TCRBV07-05,TCRBV07-07				01,02								CASSRTSATNTGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCCGACTAGCGGGGTACAATGAGCAGTTCTTCGGGCCA	CASSRLAGYNEQFF	In	VDJ	1	37	3.368106759881297E-4	4.066425611887151E-4	42	TCRBV11	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	2	3	4	1	0	19	31	-1	32	43		TCRBV11-01,TCRBV11-03												CASSRLAGYNEQFF+TCRBV11-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGGSGACTCRGCTGTGTATCTCTGTGCCAGCAGCAGAATCGATCGAGGGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	38	3.4591366723105214E-4		49	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	11	0	4	10	6	22	34	49	44	55		TCRBV07-04,TCRBV07-05												X+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTGCCAGGTCCGCATCGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	43	3.9142862344566427E-4		56	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	2	6	5	14	5	24	37	55	51	60		TCRBV06-05,TCRBV06-06,TCRBV06-08												X+TCRBV06-X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGGACTCSGCCRTGTATCKCTGTGCCAGCAGCCCGAGCCGCCATGGGCAGGGAAGAGTCACAGATACGCAGTATTTTGGCCCA	CASSPSRHGQGRVTDTQYF	In	VDJ	1	47	4.2784058841735393E-4	5.16545956104584E-4	57	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	3	2	15	6	18	30	50	45	56		TCRBV07-06,TCRBV07-08												CASSPSRHGQGRVTDTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTCAGACTAGCGAAGGTGAGCAGTTCTTCGGGCCA	CASSQTSEGEQFF	In	VDJ	1	48	4.3694357966027634E-4	5.275362955961709E-4	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	6	9	2	4	23	35	45	37	49		TCRBV06-04,TCRBV06-08				01,02								CASSQTSEGEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTCCCTGGAGGGAGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	52	4.7335554463196606E-4		41	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	0	3	4	2	28	40	50	44	52		TCRBV06-04,TCRBV06-08												X+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGGGGACTCRGCYGTGTATCTCTGTGCCAGCAGCGTAACAGGGGTGGAGACCCAGTACTTCGGGCCA	CASSVTGVETQYF	In	VDJ	1	60	5.461794745753454E-4	6.594203694952137E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	2	5	3	2	18	30	40	33	42		TCRBV07-02,TCRBV07-04												CASSVTGVETQYF+TCRBV07-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTCGTTTCGGCAGGCCACCTTGATCAATCAGCCCCAGCATTTTGGTGAT	CASSYSFRQATLINQPQHF	In	VDJ	2	67	6.099004132758024E-4	7.36352745936322E-4	57	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	4	3	7	10	23	40	51	47	61		TCRBV06-07,TCRBV06-08												CASSYSFRQATLINQPQHF+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTGAAGCTATGGGGGATAACACTGAAGCTTTCTTTGGACAA	CASSEAMGDNTEAFF	In	VDJ	2	83	7.555482731625612E-4	9.121981778017123E-4	45	TCRBV06	unresolved					TCRBJ01	TCRBJ01-01	01	3	6	1	2	6	2	28	42	53	48	55		TCRBV06-04,TCRBV06-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEAMGDNTEAFF+TCRBV06-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCTTAGGATAGCGGGAGGCGTCAACAGATACGCAGTATTTTGGCCCA	CASSLG*REASTDTQYF	Stop	VDJ	2	87	7.919602381342509E-4		51	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	5	1	3	2	5	18	34	46	36	51		TCRBV07-05,TCRBV07-06												CASSLG*REASTDTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTCTACTTACGACGGTTACAATGAGCAGTTCTTCGGGCCA	CASSSTYDGYNEQFF	In	VDJ	3	111	0.0010104320279643892	0.0012199276835661453	45	TCRBV11	unresolved					TCRBJ02	TCRBJ02-01	01	4	2	7	4	8	3	18	31	42	39	45		TCRBV11-01,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSTYDGYNEQFF+TCRBV11-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTCTATTAGCGGGACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSISGTNTGELFF	In	VDJ	7	307	0.002794618311577184	0.0033740342239171766	48	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	5	3	0	4	0	22	35	-1	39	47		TCRBV07-01,TCRBV07-04												CASSSISGTNTGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
SGACTCRGCYRTGTATCKCTGTGCCAGAAGCTTGGCAGGAGAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	13	543	0.0049429242449068765		40	TCRBV07	unresolved					TCRBJ02	TCRBJ02-05	01	2	4	4	3	2	3	19	33	39	35	42		TCRBV07-05,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-X+TCRBJ02-05	unresolved		TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCACGGGGAGGTTCTGCAATCAGCCCCAGCATTTTGGTGAT	CASTGRFCNQPQHF	In	VDJ	61	2622	0.023868043038942598	0.02881667014694084	42	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	7	9	1	2	2	4	23	33	41	35	45		TCRBV10-01,TCRBV10-02												CASTGRFCNQPQHF+TCRBV10-X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GAAGACTCGGCCCTGTATCTCTGCGCCAGCAGCCAAGAGGGGGGGGAAAAACTGTTTTTTGGCAGT	CASSQEGGEKLFF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	39	TCRBV04	TCRBV04-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	0	9	0	8	0	0	21	-1	-1	38	45													Vb 7.2	CASSQEGGEKLFF+TCRBV04-03+TCRBJ01-04	TCRBV04-03*01	TCRBD02-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAGCCAAACAGCTTTGTACTTCTGTGCCAGCAGTTTCCTCGGACAGGGATGGGCTAATGAAAAACTGTTTTTTGGCAGT	CASSFLGQGWANEKLFF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	51	TCRBV22	TCRBV22-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	13	1	3	3	15	5	25	28	51	43	56														CASSFLGQGWANEKLFF+TCRBV22-01+TCRBJ01-04	TCRBV22-01*01	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCAGCCAAACAGCTTTGTACTTCTGTGCCAGCAGTTACGGGCGGAAACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	36	3.2770768474520726E-4		43	TCRBV22	TCRBV22-01	01				TCRBJ02	TCRBJ02-03	01	13	8	0	2	12	5	25	28	44	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV22-01+TCRBJ02-03	TCRBV22-01*01		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCGGGACAGAATAATTCACCCCTCCACTTTGGGAAC	CASSPGQNNSPLHF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	42	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	0	5	5	1	1	23	36	44	37	45													Vb 7.1	CASSPGQNNSPLHF+TCRBV04-01+TCRBJ01-06	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAACCAGGGGTAGGAACGAGCAGTACTTCGGGCCG	CASSQTRGRNEQYF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	42	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	2	5	2	5	23	38	46	40	51													Vb 7.1	CASSQTRGRNEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGGCACAGCTAATGAAAAACTGTTTTTTGGCAGT	YASSQGTANEKLFF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	42	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	3	5	3	2	0	22	38	-1	40	44													Vb 7.1	YASSQGTANEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGTCCTAGCGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	YASSQVLAGSSYNEQFF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	51	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	4	3	0	2	2	22	38	49	40	51													Vb 7.1	YASSQVLAGSSYNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATGCGGGAGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	22	2.0026580734429334E-4		43	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	7	2	4	1	0	23	40	-1	41	48													Vb 7.1	X+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCGAGATTGGACCCCTCGCAATTCACCCCTCCACTTTGGGAAC	CASSRDWTPRNSPLHF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	48	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-06	01	0	1	7	7	2	7	23	40	46	42	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSRDWTPRNSPLHF+TCRBV04-01+TCRBJ01-06	TCRBV04-01*01		TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGCTCGTATGGGTAACACTGAAGCTTTCTTTGGACAA	XASSQARMGNTEAFF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	45	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-01	01	1	0	9	2	7	1	23	39	49	46	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	XASSQARMGNTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCGGGAGGGAGGGCAGAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSREGGQNSNQPQHF	In	VDJ	1	34	3.0950170225936243E-4	3.7367154271395446E-4	51	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	9	0	0	0	9	23	-1	43	36	52													Vb 7.1	CASSREGGQNSNQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01	TCRBD02-01*02	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGTCCGGGGGCCGTAGGATTCACCCCTCCACTTTGGGAAC	YASSQVRGP*DSPLHF	Stop	VDJ	1	38	3.4591366723105214E-4		48	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-06	01	1	6	0	8	3	6	22	38	47	41	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	YASSQVRGP*DSPLHF+TCRBV04-01+TCRBJ01-06	TCRBV04-01*01		TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGATCCCGGCCACGAGCAGTACTTCGGGCCG	YASSQDPGHEQYF	In	VDJ	1	39	3.5501665847397456E-4	4.2862324017188893E-4	39	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-07	01	0	9	0	5	4	1	22	39	46	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	YASSQDPGHEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCTCTGCGCCAGTAGCTCGAAGACTGTTTCGAAGACGGCAGACAGGGGGCCCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	48	4.3694357966027634E-4		64	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	0	4	24	1	4	16	50	40	51													Vb 7.1	X+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGTTCCCAGTCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQGSQSSGANVLTF	In	VDJ	1	53	4.8245853587488847E-4	5.824879930541054E-4	51	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	4	5	0	5	2	23	39	47	44	49													Vb 7.1	CASSQGSQSSGANVLTF+TCRBV04-01+TCRBJ02-06	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCATTACGGGAGACGAGCTGAAGCTTTCTTTGGACAA	CASSHYGRRAEAFF	In	VDJ	2	80	7.282392994337939E-4	8.792271593269516E-4	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	8	2	6	3	5	23	37	46	40	51													Vb 7.1	CASSHYGRRAEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD02-01*02	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAATCTGACCCGGCGGACTACGAGCAGTACTTCGGGCCG	XASSQSDPADYEQYF	In	VDJ	2	83	7.555482731625612E-4	9.121981778017123E-4	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	7	5	3	9	1	22	37	50	46	51						01,02							Vb 7.1	XASSQSDPADYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGTGACAATCTCTGGGCCAACGTCCTGACTTTCGGGGCC	CASSQGDNLWANVLTF	In	VDJ	4	179	0.001629435432483114	0.0019672707689940543	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	2	6	5	2	6	23	39	45	41	51													Vb 7.1	CASSQGDNLWANVLTF+TCRBV04-01+TCRBJ02-06	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATTATCGGGCCACTCGCCCATGGTACTTCGGCGCC	CASSQDYRATRPWYF	In	VDJ	9	391	0.0035592695759826677	0.004297222741210476	45	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-04	01	0	8	0	15	5	12	23	40	49	45	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQDYRATRPWYF+TCRBV04-01+TCRBJ02-04	TCRBV04-01*01		TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCAGCAGTTCCCGGGGGGAGAGCAGTACTTCGGGCCG		Out	VDJ	1	17	1.5475085112968121E-4		35	TCRBV06	TCRBV06-09	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	8	1	7	2	1	26	39	48	41	49													Vb 13.1	X+TCRBV06-09+TCRBJ02-07	TCRBV06-09*01	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GCCACGTTTGGTGGCCTCCTCCCAGACATCTGTATTTTCTGCGCCAGCACGGGGAGGTTCTGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	14	1.2744187740091394E-4		41	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	22	9	1	2	16	4	40	35	57	51	61			01,02										Vb 12	X+TCRBV10-01+TCRBJ01-05	TCRBV10-01	TCRBD02-01*02	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCCTGAGAGGGGATACGCAGTATTTTGGCCCA	CASLRGDTQYF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	33	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	11	0	6	4	0	26	35	-1	39	44			01,02										Vb 12	CASLRGDTQYF+TCRBV10-01+TCRBJ02-03	TCRBV10-01	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGGTCGCCAAAGACGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	46	4.187375971744315E-4		41	TCRBV10	TCRBV10-01					TCRBJ02	TCRBJ02-07	01	6	2	7	3	9	2	26	37	49	46	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-01+TCRBJ02-07	TCRBV10-01		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTCACGAAGGGACTAGCCCGACAATGAGCAGTTCTTCGGGCCA	CASSSRRD*PDNEQFF	Stop	VDJ	1	39	3.5501665847397456E-4		48	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	7	5	6	3	22	35	50	41	53						01,02								CASSSRRD*PDNEQFF+TCRBV12-01+TCRBJ02-01	TCRBV12-01*01	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAAGGATAAATTGGAACAGGGGGTCACCGGGGAGCTGTTTTTTGGAGAA	CATSKDKLEQGVTGELFF	In	VDJ	1	20	1.8205982485844849E-4	2.198067898317379E-4	54	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	3	1	4	13	1	18	31	52	44	53														CATSKDKLEQGVTGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCGACAACACGAGACCCAGTACTTCGGGCCA	CATSRDRQHETQYF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	2	6	5	2	4	18	35	41	37	45														CATSRDRQHETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCCGGGACAGGGGGCTAAATGAAAAACTGTTTTTTGGCAGT	CATSRDRGLNEKLFF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	0	5	1	2	18	30	43	31	45														CATSRDRGLNEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACCAGTACGGGACTAGCGGAACAAGAGACCCAGTACTTCGGGCCA	CATSTGLAEQETQYF	In	VDJ	1	34	3.0950170225936243E-4	3.7367154271395446E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	0	5	2	3	2	18	29	43	32	45						01,02								CATSTGLAEQETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCCGGACCGTCAAGTCCGGTTCACCCCTCCACTTTGGGAAC	CATSSRTVKSGSPLHF	In	VDJ	1	36	3.2770768474520726E-4	3.9565222169712824E-4	48	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-06	01	3	1	7	9	2	12	18	32	38	34	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSSRTVKSGSPLHF+TCRBV15-01+TCRBJ01-06	TCRBV15-01*01		TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGTGAAGACAGGGATCACTGAAGCTTTCTTTGGACAA	CATSVKTGITEAFF	In	VDJ	1	44	4.005316146885867E-4	4.835749376298234E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	3	4	5	2	18	30	42	35	44														CATSVKTGITEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCTCCCAAGCGGGAGAGGCGTACGAGCAGTACTTCGGGCCG	CATSSQAGEAYEQYF	In	VDJ	1	44	4.005316146885867E-4	4.835749376298234E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	6	2	4	5	5	18	30	43	35	48														CATSSQAGEAYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCCATGGGGGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CATSRDPWGSSYNSPLHF	In	VDJ	1	45	4.096346059315091E-4	4.945652771214103E-4	54	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-06	01	0	6	1	0	5	2	18	35	45	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDPWGSSYNSPLHF+TCRBV15-01+TCRBJ01-06	TCRBV15-01*01		TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGCTCGGGGGGGCTCTGGCTACACCTTCGGTTCG	CATSRARGGSGYTF	In	VDJ	1	49	4.460465709031988E-4	5.385266350877579E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	1	8	0	7	2	3	18	34	44	36	47														CATSRARGGSGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD02-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGTGCGGACTGGTTTTAATGAGCAGTTCTTCGGGCCA	CATSVRTGFNEQFF	In	VDJ	1	51	4.6425255338904364E-4	5.605073140709316E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	10	7	4	6	18	30	39	34	45						01,02								CATSVRTGFNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGTGGACTAGCGGGAGGGCCTAGGGAGACCCAGTACTTCGGGCCA	CATSRGGLAGGPRETQYF	In	VDJ	1	53	4.8245853587488847E-4	5.824879930541054E-4	54	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	1	0	5	2	6	18	34	51	36	57														CATSRGGLAGGPRETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGGGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CATSREGGNTGELFF	In	VDJ	1	56	5.097675096036558E-4	6.154590115288661E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	9	1	1	0	0	18	-1	-1	35	41														CATSREGGNTGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGACAGGGCATCGCCGGGGGCCAACGTCCTGACTTTCGGGGCC	CATSRDRASPGANVLTF	In	VDJ	1	61	5.552824658182679E-4	6.704107089868006E-4	51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	4	3	4	0	8	18	-1	40	35	48														CATSRDRASPGANVLTF+TCRBV15-01+TCRBJ02-06	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTATAGGGGTAGGGGATAGATACGCAGTATTTTGGCCCA	CATSRV*G*GIDTQYF	Stop	VDJ	2	67	6.099004132758024E-4		48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	5	2	5	3	8	18	34	42	37	50														CATSRV*G*GIDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACCAGTAAGGGGCAGGAACGCTCTGGAAACACCATATATTTTGGAGAG	CATSKGQERSGNTIYF	In	VDJ	2	67	6.099004132758024E-4	7.36352745936322E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	5	2	0	2	8	18	29	36	31	44														CATSKGQERSGNTIYF+TCRBV15-01+TCRBJ01-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGACTGCGGGACTAGTCCAGCGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	68	6.190034045187249E-4		53	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	0	8	4	4	7	18	35	47	39	54						01,02								X+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGACAGGGGGTAACACACCGGGGAGCTGTTTTTTGGAGAA	CATSRDRG*HTGELFF	Stop	VDJ	2	74	6.736213519762595E-4		48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	1	1	3	0	4	18	-1	42	32	46														CATSRDRG*HTGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCCAAACTGGGGGGCGCCCTAATGAAAAACTGTTTTTTGGCAGT	CATSQTGGRPNEKLFF	In	VDJ	2	75	6.827243432191818E-4	8.242754618690172E-4	48	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-04	01	5	6	0	3	7	3	18	30	43	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSQTGGRPNEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01		TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACTCCAACCGAGCCCAGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	84	7.646512644054836E-4		43	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-01	01	9	4	5	1	12	1	18	26	41	38	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGTATGTCATCCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	87	7.919602381342509E-4		41	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-07	01	3	4	6	2	5	3	18	32	39	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACCAGTGGGGAGATAGGACTAGCGGGCCTCACAGATACGCAGTATTTTGGCCCA	CATSGEIGLAGLTDTQYF	In	VDJ	2	94	8.556811768347079E-4	0.001033091912209168	54	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	1	4	2	10	3	18	29	50	39	53						01,02								CATSGEIGLAGLTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGACTCGGTTGCCGTCAGATACGCAGTATTTTGGCCCA	CATSRTRLPSDTQYF	In	VDJ	2	95	8.647841680776303E-4	0.001044082251700755	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	2	10	4	0	10	18	-1	36	32	46						01,02								CATSRTRLPSDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAAAAATCCGACAAACTTGGTCCTGAGGACAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	102	9.285051067780873E-4		59	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-04	01	2	1	7	6	24	0	18	33	-1	57	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV15-01+TCRBJ02-04	TCRBV15-01*01		TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAACTTAAGAGGGGTCCGCCTGAGGGAAAAACTGTTTTTTGGCAGT	CATSNLRGVRLREKLFF	In	VDJ	2	107	9.740200629926994E-4	0.0011759663255997979	51	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-04	01	4	5	2	8	7	11	18	31	43	38	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSNLRGVRLREKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01		TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATACGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CATSRDTGSGANVLTF	In	VDJ	4	164	0.0014928905638392775	0.0018024156766202509	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	0	8	4	0	2	0	18	35	-1	37	41						01,02								CATSRDTGSGANVLTF+TCRBV15-01+TCRBJ02-06	TCRBV15-01*01	TCRBD02-01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCTGGACCGGACAGGGGAGGAGGGAGACCCAGTACTTCGGGCCA	CATSWTGQGRRETQYF	In	VDJ	5	199	0.0018114952573415625	0.002187077558825792	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	2	5	6	6	18	30	45	36	51														CATSWTGQGRRETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGAACTCCAGAACACTGAAGCTTTCTTTGGACAA	CASSLELQNTEAFF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	3	1	8	1	0	6	26	-1	43	40	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLELQNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGTAGCACAGATACGCAGTATTTTGGCCCA	CASSLGSTDTQYF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	39	TCRBV12						TCRBJ02	TCRBJ02-03	01	3	0	9	0	0	1	26	-1	43	40	44		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACCCAGACAGGGAAGAGCACTGAAGCTTTCTTTGGACAA	CASTQTGKSTEAFF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	3	4	0	5	26	-1	47	40	52		TCRBV03-01,TCRBV03-02												CASTQTGKSTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAAGGGACAGGCGTATAATTCACCCCTCCACTTTGGGAAC	CASSKGQAYNSPLHF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	4	4	2	2	26	38	48	40	50		TCRBV03-01,TCRBV03-02												CASSKGQAYNSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCCGTTAGCATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	12	1.0923589491506909E-4		35	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	7	8	5	0	26	38	-1	43	47		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCCAGGGTAGGATATGGCAATCAGCCCCAGCATTTTGGTGAT	CSARPRVGYGNQPQHF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	3	2	2	9	26	38	45	40	54		TCRBV20-01,TCRBV20-or09_02												CSARPRVGYGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGACAATTTCCAAGAGACCCAGTACTTCGGGCCA	CSARDNFQETQYF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	6	1	0	4	26	-1	42	37	46		TCRBV20-01,TCRBV20-or09_02												CSARDNFQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGCGATCGGAGACAGGGTAATAACTACGAGCAGTACTTCGGGCCG	CSGDRRQGNNYEQYF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	2	3	3	9	6	26	33	49	42	55		TCRBV20-01,TCRBV20-or09_02												CSGDRRQGNNYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGGGACTCRGCYGTGTAYKTCTGTGCCAGCAGCCAAGAAGACAGTGAGTTCTATGGCTACACCTTCGGTTCG	CASSQEDSEFYGYTF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	5	4	7	6	22	33	45	40	51	TCRBV04,TCRBV11,TCRBV12													CASSQEDSEFYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCCCGACAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPDSSGANVLTF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	5	0	3	0	23	35	-1	38	43	TCRBV06,TCRBV10													CASSPDSSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTCGTCCCCCCGACAGGGCACGGGCTACACCTTCGGTTCG	CASSSSPRQGTGYTF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	3	8	9	4	23	36	52	45	56	TCRBV06,TCRBV24													CASSSSPRQGTGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GMGACWCGGCWSTGTATCTCTGYGCCAGCAGCTTAAGGGGTTACAGTTCCTACGAGCAGTACTTCGGGCCG	CASSLRGYSSYEQYF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	5	2	1	0	7	19	-1	39	34	46	TCRBV07,TCRBV23													CASSLRGYSSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCRGCYGTGTATKTYTGTGCCAGCAATGCTCCGGGACATGGAAGATACGAGCAGTACTTCGGGCCG	CASNAPGHGRYEQYF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	6	4	7	7	18	28	41	35	48	TCRBV11,TCRBV12													CASNAPGHGRYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTTACGGACAGGGGATGGGAGACCCAGTACTTCGGGCCA	CASSFTDRGWETQYF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	2	5	3	4	18	32	44	35	48	TCRBV07,TCRBV11													CASSFTDRGWETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGGAGACWCRGCMSKGTATKTCTGTGCCAGCAGTGAAGGTAACCTTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	12	1.0923589491506909E-4		43	unresolved						TCRBJ01	TCRBJ01-01	01	6	5	4	0	3	6	18	29	35	32	41	TCRBV11,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGCTTAGCACGGCAGGGCTACGAGCAGTACTTCGGGCCG	CASSLARQGYEQYF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	3	4	0	19	36	-1	40	45	TCRBV07,TCRBV11													CASSLARQGYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCRGCCMTGTATCKCTGTGCCAGCAGCTTAGGGAGGTTAGAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGRLENTGELFF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	9	1	1	1	5	19	33	40	34	45	TCRBV05,TCRBV07,TCRBV11													CASSLGRLENTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GRGACWCGGCMCTKTATCTYTGCGCCAGCAGCCCTGGGACAGGGCCGCAAGAGACCCAGTACTTCGGGCCA	CASSPGTGPQETQYF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	3	2	3	3	19	31	43	34	46	TCRBV05,TCRBV23													CASSPGTGPQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCCCTCAGGTTTGGGACACAGATACGCAGTATTTTGGCCCA	CASSPQVWDTDTQYF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	45	unresolved						TCRBJ02	TCRBJ02-03	01	5	0	8	2	10	0	22	34	-1	44	48	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPQVWDTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCTTGTATTCGGGGCAGACCTACGAGCAGTACTTCGGGCCG	CASSLYSGQTYEQYF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	45	unresolved						TCRBJ02	TCRBJ02-07	01	3	7	0	2	6	3	22	36	47	42	50	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLYSGQTYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCATCGGGACGGCCTGGCAAGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	12	1.0923589491506909E-4		46	unresolved						TCRBJ02	TCRBJ02-05	01	4	0	7	5	3	11	23	35	43	38	54	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGCCCCCCCTCCGTCAGGGTAGGTAATCAGCCCCAGCATTTTGGTGAT	CASSPPSVRVGNQPQHF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	51				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	3	4	12	5	24	35	52	47	57	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSPPSVRVGNQPQHF+X+TCRBJ01-05		TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTACTAGCGGGTCTTTGTTTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	13	1.1833888615799151E-4		55	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	3	4	1	1	8	26	42	52	43	60		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGACTAGCGGGGGGAGTATCGAGCAGTACTTCGGGCCG	CASSQTSGGSIEQYF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	2	1	6	0	5	26	-1	53	40	58		TCRBV03-01,TCRBV03-02												CASSQTSGGSIEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTACTCCCCGGACAGGGGGCAATACTGAAGCTTTCTTTGGACAA	CASSPTPRTGGNTEAFF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	0	5	9	3	26	39	59	48	62		TCRBV03-01,TCRBV03-02												CASSPTPRTGGNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGGTTCGACAGGGAATGCGCCGAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	13	1.1833888615799151E-4		50	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	9	2	3	1	4	9	26	34	45	38	54		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGGAGTCCCGGATGGCTACACCTTCGGTTCG	CSAREGVPDGYTF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	10	2	6	1	6	26	40	45	41	51		TCRBV20-01,TCRBV20-or09_02												CSAREGVPDGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGACAGGGGGGTATATGGCTACACCTTCGGTTCG	CSARGDRGVYGYTF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	1	5	0	3	26	-1	50	39	53		TCRBV20-01,TCRBV20-or09_02												CSARGDRGVYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATTACCCACAGGGCGGAGCAATCAGCCCCAGCATTTTGGTGAT	CSARLPTGRSNQPQHF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	3	1	6	3	26	38	50	44	53		TCRBV20-01,TCRBV20-or09_02												CSARLPTGRSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGAGGGTTCCTACGAGCAGTACTTCGGGCCG	CSASEGSYEQYF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	11	0	1	1	1	26	37	43	38	44		TCRBV20-01,TCRBV20-or09_02												CSASEGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCACTCGACTAGCTACCTACAATGAGCAGTTCTTCGGGCCA	CASTRLATYNEQFF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	2	7	2	3	2	22	32	42	35	44		TCRBV12-03,TCRBV12-04				01,02								CASTRLATYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTAGAGGGGGCGAGGGTTTACGAGCAGTACTTCGGGCCG	CASSLEGARVYEQYF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	5	0	4	1	7	23	38	46	39	53	TCRBV24,TCRBV27													CASSLEGARVYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACCAAAGGGTTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASTKGFSGANVLTF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	45	TCRBV24						TCRBJ02	TCRBJ02-06	01	11	5	3	0	7	2	24	31	42	38	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTKGFSGANVLTF+TCRBV24-X+TCRBJ02-06	TCRBV24		TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGCAGTATGGAGATACGCAGTATTTTGGCCCA	CASSLQYGDTQYF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	5	5	3	5	24	36	42	39	47		TCRBV24-01,TCRBV24-or09_02												CASSLQYGDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGACCGGGACCGGAGAGAATCCGGGGAGCTGTTTTTTGGAGAA	CAISDRDRRESGELFF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	48							TCRBJ02	TCRBJ02-02	01	5	0	7	6	4	10	23	35	44	39	54	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISDRDRRESGELFF+X+TCRBJ02-02			TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAATGGGGACAGGGGTTTCGACTAATGAAAAACTGTTTTTTGGCAGT	CASSLMGTGVSTNEKLFF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	54	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	0	2	2	4	5	19	33	47	37	52		TCRBV05-06,TCRBV05-07												CASSLMGTGVSTNEKLFF+TCRBV05-X+TCRBJ01-04	TCRBV05	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCAACCGGGACAGGTGACACTGAAGCTTTCTTTGGACAA	CASSPTGTGDTEAFF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	4	3	6	2	26	38	52	44	54		TCRBV12-03,TCRBV12-04												CASSPTGTGDTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCAGTGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSFSASTDTQYF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	5	0	0	4	26	-1	43	40	47		TCRBV12-03,TCRBV12-04												CASSFSASTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGTCTAGGGACTCCGAGCGATGAGCAGTTCTTCGGGCCA	CASSLGTPSDEQFF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	8	3	7	24	36	45	39	52	TCRBV06,TCRBV10					01,02								CASSLGTPSDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCTTAAGGCCTGGCTCCTACGAGCAGTACTTCGGGCCG	CSLRPGSYEQYF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	36	TCRBV20						TCRBJ02	TCRBJ02-07	01	9	5	4	0	4	5	26	31	38	35	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSLRPGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGGGTGACCTGATCTATGGCTACACCTTCGGTTCG	CSAKGDLIYGYTF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	39	TCRBV20						TCRBJ01	TCRBJ01-02	01	4	5	3	4	0	9	26	-1	40	36	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKGDLIYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAAGGAGGGCCCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	14	1.2744187740091394E-4		40	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	10	0	5	3	3	26	37	46	40	49		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAAGCACAGGGAGCTGCGCGGCTACACCTTCGGTTCG	CSASKHRELRGYTF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	3	8	5	8	26	37	48	42	56		TCRBV20-01,TCRBV20-or09_02												CSASKHRELRGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGTGGGGGACAGGGAAGATACGCAGTATTTTGGCCCA	CSAVGDREDTQYF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	3	5	4	1	26	35	48	39	49		TCRBV20-01,TCRBV20-or09_02												CSAVGDREDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGGGCCCGCGGGGGCCGCACAGATACGCAGTATTTTGGCCCA	CASRARGGRTDTQYF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	7	2	1	5	2	22	33	45	38	47		TCRBV12-03,TCRBV12-04												CASRARGGRTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGTTATAGGTAATGAGCAGTTCTTCGGGCCA	CASSVIGNEQFF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	36	TCRBV24						TCRBJ02	TCRBJ02-01	01	5	5	4	7	4	1	24	37	44	41	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVIGNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTAGGGGGAGGGGGGCAGATACGCAGTATTTTGGCCCA	CASSFRGRGADTQYF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	9	0	4	6	3	24	36	49	42	52		TCRBV24-01,TCRBV24-or09_02												CASSFRGRGADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATCGCCGGGACTAGCTGCCGGGGAGCTGTTTTTTGGAGAA	CASSESPGLAAGELFF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	48	TCRBV06			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	0	7	6	5	2	23	38	52	43	54		TCRBV06-01,TCRBV06-08				01,02								CASSESPGLAAGELFF+TCRBV06-X+TCRBJ02-02	TCRBV06	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCGGTAGCGGGAGGGCCGGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	14	1.2744187740091394E-4		47	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	5	0	7	3	5	19	32	46	35	51	TCRBV07,TCRBV11													X+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTATCATTATTGGGACCCGGGGAGCTGTTTTTGGAGAA		Out	VDJ	1	14	1.2744187740091394E-4		44	unresolved						TCRBJ02	TCRBJ02-02	01	2	0	7	18	8	11	18	33	46	41	57	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCSTSTATCTCTGTGCCAGCAGCCAAGGAGAGGGGGTTTGGCTAGCGGGACACACCGGGGAGCTGTTTTTTGGAGAA	CASSQGEGVWLAGHTGELFF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	60	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	4	3	3	18	1	18	30	57	48	58	TCRBV05,TCRBV11													CASSQGEGVWLAGHTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCCCAACAGGGGCGGCTACGAGCAGTACTTCGGGCCG	CASSPNRGGYEQYF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	2	3	4	3	18	30	41	34	44	TCRBV07,TCRBV11													CASSPNRGGYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCCCCCCTAGCGGGGGGGCCAATGAGCAGTTCTTCGGGCCA	CASSPPSGGANEQFF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	0	6	4	1	18	30	46	34	47	TCRBV07,TCRBV11													CASSPPSGGANEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCCCTTGGGACAGGGACCTACGAGCAGTACTTCGGGCCG	CASSSLGTGTYEQYF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	2	5	1	18	31	45	36	46	TCRBV07,TCRBV11													CASSSLGTGTYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAGTTGGGACAGGGGGCTACGAGCAGTACTTCGGGCCG	CASSLVGTGGYEQYF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	1	3	2	0	18	34	-1	36	47	TCRBV07,TCRBV11													CASSLVGTGGYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCATTGAGTGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSIEWGNTEAFF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	42	unresolved						TCRBJ01	TCRBJ01-01	01	5	6	2	1	7	0	19	31	-1	38	42	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSIEWGNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCACCAATAGCCGGGCCGAGGGGATGCCTAATGAAAAACTGTTTTTTGGCAGT	CASTNSRAEGMPNEKLFF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	54	TCRBV05						TCRBJ01	TCRBJ01-04	01	6	5	2	3	15	4	19	29	49	44	53		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTNSRAEGMPNEKLFF+TCRBV05-X+TCRBJ01-04	TCRBV05		TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTAGTCAGGGATCTGTGGCTACACCTTCGGTTCG		Out	VDJ	1	14	1.2744187740091394E-4		40	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	3	7	3	5	19	33	41	36	46	TCRBV05,TCRBV11													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTTGAGTCGTCGGGACAGGGGAGATGGCTACACCTTCGGTTCG	CASSLSRRDRGDGYTF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	2	6	7	2	19	34	51	41	53	TCRBV05,TCRBV07													CASSLSRRDRGDGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGRGGACTCAGCCMTGTACTTCTGTGCCAGCACAACAGGACTAGCGGGGACAGATACGCAGTATTTTGGCCCA	CASTTGLAGTDTQYF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	1	3	3	5	0	23	33	-1	38	50	TCRBV02,TCRBV13													CASTTGLAGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGTACYSKSKSASWCAKCTKTGTAYTTCTGTGCCAGCAAGTCAGGTGAGGAGCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	14	1.2744187740091394E-4		44	unresolved						TCRBJ01	TCRBJ01-02	01	7	4	4	0	3	7	28	38	45	41	52	TCRBV06,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TTTGGTGCATCCTGAAGACAGCAGCTTCTCATCTGCAGTGCTAGAGATGGGGGGCGGGAAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	14	1.2744187740091394E-4		47	TCRBV20						TCRBJ02	TCRBJ02-03	01	19	6	0	0	20	5	34	29	55	49	60		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGACTATAGCACAGATACGCAGTATTTTGGCCCA	CASSDYSTDTQYF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	2	9	0	1	1	26	37	43	38	44		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSDYSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGCGGGGGGCTTTCCGGATACGCAGTATTTTGGCCCA	CASSQDAGGFPDTQYF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	7	1	6	1	7	26	43	52	44	59		TCRBV03-01,TCRBV03-02												CASSQDAGGFPDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCACCCCGGGGACAGGGTCTAACGAGCAGTACTTCGGGCCG	CATPGTGSNEQYF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	0	3	5	5	4	22	29	43	34	47		TCRBV12-03,TCRBV12-04												CATPGTGSNEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCGTAGAGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSVEGYNEQFF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	11	0	3	4	0	22	33	-1	37	42	TCRBV12,TCRBV21													CASSVEGYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCGTAGGATTCCAGGGGATTAATACGCAGTATTTTGGCCCA	CASSVGFQGINTQYF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	2	7	10	4	22	33	49	43	53	TCRBV09,TCRBV12													CASSVGFQGINTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTAGCCGAGGGGGGCGAGCAGTACTTCGGGCCG	CASSLAEGGEQYF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	39	TCRBV12						TCRBJ02	TCRBJ02-07	01	0	5	1	6	2	1	22	39	47	41	48		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAEGGEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCAGGGGAAATCAATGAGCAGTTCTTCGGGCCA	CATSDPGEINEQFF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	2	6	2	4	24	38	46	40	50		TCRBV24-01,TCRBV24-or09_02												CATSDPGEINEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGGGGTTCTATGGCTACACCTTCGGTTCG	CATSDLGFYGYTF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	39	TCRBV24						TCRBJ01	TCRBJ01-02	01	0	0	9	4	0	2	24	-1	45	42	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDLGFYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATGCGTGCCTACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	15	1.3654486864383636E-4		43	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	4	9	2	10	0	24	36	-1	46	49		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCAGACCGACTAGCGGGAGCCACCAGGAGGAATGAGCAGTTCTTCGGGCCA	CASSPDRLAGATRRNEQFF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	57	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	2	2	7	7	11	24	36	55	43	66		TCRBV12-03,TCRBV12-04												CASSPDRLAGATRRNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCGAGAACTAGAGCCCCTTTTTGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	15	1.3654486864383636E-4		50				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	3	8	6	4	13	18	30	39	34	52	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03				01,02								X+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGTGCATCCTGAAGACAGCAGCTTTACATCTGCAGTGCTAGAGATGCAGGCAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	15	1.3654486864383636E-4		41	TCRBV20						TCRBJ02	TCRBJ02-03	01	21	4	4	0	22	1	32	25	51	47	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCGCCCGGGAAGGGTATGAACACTGAAGCTTTCTTTGGACAA	CASSLAPGKGMNTEAFF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	51	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	8	3	0	3	6	26	43	51	46	57		TCRBV12-03,TCRBV12-04												CASSLAPGKGMNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*02	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGGGGACGGTGAAGCTTTCTTTGGACAA	CASSQGGDGEAFF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	39	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	9	1	7	0	4	26	-1	48	42	52		TCRBV03-01,TCRBV03-02												CASSQGGDGEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTGGCAGGGGACCCCAGCATTTTGGTGAT		Out	VDJ	1	16	1.456478598867588E-4		38	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	4	2	10	3	1	26	42	51	45	52		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATTCAAGCGGGAGTCAGATACGCAGTATTTTGGCCCA	CASSQFKRESDTQYF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	6	2	4	4	1	26	41	53	45	54		TCRBV03-01,TCRBV03-02												CASSQFKRESDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGGGGACTCRGCCSTGTATCTCTGTGCCAGCAGCTTAGTCACAGGGGGGGAAGCTTTCTTTGGACAA	CASSLVTGGEAFF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	1	8	4	1	22	36	48	40	49	TCRBV05,TCRBV07													CASSLVTGGEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAGGGTTCGGGGATGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	16	1.456478598867588E-4		44	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	6	8	3	1	8	2	26	34	47	42	49		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*01	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGACGCAACTAGCGGGGGTTACAATGAGCAGTTCTTCGGGCCA	CSADATSGGYNEQFF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	3	2	4	7	1	26	34	52	41	53		TCRBV20-01,TCRBV20-or09_02												CSADATSGGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGAGGACTTGGCTCCTACGAGCAGTACTTCGGGCCG	CSARDGGLGSYEQYF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	1	10	0	4	3	26	40	49	44	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDGGLGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCTAGCAGCCCGGACACCACCGGGGAGCTGTTTTTTGGAGAA	CASSPDTTGELFF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	6	4	3	1	23	34	42	37	43	TCRBV24,TCRBV27													CASSPDTTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGACGAAGCTGCCACCTACGAGCAGTACTTCGGGCCG	CASSQDEAATYEQYF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	45				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	6	7	2	3	5	18	35	41	38	46	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03				01,02								CASSQDEAATYEQYF+X+TCRBJ02-07		TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGGGGGTCCCACTGAAGCTTTCTTTGGACAA	CASSLAGGPTEAFF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	42				TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	9	1	4	0	3	18	-1	41	35	44	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAGGPTEAFF+X+TCRBJ01-01		TCRBD02-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GAGRGACWCRGCMSTGTATCTCTRCGCCAGCAGCCAAGACTCGGGGTCGGGGGCCAACGTCCTGACTTTCGGGGCC	XASSQDSGSGANVLTF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	2	8	3	4	4	3	20	35	44	39	47	TCRBV04,TCRBV23													XASSQDSGSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD02-01*01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTAGCCACTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSLATSGSTDTQYF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	48	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	3	4	0	1	0	26	43	-1	44	53		TCRBV12-03,TCRBV12-04				01,02								CASSLATSGSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTGGGGGCAAGAGACCCAGTACTTCGGGCCA	CASSWGQETQYF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	36	TCRBV12						TCRBJ02	TCRBJ02-05	01	4	6	1	2	0	0	26	-1	-1	39	44		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWGQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12		TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCATGGCTCCTCCATTTGCAAAGAAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	17	1.5475085112968121E-4		52	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	9	0	4	2	17	26	38	43	40	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD01-01*01	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAGTGACAGGGCTATCCAAAAACATTCAGTACTTCGGCGCC	CASSPVTGLSKNIQYF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	2	3	2	4	4	26	39	50	43	54		TCRBV03-01,TCRBV03-02												CASSPVTGLSKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD01-01*01	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACTCTTGGGTTAGCGGGCGGAGAGACCCAGTACTTCGGGCCA	CSARTLGLAGGETQYF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	5	4	4	10	3	26	38	55	48	58		TCRBV20-01,TCRBV20-or09_02				01,02								CSARTLGLAGGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCTTAAACAGGGCGGAGAATCAGCCCCAGCATTTTGGTGAT	CSARALNRAENQPQHF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	3	3	4	6	5	26	39	51	45	56		TCRBV20-01,TCRBV20-or09_02												CSARALNRAENQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGCCCCCTCAGGCTACGACACTGAAGCTTTCTTTGGACAA	CSASAPSGYDTEAFF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	4	3	8	5	26	37	49	45	54		TCRBV20-01,TCRBV20-or09_02												CSASAPSGYDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGCAGGGGGGATGGCTACACCTTCGGTTCG	CSASGRGDGYTF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	1	6	3	1	26	37	47	40	48		TCRBV20-01,TCRBV20-or09_02												CSASGRGDGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCAGAGGGGGACAGGGTAACAATGAGCAGTTCTTCGGGCCA	CSAPRGGQGNNEQFF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	5	8	2	26	35	52	43	54		TCRBV20-01,TCRBV20-or09_02												CSAPRGGQGNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCGGGTTAGGGAGCAACAATGAGCAGTTCTTCGGGCCA	CASGLGSNNEQFF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	10	2	5	0	2	22	-1	42	38	44		TCRBV12-03,TCRBV12-04												CASGLGSNNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCWSSSASWCAKCTGTGTACTTCTGTGCCATCAGCGTTAGTCAGGGGAATCAGCCCCAGCATTTTGGTGAT	CAISVSQGNQPQHF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	2	4	7	0	22	33	-1	40	46	TCRBV10,TCRBV12													CAISVSQGNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTAAAGGACAGGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSLKDRGSYEQYF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	2	0	5	0	24	36	-1	41	50	TCRBV06,TCRBV24													CASSLKDRGSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCCTGGACTAGCGTCACAGATACGCAGTATTTTGGCCCA	CASSPWTSVTDTQYF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	45	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	1	6	2	4	1	19	31	44	35	45		TCRBV05-06,TCRBV05-07				01,02								CASSPWTSVTDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCCAACAAGAGAACACTGAAGCTTTCTTTGGACAA	CASSQQENTEAFF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	6	1	2	3	24	36	41	38	44	TCRBV12,TCRBV21													CASSQQENTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCGCGGGGACTAGCCTACAATGAGCAGTTCTTCGGGCCA	CASSLARGLAYNEQFF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	48	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	8	2	3	0	26	43	-1	46	54		TCRBV12-03,TCRBV12-04				01,02								CASSLARGLAYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGGGGCGAGCAGTACTTCGGGCCG	CASSLGGEQYF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	33	TCRBV12						TCRBJ02	TCRBJ02-07	01	1	6	2	6	0	0	26	-1	-1	42	46		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGGGCCGAGGACACTCCGCTACGAGCAGTACTTCGGGCCG	CASSQEGPRTLRYEQYF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	6	3	8	5	26	43	56	51	61		TCRBV03-01,TCRBV03-02												CASSQEGPRTLRYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGCTGGGGGAGAGCGAGCAGTACTTCGGGCCG	CASSQLGESEQYF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	39	TCRBV03						TCRBJ02	TCRBJ02-07	01	3	6	1	6	3	4	26	40	48	43	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQLGESEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGGGGACTCRGCCSTGTATSTCTGTGCCAGCAGCCGGAGGGTGGGAAATAACTATGGCTACACCTTCGGTTCG	CASSRRVGNNYGYTF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	10	0	1	3	7	22	32	41	35	48	TCRBV05,TCRBV11													CASSRRVGNNYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGCCACACACCCGGGACAGGGGGTTTCTCCTACGAGCAGTACTTCGGGCCG	CSASHTPGTGGFSYEQYF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	1	0	13	3	26	34	58	47	61		TCRBV20-01,TCRBV20-or09_02												CSASHTPGTGGFSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTGCTAGCGGGAGTCACAGATACGCAGTATTTTGGCCCA	CSARDLLAGVTDTQYF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	4	2	2	4	1	26	40	54	44	55		TCRBV20-01,TCRBV20-or09_02												CSARDLLAGVTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGAGGAGAACATTCAGTACTTCGGCGCC	CSAREENIQYF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	33	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	3	10	1	7	0	2	26	-1	42	37	44		TCRBV20-01,TCRBV20-or09_02												CSAREENIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*02	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCACAACCTAAGGAGCTCCTACGAGCAGTACTTCGGGCCG	CSAHNLRSSYEQYF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	10	2	0	10	0	26	35	-1	45	49		TCRBV20-01,TCRBV20-or09_02												CSAHNLRSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAGTGGCGGGGGGGGAACAATGAGCAGTTCTTCGGGCCA	CASSEWRGGNNEQFF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	0	5	5	2	22	34	48	39	50	TCRBV02,TCRBV12													CASSEWRGGNNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTGGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGNTGELFF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	39	TCRBV12						TCRBJ02	TCRBJ02-02	01	3	0	8	2	0	0	22	-1	-1	36	40		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGCGGTAGCGGCTTCCGGGAGACCCAGTACTTCGGGCCA	CATSGGSGFRETQYF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	5	5	5	4	7	24	37	47	41	54		TCRBV24-01,TCRBV24-or09_02				01,02								CATSGGSGFRETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGAGGGAGACAGGGGGCCCCGGGGAGCTGTTTTTTGGAGAA	CASRRETGGPGELFF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	2	0	6	6	1	24	35	51	41	52		TCRBV24-01,TCRBV24-or09_02												CASRRETGGPGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGATCTCTCATGCCTCAGGGTAGGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	18	1.6385384237260363E-4		53				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	4	3	6	13	4	18	34	52	47	56	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02												X+X+TCRBJ02-03		TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTCTAGCGGGGGGCAGTCCTACGAGCAGTACTTCGGGCCG	CASSSSGGQSYEQYF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	4	1	1	0	3	18	-1	42	31	45	TCRBV07,TCRBV11													CASSSSGGQSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACKCRGCCRTGTAYSTSTGTGCCAGCAGCTTAGCTGGGACTAGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	18	1.6385384237260363E-4		44	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	0	8	3	1	1	18	35	44	36	45	TCRBV07,TCRBV11,TCRBV15					01,02								X+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GCCACGTTTGGTGCATCCTGAAGACAGCAGCTTCTAATCTGCAGTGCTAGAGATGCAGGCAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	18	1.6385384237260363E-4		41	TCRBV20						TCRBJ02	TCRBJ02-03	01	18	4	4	0	19	1	40	36	59	55	60		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCCGAGACTAGCGGGGAAGCAAGAGACCCAGTACTTCGGGCCA	CASSPRLAGKQETQYF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	2	3	2	4	3	19	31	46	35	49	TCRBV07,TCRBV11													CASSPRLAGKQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTGTAGCCCCCGGGACAGGGCCCTAGGGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	18	1.6385384237260363E-4		61	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	3	0	9	8	19	32	50	41	58		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCSTSTATCTCTGTGCCAGCAGCTTAACGGACAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLTDSSYEQYF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	5	0	3	0	19	33	-1	36	42	TCRBV05,TCRBV07													CASSLTDSSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGCTTGATCGTACGGTGCAAGAGACCCAGTACTTCGGGCCA	CASSLLDRTVQETQYF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	8	5	2	10	2	19	34	47	44	49	TCRBV05,TCRBV11					01,02								CASSLLDRTVQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCTTGTCGGGACAGGGAGGTGGGGAGACCCAGTACTTCGGGCCA	CASSLSGQGGGETQYF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	0	3	5	2	7	19	34	45	36	52	TCRBV05,TCRBV07													CASSLSGQGGGETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGGACAGGCCAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSGQASSYNSPLHF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	1	4	0	1	4	26	37	45	38	49		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSGQASSYNSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCACCAATATCGGACAGGGGGCCTACGAGCAGTACTTCGGGCCG	CATNIGQGAYEQYF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	1	1	2	8	0	24	31	-1	39	49	TCRBV06,TCRBV10													CATNIGQGAYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGCTCTCTCACAGCGGGGGGGCCTATGAAAGAGCAGTTCTTCGGGCCA	CASSSLTAGGPMKEQFF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	6	0	10	9	9	24	35	54	44	63	TCRBV06,TCRBV10													CASSSLTAGGPMKEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAGTTATGGCTACACCTTCGGTTCG	CASSQSYGYTF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	33	TCRBV03						TCRBJ01	TCRBJ01-02	01	2	5	5	5	0	1	26	-1	43	41	44		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQSYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTACCTCCTATGGCTACACCTTCGGTTCG	CASSLTSYGYTF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	36	TCRBV03						TCRBJ01	TCRBJ01-02	01	4	3	7	4	2	3	26	39	43	41	46		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTSYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGGCCAACAGAAATGAACACTGAAGCTTTCTTTGGACAA	CASRPTEMNTEAFF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	5	0	4	3	26	37	45	41	48		TCRBV03-01,TCRBV03-02												CASRPTEMNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAACTCTAGCGGGAGGGCCCGGGGAGCAGTACTTCGGGCCG	CSATLAGGPGEQYF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	4	0	7	4	6	26	34	50	38	56		TCRBV20-01,TCRBV20-or09_02												CSATLAGGPGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGATACTAGGATTCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAKILGFSSYNEQFF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	3	8	0	4	7	26	36	45	40	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSAKILGFSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATCGGAGATTCACCCCTCCACTTTGGGAAC	CSARDIGDSPLHF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	0	10	2	8	4	0	26	40	-1	44	48		TCRBV20-01,TCRBV20-or09_02												CSARDIGDSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD02-01*02	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCCGGGCAGCGAACACTGAAGCTTTCTTTGGACAA	CSARDPRAANTEAFF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	45	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	8	0	1	5	3	26	40	49	45	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDPRAANTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCTGACAGGGAACCCTACGAGCAGTACTTCGGGCCG	CSARADREPYEQYF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	3	2	2	3	26	39	48	41	51		TCRBV20-01,TCRBV20-or09_02												CSARADREPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGGTGGAACAACAAGAGACCCAGTACTTCGGGCCA	CSARGVEQQETQYF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	42	TCRBV20						TCRBJ02	TCRBJ02-05	01	3	6	1	2	0	8	26	-1	42	37	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGVEQQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGTACGGGACAGGGGGCGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	19	1.7295683361552607E-4		44	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	0	5	5	1	26	37	54	42	55		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCCACAGGGACGTCTCTGGCAATGAGCAGTTCTTCGGGCCA	CASHRDVSGNEQFF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	3	3	6	1	10	22	31	38	32	48	TCRBV09,TCRBV12													CASHRDVSGNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCGCAGGGGTACACTGAAGCTTTCTTTGGACAA	CASSPQGYTEAFF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	2	3	3	1	24	36	45	39	46		TCRBV24-01,TCRBV24-or09_02												CASSPQGYTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATAGCGTGACAGATACGCAGTATTTTGGCCCA	CASSQDSVTDTQYF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	5	6	3	0	2	18	-1	40	35	42	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03				01,02								CASSQDSVTDTQYF+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCTAGTCGACAAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPSRQTNTGELFF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	48	TCRBV05						TCRBJ02	TCRBJ02-02	01	4	2	6	0	7	2	19	31	42	38	44		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSRQTNTGELFF+TCRBV05-X+TCRBJ02-02	TCRBV05		TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCACGGACAGGGACTATGGCTACACCTTCGGTTCG	CASSTDRDYGYTF	In	VDJ	1	20	1.8205982485844849E-4	2.198067898317379E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	3	3	3	0	26	37	-1	40	48		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSTDRDYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCTAGACCCTCCGCCACAGATACGCAGTATTTTGGCCCA	CASSPRPSATDTQYF	In	VDJ	1	20	1.8205982485844849E-4	2.198067898317379E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	8	2	2	9	26	37	43	39	52		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSPRPSATDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGACTCGACTAGCGGGCACACAGATACGCAGTATTTTGGCCCA	CASSDSTSGHTDTQYF	In	VDJ	1	20	1.8205982485844849E-4	2.198067898317379E-4	48				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	2	4	2	3	2	24	38	51	41	53	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-04,TCRBV06-05,TCRBV06-06,TCRBV10-03				01,02								CASSDSTSGHTDTQYF+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTCCGGCGGGCCGGGGACCGTTGGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	1.8205982485844849E-4		50	TCRBV03						TCRBJ02	TCRBJ02-07	01	1	0	7	7	12	5	26	42	59	54	64		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCTGAGGAACACTGAAGCTTTCTTTGGACAA	CASSPLRNTEAFF	In	VDJ	1	20	1.8205982485844849E-4	2.198067898317379E-4	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	11	2	1	4	0	26	39	-1	43	46		TCRBV03-01,TCRBV03-02												CASSPLRNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*02	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGTGGTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPVVSGANVLTF	In	VDJ	1	20	1.8205982485844849E-4	2.198067898317379E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	4	8	5	0	0	4	26	-1	42	39	46		TCRBV03-01,TCRBV03-02				01,02								CASSPVVSGANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD02-01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGATCAGGACGGGAGGGCCTAGAAAATGAGCAGTTCTTCGGGCCA	CSARGSGREGLENEQFF	In	VDJ	1	20	1.8205982485844849E-4	2.198067898317379E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	8	0	7	8	7	26	39	55	47	62		TCRBV20-01,TCRBV20-or09_02												CSARGSGREGLENEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCATAATGGAGGCTACACCTTCGGTTCG	CSARHNGGYTF	In	VDJ	1	20	1.8205982485844849E-4	2.198067898317379E-4	33	TCRBV20						TCRBJ01	TCRBJ01-02	01	3	1	8	8	7	0	26	37	-1	44	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARHNGGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCTCTGAGGCGGGAGCGGCCGGGGAGCTGTTTTTTGGAGAA	CATSSEAGAAGELFF	In	VDJ	1	20	1.8205982485844849E-4	2.198067898317379E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	7	2	6	7	3	24	35	49	42	52		TCRBV24-01,TCRBV24-or09_02												CATSSEAGAAGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCWMCCAGACMTCTSTGTACTTSTGTGCCAGCAGCTTAGAACAGGGGCGCGAGGCTTTCTTTGGACAA	CASSLEQGREAFF	In	VDJ	1	20	1.8205982485844849E-4	2.198067898317379E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	2	11	6	6	23	34	47	40	53	TCRBV06,TCRBV27													CASSLEQGREAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCWMCCAGACMTCTSTGTACTTSTGTGCCAGCAGTTTGGACAGATCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	1.8205982485844849E-4		38	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	5	3	1	2	23	36	43	37	45	TCRBV06,TCRBV27													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCTCAAAAGGGGGCACTGAAGCTTTCTTTGGACAA	CAISKGGTEAFF	In	VDJ	1	20	1.8205982485844849E-4	2.198067898317379E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	5	1	4	7	0	23	30	-1	37	43	TCRBV06,TCRBV10													CAISKGGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTGAACTAGGCGGACTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSELGGLSYNEQFF	In	VDJ	1	20	1.8205982485844849E-4	2.198067898317379E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	1	10	0	10	0	24	35	-1	45	50	TCRBV02,TCRBV21					01,02								CASSELGGLSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCACCCGACAGGGAGGGACTGAAGCTTTCTTTGGACAA	CASSTRQGGTEAFF	In	VDJ	1	21	1.911628161013709E-4	2.307971293233248E-4	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	6	2	3	5	5	4	26	37	49	42	53		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTRQGGTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATACTACGAGCAGTACTTCGGGCCG	CASSQYYEQYF	In	VDJ	1	21	1.911628161013709E-4	2.307971293233248E-4	33	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	5	9	3	0	0	26	-1	-1	41	43		TCRBV03-01,TCRBV03-02				01,02								CASSQYYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCCCGGGTCGGGTGTTGGGCAGTTCTTCGGGCCA	CASSHPGSGVGQFF	In	VDJ	1	21	1.911628161013709E-4	2.307971293233248E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	8	4	12	3	11	26	40	47	43	58		TCRBV03-01,TCRBV03-02				01,02								CASSHPGSGVGQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTGGGACAGGGACAAGCAGTTCTTCGGGCCA	CSAWDRDKQFF	In	VDJ	1	21	1.911628161013709E-4	2.307971293233248E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	11	2	3	26	34	45	36	48		TCRBV20-01,TCRBV20-or09_02												CSAWDRDKQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGATACGGGACTAGCCTTGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	21	1.911628161013709E-4		50	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	0	7	1	6	3	26	38	53	44	56		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTCTGGGACTAGCGGACTACGAGCAGTACTTCGGGCCG	CSARGLGLADYEQYF	In	VDJ	1	21	1.911628161013709E-4	2.307971293233248E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	0	5	3	4	1	26	39	54	43	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGLGLADYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGARGACTCRGCCCTKTATCTYTGCGCCAGCAGCCAAAAGGGGAAGGGTGGGGAGACCCAGTACTTCGGGCCA	CASSQKGKGGETQYF	In	VDJ	1	21	1.911628161013709E-4	2.307971293233248E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	5	2	5	1	9	23	38	44	39	53	TCRBV04,TCRBV05													CASSQKGKGGETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAACTAGGAGGATCTCTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSELGGSLSNQPQHF	In	VDJ	1	21	1.911628161013709E-4	2.307971293233248E-4	51	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	3	8	0	2	10	22	34	41	36	51		TCRBV12-03,TCRBV12-04				01,02								CASSELGGSLSNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD02-01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGAAAGCGAGCGATGAGCAGTTCTTCGGGCCA	CATSDLKASDEQFF	In	VDJ	1	21	1.911628161013709E-4	2.307971293233248E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	6	6	8	2	4	24	42	48	44	52		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDLKASDEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CMCCARCCARACAGCTYTKTACTTCTGTGCCAGCAGTTACCGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	21	1.911628161013709E-4		35	unresolved			unresolved			TCRBJ02	TCRBJ02-05	01	6	8	5	3	3	0	24	36	-1	39	42	TCRBV22,TCRBV24			TCRBD01,TCRBD02										X+X+TCRBJ02-05	unresolved	unresolved	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTCCGGGGGGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	21	1.911628161013709E-4		41				TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	1	0	1	0	18	31	-1	32	39	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ01-01		TCRBD02-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GCTTCTACATCTGCAGTGCTAGGGACGGGACAGGGGGCGGAGAGCGGGAGGGCCAGGAGAGACCCAGTACTTCGGGCCA		Out	VDDJ	1	21	1.911628161013709E-4		62	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	6	0	4	4	5	11	38	52	42	57		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGAAGGATGGGGGGTTGGGAGACAGGGGACCCAGTACTTCGGGCCA	CASSEGWGVGRQGTQYF	In	VDJ	1	21	1.911628161013709E-4	2.307971293233248E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	2	3	7	15	0	24	40	-1	55	62	TCRBV12,TCRBV21													CASSEGWGVGRQGTQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTGAGGGGACCACAGATACGCAGTATTTTGGCCCA	CASSEGTTDTQYF	In	VDJ	1	21	1.911628161013709E-4	2.307971293233248E-4	39	unresolved						TCRBJ02	TCRBJ02-03	01	5	0	7	2	4	0	23	34	-1	38	43	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGTTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TTTGGTGCATCCTGAAGACAGCAGCTTTACATCTGCAGTGCTAGAGATGGGGGGCGGGAAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	21	1.911628161013709E-4		47	TCRBV20						TCRBJ02	TCRBJ02-03	01	21	6	0	0	22	5	34	27	55	49	60		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTCGACGGAATATGGCTACACCTTCGGTTCG	CASSSTEYGYTF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	36	TCRBV12						TCRBJ01	TCRBJ01-02	01	6	1	8	5	6	1	26	37	46	43	47		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSTEYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTCGGACGGGCCTATGGCTACACCTTCGGTTCG	CASSFGRAYGYTF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	39	TCRBV12						TCRBJ01	TCRBJ01-02	01	6	1	7	4	4	4	26	37	45	41	49		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGRAYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTAAGGGGGTGCCACCCTACGAGCAGTACTTCGGGCCG	CASSKGVPPYEQYF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	5	1	2	1	6	26	38	45	39	51		TCRBV12-03,TCRBV12-04												CASSKGVPPYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCTCGGACAGGGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	22	2.0026580734429334E-4		46	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	4	1	5	0	26	38	-1	43	50		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTAGGGGGGCGGGGGACCCACACAGATACGCAGTATTTTGGCCCA	CASSLGGRGTHTDTQYF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	51	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	7	2	2	4	5	26	42	53	46	58		TCRBV12-03,TCRBV12-04												CASSLGGRGTHTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACTAGCGGGAGGGCCTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	22	2.0026580734429334E-4		47	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	4	0	4	0	3	26	-1	55	43	58		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGTTTGGCAGTTCTGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	22	2.0026580734429334E-4		55	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	5	0	7	5	26	43	53	50	58		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCACCGGGACTAGCCAAGAGACCCAGTACTTCGGGCCA	CSATTGTSQETQYF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	8	1	5	0	26	36	-1	41	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSATTGTSQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACAGGCCAGATCTGGAAACACCATATATTTTGGAGAG	CSARQARSGNTIYF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	4	4	1	0	5	26	-1	42	38	47		TCRBV20-01,TCRBV20-or09_02												CSARQARSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGGCAGGGGCCAAGAGACCCAGTACTTCGGGCCA	CSAREGRGQETQYF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	2	1	3	0	26	40	-1	43	49		TCRBV20-01,TCRBV20-or09_02												CSAREGRGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAAGTAGCTAGCGGGAGGGCAAATGAGCAGTTCTTCGGGCCA	CSARDQVASGRANEQFF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	4	0	7	8	2	26	40	60	48	62		TCRBV20-01,TCRBV20-or09_02												CSARDQVASGRANEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCCCTTGGGGCCCGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSARDSLGARSYNEQFF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	7	0	0	7	3	26	40	52	47	55		TCRBV20-01,TCRBV20-or09_02												CSARDSLGARSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGACAGGGGGCTTGACTGAAGCTTTCTTTGGACAA	CSARTGGLTEAFF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	0	5	0	3	26	-1	47	37	50		TCRBV20-01,TCRBV20-or09_02												CSARTGGLTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTTCGCCGGGACTAGCGGGGGACCCCAAGAGACCCAGTACTTCGGGCCA	CSARFAGTSGGPQETQYF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	54	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	0	2	1	7	3	26	37	58	44	61		TCRBV20-01,TCRBV20-or09_02												CSARFAGTSGGPQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTGAGGAGGGAGTACAATCAGCCCCAGCATTTTGGTGAT	CSVRREYNQPQHF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	7	10	0	3	3	4	26	33	42	36	46		TCRBV20-01,TCRBV20-or09_02												CSVRREYNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTGCAGACCCCGGACAGGGTTGGGCAGCCCCAGCATTTTGGTGAT	CSVQTPDRVGQPQHF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	1	3	7	10	5	26	33	51	43	56		TCRBV20-01,TCRBV20-or09_02												CSVQTPDRVGQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CACCWMMCAKACMTCTMWGTACCTCTGTGCCAGCAGTACTCCTTCGGGGACAGCTGAAGCTTTCTTTGGACAA	CASSTPSGTAEAFF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	6	9	0	25	37	-1	46	53	TCRBV25,TCRBV28													CASSTPSGTAEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCATTTTACCGGGACAGGGAACGAGCAGTACTTCGGGCCG	CASSHFTGTGNEQYF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	5	7	1	23	37	53	44	54	TCRBV04,TCRBV23													CASSHFTGTGNEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCACCGGGACAGGGGTGGGACGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	22	2.0026580734429334E-4		50	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	2	8	5	6	24	38	53	43	59		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCGACAGGTTTCACAGATACGCAGTATTTTGGCCCA	CATSDPTGFTDTQYF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	4	2	3	3	24	38	47	41	50		TCRBV24-01,TCRBV24-or09_02												CATSDPTGFTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGGGACTAGCGGTATAATAGGGGAGCTGTTTTTTGGAGAA	CATGTSGIIGELFF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	9	0	5	8	0	7	24	-1	44	33	51		TCRBV24-01,TCRBV24-or09_02				01,02								CATGTSGIIGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTATCCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLSGANVLTF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	39	unresolved			unresolved			TCRBJ02	TCRBJ02-06	01	6	5	9	4	1	3	24	36	39	37	42	TCRBV24,TCRBV27			TCRBD02										CASSLSGANVLTF+X+TCRBJ02-06	unresolved	unresolved	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAACTAGCGGGGGGGCCGTTTGGGGCCAACGTCCTGACTTTCGGGGCC	CSARDQLAGGPFGANVLTF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	57	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	0	3	0	3	3	5	24	38	54	41	59		TCRBV20-01,TCRBV20-or09_02												CSARDQLAGGPFGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD02-01*01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATCGGGGGCTAAACTACGAGCAGTACTTCGGGCCG	CASSQDRGLNYEQYF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	45							TCRBJ02	TCRBJ02-07	01	0	6	0	3	2	4	18	35	43	37	47	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRGLNYEQYF+X+TCRBJ02-07			TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGGACAGGGTATAACATCGACGCAGTATTTTGGCCCA	CASSLGQGITSTQYF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	2	3	9	0	10	18	-1	41	34	51	TCRBV05,TCRBV11													CASSLGQGITSTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTTCGGACAGACCCCACAGATACGCAGTATTTTGGCCCA	CASSFRTDPTDTQYF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	1	5	2	2	4	18	32	40	34	44	TCRBV07,TCRBV11													CASSFRTDPTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GCCACGTTTGGTGCATCCTGAAGACAGCAGTTCTACATCTGCAGTGCTAGAGATGCAGGCAGCACAGATACGCAGTATTTTGGCCCA	CSARDAGSTDTQYF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	4	0	2	1	39	53	59	55	60		TCRBV20-01,TCRBV20-or09_02												CSARDAGSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCACTAGCGGGGGGAAGCACAGATACGCAGTATTTTGGCCCA	CASSPLAGGSTDTQYF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	48	TCRBV05			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	3	1	0	2	1	19	31	45	33	46		TCRBV05-06,TCRBV05-07												CASSPLAGGSTDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGCCAGGGGGCCTACGAGCAGTACTTCGGGCCG	CASSQGQGAYEQYF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	1	2	2	0	26	42	-1	44	51		TCRBV03-01,TCRBV03-02												CASSQGQGAYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTTATGGACTGTATGGCTACACCTTCGGTTCG	CASSYGLYGYTF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	1	10	5	4	1	26	37	46	41	47		TCRBV03-01,TCRBV03-02				01,02								CASSYGLYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGCCAGGGTCAGGCAATGAGCAGTTCTTCGGGCCA	CSARDGPGSGNEQFF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	3	6	5	5	26	40	50	45	55		TCRBV20-01,TCRBV20-or09_02												CSARDGPGSGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGCGGGGGCAACAGGATACGCAGTATTTTGGCCCA	CSARDGRGQQDTQYF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	7	2	6	3	6	26	40	50	43	56		TCRBV20-01,TCRBV20-or09_02												CSARDGRGQQDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGACGGGACTAGGTACAGATACGCAGTATTTTGGCCCA	CSARTGLGTDTQYF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	0	8	3	3	2	26	37	48	40	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARTGLGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCGCGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSASSRSSYNEQFF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	7	5	0	3	2	26	37	44	40	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSASSRSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGARGACTCRGCCCTSTATCTCTGYGCCAGCAGCGTTCAAGGACTAGCGGATGATACGCAGTATTTTGGCCCA	CASSVQGLADDTQYF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	1	5	6	6	2	23	35	51	41	53	TCRBV04,TCRBV05					01,02								CASSVQGLADDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTACGGGACTACTTACGAGCAGTACTTCGGGCCG	CASSYGTTYEQYF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	9	4	2	2	23	36	45	38	47	TCRBV24,TCRBV27					01,02								CASSYGTTYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCTGGGCCCATTAAATATGGCTACACCTTCGGTTCG	CASSPGPIKYGYTF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	8	0	5	3	8	24	36	43	39	51		TCRBV24-01,TCRBV24-or09_02												CASSPGPIKYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATACCCAGGACAGAGTCCCCGATATAAGTATGGCTACACCTTCGGTTCG	CASSQYPGQSPRYKYGYTF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	57	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	1	5	5	6	15	24	39	51	45	66		TCRBV03-01,TCRBV03-02												CASSQYPGQSPRYKYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATCCAGCGGGGGTGCTTGAGCAGTTCTTCGGGCCA	CASSQDPAGVLEQFF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	45				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	6	2	9	3	4	18	35	46	38	50	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDPAGVLEQFF+X+TCRBJ02-01		TCRBD02-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGACGGGGGACTCCAAGAGACCCAGTACTTCGGGCCA	CASSLDGGLQETQYF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	0	10	1	6	0	18	32	-1	38	44	TCRBV07,TCRBV11					01,02								CASSLDGGLQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGGGACAGGGGGAAACACCATATATTTTGGAGAG	CASSGTGGNTIYF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	3	4	1	0	23	34	-1	35	44	TCRBV02,TCRBV09													CASSGTGGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGCGACGGTAGGGGTGTTGAGACCCAGTACTTCGGGCCA	CASSDGRGVETQYF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	5	2	5	7	4	24	35	47	42	51	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSDGRGVETQYF+X+TCRBJ02-05		TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TMSCTCCCARACATCTGTGTACTTCTGTGCCAGCAGTTACACCCACGTGAGGGAGACGAGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	24	2.1847178983013817E-4		55	TCRBV06			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	9	2	1	10	5	24	39	54	49	59		TCRBV06-05,TCRBV06-06												X+TCRBV06-X+TCRBJ02-03	TCRBV06	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCCGCGGGGTGGGGAGACCCAGTACTTCGGGCCA	CASSQDPRGGETQYF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	7	3	5	3	4	26	43	52	46	56		TCRBV03-01,TCRBV03-02												CASSQDPRGGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGGCCCCTGCCGAAAGAGACCCAGTACTTCGGGCCA	CASSQGPLPKETQYF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	7	0	3	0	9	26	-1	45	40	54		TCRBV03-01,TCRBV03-02												CASSQGPLPKETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCTCTACCGGGACAGGCCACCACGAGCAGTACTTCGGGCCG	CASSPSTGTGHHEQYF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	4	5	8	5	26	39	55	47	60		TCRBV03-01,TCRBV03-02												CASSPSTGTGHHEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCTGGTATTTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	24	2.1847178983013817E-4		46	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	5	8	5	16	0	26	39	-1	55	58		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGCGAGACGAGCGCGAATGAGCAGTTCTTCGGGCCA	CSARSETSANEQFF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	6	6	7	0	11	26	-1	42	38	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSARSETSANEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCGCGGGAGTACGAGCAGTACTTCGGGCCG	CSARAREYEQYF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	7	2	4	3	0	26	37	-1	40	47		TCRBV20-01,TCRBV20-or09_02												CSARAREYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTACAGAGCACATACGGGGCTACACCTTCGGTTCG	CSASTEHIRGYTF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	5	8	1	11	26	37	42	38	53		TCRBV20-01,TCRBV20-or09_02												CSASTEHIRGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGGAGGGCTGGAACTGAAGCTTTCTTTGGACAA	CSARRAGTEAFF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	0	5	1	5	26	35	42	36	47		TCRBV20-01,TCRBV20-or09_02												CSARRAGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCGGACTAGCGGGGGATCTCGAGCAGTACTTCGGGCCG		Out	VDJ	1	24	2.1847178983013817E-4		41	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	1	2	6	2	4	26	35	50	37	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGATATGGACGGACCTCCTACGAGCAGTACTTCGGGCCG	CSGYGRTSYEQYF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	7	1	7	0	5	4	26	33	42	38	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSGYGRTSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGGGACTCRGCYGTGTAYYTCTGTGCCAGCAGCTTTGGGACAGGGCTTGAGCAGTTCTTCGGGCCA	CASSFGTGLEQFF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	9	4	2	22	33	46	37	48	TCRBV07,TCRBV12													CASSFGTGLEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTTTGGGGCTAGCGGGCGTGAACTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	24	2.1847178983013817E-4		56	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	4	0	7	6	24	37	52	44	58		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCTTAGATAATCCCCCGGGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	24	2.1847178983013817E-4		47	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	8	4	2	14	0	20	31	-1	45	49	TCRBV07,TCRBV11,TCRBV23					01,02								X+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCRGCCATGTATCKCTGTGCAAGTCGCCCCAGCGAGGGTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	24	2.1847178983013817E-4		40	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	12	11	0	4	13	1	19	24	42	37	43	TCRBV07,TCRBV11,TCRBV12													X+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GRGACWCGGCMCTSTATCTCTGYGCCAGCAGCTTGAACGGGGGCTCTTACAATGAGCAGTTCTTCGGGCCA	CASSLNGGSYNEQFF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	45	unresolved						TCRBJ02	TCRBJ02-01	01	1	6	0	4	3	3	19	34	43	37	46	TCRBV05,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNGGSYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGATGGTGGGACAGGGGGTCACAGATACGCAGTATTTTGGCCCA	CASSLMVGQGVTDTQYF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	51	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	0	1	2	5	1	19	34	50	39	51		TCRBV05-06,TCRBV05-07												CASSLMVGQGVTDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCAGCTCTGGAAACACCATATATTTTGGAGAG	CASSPSSGNTIYF	In	VDJ	1	25	2.275747810730606E-4	2.7475848728967237E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	4	5	0	1	0	26	39	-1	40	43		TCRBV03-01,TCRBV03-02												CASSPSSGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGGGCCAGGAGGGACAGCCCCAGCATTTTGGTGAT	CSAKGQEGQPQHF	In	VDJ	1	25	2.275747810730606E-4	2.7475848728967237E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	10	0	7	7	1	26	36	49	43	50		TCRBV20-01,TCRBV20-or09_02												CSAKGQEGQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACCGGGACCGGGGAGCAGTACTTCGGGCCG	CSARTGTGEQYF	In	VDJ	1	25	2.275747810730606E-4	2.7475848728967237E-4	36	TCRBV20						TCRBJ02	TCRBJ02-07	01	2	0	7	7	3	4	26	38	46	41	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARTGTGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCGACCGGAGGGATGAGCAGTTCTTCGGGCCA	CSAPDRRDEQFF	In	VDJ	1	25	2.275747810730606E-4	2.7475848728967237E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	10	0	8	7	0	26	35	-1	42	48		TCRBV20-01,TCRBV20-or09_02												CSAPDRRDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCGCCCGACAGGGACGGATCGGACATGGCTACACCTTCGGTTCG	CARQGRIGHGYTF	In	VDJ	1	25	2.275747810730606E-4	2.7475848728967237E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	11	2	3	6	4	11	26	29	40	33	51		TCRBV20-01,TCRBV20-or09_02												CARQGRIGHGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCATGCTCAGGGCGGGGGTCGGAGAGACCCAGTACTTCGGGCCA	CASMLRAGVGETQYF	In	VDJ	1	25	2.275747810730606E-4	2.7475848728967237E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	7	2	4	8	4	23	33	48	41	52	TCRBV24,TCRBV27													CASMLRAGVGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAGAGGTGAGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSLRGEGYNEQFF	In	VDJ	1	25	2.275747810730606E-4	2.7475848728967237E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	11	0	3	9	0	24	36	-1	45	50		TCRBV24-01,TCRBV24-or09_02												CASSLRGEGYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGATCTAACAGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	25	2.275747810730606E-4		41	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	5	1	6	0	23	35	-1	41	45	TCRBV06,TCRBV10													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCAGGGACCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLAGTSYNEQFF	In	VDJ	1	25	2.275747810730606E-4	2.7475848728967237E-4	45							TCRBJ02	TCRBJ02-01	01	0	0	7	0	1	0	18	35	-1	36	41	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGTSYNEQFF+X+TCRBJ02-01			TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAGAACAGGGAGTCAGCCCCAGCATTTTGGTGAT	CASSQDRTGSQPQHF	In	VDJ	1	26	2.3667777231598303E-4	2.857488267812593E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	3	6	4	2	26	43	53	47	55		TCRBV03-01,TCRBV03-02												CASSQDRTGSQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCGAGGGAGAGTCACAGATACGCAGTATTTTGGCCCA	CSASRGRVTDTQYF	In	VDJ	1	26	2.3667777231598303E-4	2.857488267812593E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	9	2	2	4	3	26	37	46	41	49		TCRBV20-01,TCRBV20-or09_02												CSASRGRVTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGGTAAGGGCTAGCGTAGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	26	2.3667777231598303E-4		44	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	4	6	6	10	3	24	36	52	46	55		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ASGACTCGGCYSTGTATCTCTGTGCCAGCAGCCAAGACTCAGCGGGGGACGTGGATACGCAGTATTTTGGCCCA	CASSQDSAGDVDTQYF	In	VDJ	1	26	2.3667777231598303E-4	2.857488267812593E-4	48				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	6	2	6	3	5	19	36	47	39	52	TCRBV03,TCRBV07	TCRBV03-01,TCRBV03-02,TCRBV07-05												CASSQDSAGDVDTQYF+X+TCRBJ02-03		TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCTTGGGGCAGGGGCTAACCTACGAGCAGTACTTCGGGCCG	CASSLGQGLTYEQYF	In	VDJ	1	26	2.3667777231598303E-4	2.857488267812593E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	2	2	4	4	18	32	42	36	46	TCRBV07,TCRBV11													CASSLGQGLTYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGGGGACTCRGCYKTGTATYTCTGTGCCAGCAGTTCAATCGGCAGGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	26	2.3667777231598303E-4		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	4	1	9	1	18	29	42	38	43	TCRBV09,TCRBV11													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATGACAGGGGAGGAGGCACTGAAGCTTTCTTTGGACAA	CASSQDDRGGGTEAFF	In	VDJ	1	26	2.3667777231598303E-4	2.857488267812593E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	2	4	1	6	18	35	44	36	50	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDDRGGGTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCCCCGATAATGGACTTAATTCACCCCTCCACTTTGGGAAC	CASSPDNGLNSPLHF	In	VDJ	1	26	2.3667777231598303E-4	2.857488267812593E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	4	1	10	6	9	0	19	31	-1	40	45	TCRBV05,TCRBV07					01,02								CASSPDNGLNSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTTAGGAACTAGCGCCGCCGGGTACGAGCAGTACTTCGGGCCG	CASSLGTSAAGYEQYF	In	VDJ	1	26	2.3667777231598303E-4	2.857488267812593E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	3	6	4	4	8	19	33	44	37	52	TCRBV05,TCRBV07					01,02								CASSLGTSAAGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGACTTCTAGCGGGAGAACCCACCGGGGAGCTGTTTTTTGGAGAA	CASRLLAGEPTGELFF	In	VDJ	1	26	2.3667777231598303E-4	2.857488267812593E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	4	2	4	4	4	23	34	48	38	52	TCRBV02,TCRBV12													CASRLLAGEPTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACTGCTAGCGGGAGGAGGGGAGCAGTACTTCGGGCCG	CASSLLLAGGGEQYF	In	VDJ	1	27	2.4578076355890547E-4	2.9673916627284615E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	4	1	7	3	4	26	41	55	44	59		TCRBV12-03,TCRBV12-04												CASSLLLAGGGEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGACTAGCGGGGATAGGACCCAGTACTTCGGGCCA	CASSLTSGDRTQYF	In	VDJ	1	27	2.4578076355890547E-4	2.9673916627284615E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	2	3	7	0	4	26	-1	51	40	55		TCRBV12-03,TCRBV12-04												CASSLTSGDRTQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACCCTCTAGCGCTGGTTCAGCCAAAAACATTCAGTACTTCGGCGCC	CASSQPSSAGSAKNIQYF	In	VDJ	1	27	2.4578076355890547E-4	2.9673916627284615E-4	54	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	2	4	6	0	4	7	26	41	51	45	58		TCRBV03-01,TCRBV03-02				01,02								CASSQPSSAGSAKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD02-01	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTTCGTACCTGGAGCAGTACTTCGGGCCG	CASSQVSYLEQYF	In	VDJ	1	27	2.4578076355890547E-4	2.9673916627284615E-4	39	TCRBV03						TCRBJ02	TCRBJ02-07	01	1	3	7	7	6	3	26	42	50	48	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVSYLEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCGCTAGCGCGAATTCCTACGAGCAGTACTTCGGGCCG	CSARAASANSYEQYF	In	VDJ	1	27	2.4578076355890547E-4	2.9673916627284615E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	4	6	1	3	5	26	39	48	42	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSARAASANSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCTCCACAGGGTAACTCCTACGAGCAGTACTTCGGGCCG	CATSAPQGNSYEQYF	In	VDJ	1	27	2.4578076355890547E-4	2.9673916627284615E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	3	0	4	3	24	37	47	41	50		TCRBV24-01,TCRBV24-or09_02												CATSAPQGNSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCATGATATGGTAGACAGGGGTTATGGCTACACCTTCGGTTCG		Out	VDJ	1	27	2.4578076355890547E-4		44	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	2	2	5	10	1	24	34	52	44	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAGCATGGGCAGGGCAGGAAAACTGTTTTTTGGCAGT	CASSESMGRAGKLFF	In	VDJ	1	27	2.4578076355890547E-4	2.9673916627284615E-4	45	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	3	10	8	4	23	38	51	46	55		TCRBV06-01,TCRBV06-08												CASSESMGRAGKLFF+TCRBV06-X+TCRBJ01-04	TCRBV06	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CTACATCTGCAGTGCTAGAGAAGGGAGACCTCTGGGGGGACGAAGGGGGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CSAREGRPLGGRRGYSNQPQHF	In	VDJ	1	27	2.4578076355890547E-4	2.9673916627284615E-4	66	TCRBV20						TCRBJ01	TCRBJ01-05	01	0	5	1	0	22	2	7	21	49	43	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREGRPLGGRRGYSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCCGCAGGCTACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPAGYSYNEQFF	In	VDJ	1	27	2.4578076355890547E-4	2.9673916627284615E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	4	0	4	3	18	30	38	34	41	TCRBV05,TCRBV11													CASSPAGYSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCTTCAGCGGGGCCAGCACAGATACGCAGTATTTTGGCCCA	CASSFSGASTDTQYF	In	VDJ	1	27	2.4578076355890547E-4	2.9673916627284615E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	6	3	0	1	2	19	33	41	34	43	TCRBV05,TCRBV07													CASSFSGASTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAGARGACTCRGCYSYKTATCTYTGCGCCAGCAGCCAAGATTGGGGGGCGGGTGAGCAGTTCTTCGGGCCA	CASSQDWGAGEQFF	In	VDJ	1	27	2.4578076355890547E-4	2.9673916627284615E-4	42	unresolved						TCRBJ02	TCRBJ02-01	01	4	6	0	9	8	3	19	31	45	39	48	TCRBV01,TCRBV05			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDWGAGEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCACAGGGTTAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSTGLNTGELFF	In	VDJ	1	28	2.548837548018279E-4	3.0772950576443307E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	3	2	1	3	26	37	44	38	47		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSTGLNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGTATTGACAGACAACACTGAAGCTTTCTTTGGACAA	XASSQVLTDNTEAFF	In	VDJ	1	28	2.548837548018279E-4	3.0772950576443307E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	5	2	4	2	23	39	48	43	50	TCRBV01,TCRBV04													XASSQVLTDNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCCAGGGATACATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	28	2.548837548018279E-4		37	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	3	5	3	4	26	34	42	37	46		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCCTTAGCGGACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	28	2.548837548018279E-4		38	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	5	5	2	4	1	26	36	46	40	47		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATCTCCCCGGGACTAGCGGGAGTCGAGCAGTACTTCGGGCCG	CSAISPGLAGVEQYF	In	VDJ	1	28	2.548837548018279E-4	3.0772950576443307E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	0	2	6	7	1	26	36	57	43	58		TCRBV20-01,TCRBV20-or09_02												CSAISPGLAGVEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTCCTGGGGGCCAAGAGACCCAGTACTTCGGGCCA	CATSPGGQETQYF	In	VDJ	1	28	2.548837548018279E-4	3.0772950576443307E-4	39	TCRBV24						TCRBJ02	TCRBJ02-05	01	6	6	1	1	3	0	24	36	-1	39	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSPGGQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTGGGACAGTTCATATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	28	2.548837548018279E-4		43	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	5	5	1	5	24	37	45	38	50		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCCCGGCACAGCCTGAAAAACTGTTTTTTGGCAGT	CASSSPAQPEKLFF	In	VDJ	1	28	2.548837548018279E-4	3.0772950576443307E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	5	7	8	2	24	36	48	44	50		TCRBV24-01,TCRBV24-or09_02												CASSSPAQPEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GAGACWCGGCMMTGTATCKCTGYGCCAGCAGCCAAGATCCGGGAGGGCCAGATACGCAGTATTTTGGCCCA	CASSQDPGGPDTQYF	In	VDJ	1	28	2.548837548018279E-4	3.0772950576443307E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	8	0	4	7	1	18	30	45	37	46	TCRBV07,TCRBV23													CASSQDPGGPDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCTGCTACCCCGGGACATACCCATTATACCCCCTTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	28	2.548837548018279E-4		62				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	6	4	10	18	18	30	46	40	64	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02,TCRBV11-03												X+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCRGCYGTGTATKTYTGTGCCAGCAGCACGGGACAGGGGGGAGGCAAAAACATTCAGTACTTCGGCGCC	CASSTGQGGGKNIQYF	In	VDJ	1	28	2.548837548018279E-4	3.0772950576443307E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	0	1	3	2	4	18	30	43	32	47	TCRBV11,TCRBV12													CASSTGQGGGKNIQYF+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCCCGTTGGGGGCGGGGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	28	2.548837548018279E-4		47	unresolved						TCRBJ02	TCRBJ02-02	01	5	6	0	5	7	4	18	30	43	37	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTCCCAGACATCTGTGTAYTTCTGYGCCAGCAGTGAAGGGGGACAGGGGAGGAATGAGCAGTTCTTCGGGCCA	CASSEGGQGRNEQFF	In	VDJ	1	28	2.548837548018279E-4	3.0772950576443307E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	2	7	3	3	23	37	50	40	53	TCRBV06,TCRBV10													CASSEGGQGRNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTKGGKGACTYKGCTGTGTATYTCTGTGCCAGCAGCCCATGACTAGGCATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	28	2.548837548018279E-4		38	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	8	8	4	2	22	34	44	38	46	TCRBV03,TCRBV07					01,02								X+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGCGTAGTTGCGACTAGCACAGATACGCAGTATTTTGGCCCA	CASSVVATSTDTQYF	In	VDJ	1	28	2.548837548018279E-4	3.0772950576443307E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	2	10	0	4	0	23	39	-1	43	47	TCRBV02,TCRBV09					01,02								CASSVVATSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGGACCGGGCTACAGTGCACATGAAGCTTTCTTTGGACAA	CASSVGPGYSAHEAFF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	48	TCRBV12						TCRBJ01	TCRBJ01-01	01	6	1	7	7	4	16	26	37	45	41	61		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGPGYSAHEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACCCCACGGGACTCCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSQDPTGLLAKNIQYF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	54	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	0	0	10	0	6	3	26	43	55	49	58		TCRBV03-01,TCRBV03-02				01,02								CASSQDPTGLLAKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD02-01	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTACCGAGGGGGGCACAGATACGCAGTATTTTGGCCCA	CSTEGGTDTQYF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	5	1	1	4	0	26	32	-1	36	42		TCRBV20-01,TCRBV20-or09_02												CSTEGGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTGGGGAAGGGAGGTTGGGAGACCCAGTACTTCGGGCCA	CSARDLGKGGWETQYF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	9	1	5	9	4	26	40	55	49	59		TCRBV20-01,TCRBV20-or09_02												CSARDLGKGGWETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCGACAGGCGGTAATGAAAAACTGTTTTTTGGCAGT	CSARSTGGNEKLFF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	2	4	4	2	3	26	38	46	40	49		TCRBV20-01,TCRBV20-or09_02												CSARSTGGNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGACGGGGGCTAGGGGAGCTTTCTTTGGACAA	CSARTGARGAFF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	36	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	6	0	10	3	6	26	37	46	40	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARTGARGAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCGACGGGACAGGGACTGAAAAACTGTTTTTTGGCAGT	CASSDGTGTEKLFF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	3	7	3	2	18	30	42	33	44	TCRBV07,TCRBV11													CASSDGTGTEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCMTSTATCKCTGTGCCAACAGCTTAGGTGGCTTTAATGAAAAACTGTTTTTTGGCAGT	CANSLGGFNEKLFF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	42	unresolved			unresolved			TCRBJ01	TCRBJ01-04	01	2	5	4	4	0	6	19	-1	36	33	42	TCRBV05,TCRBV07			TCRBD01,TCRBD02										CANSLGGFNEKLFF+X+TCRBJ01-04	unresolved	unresolved	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGAACTAGCGGGTAAGAATGAGCAGTTCTTCGGGCCA	CASSLELAGKNEQFF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	45	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	3	4	7	3	4	19	33	45	36	49		TCRBV05-06,TCRBV05-07				01,02								CASSLELAGKNEQFF+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGACAGGGGATAATTCACCCCTCCACTTTGGGAAC	CSARDGTGDNSPLHF	In	VDJ	1	30	2.730897372876727E-4	3.2971018474760685E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	0	2	5	1	0	26	40	-1	41	51		TCRBV20-01,TCRBV20-or09_02												CSARDGTGDNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGACTTCAATGGCTACACCTTCGGTTCG	CSASDFNGYTF	In	VDJ	1	30	2.730897372876727E-4	3.2971018474760685E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	2	10	6	1	3	26	37	42	38	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSASDFNGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCAGGGAAAACTGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	30	2.730897372876727E-4		41	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	3	1	1	6	26	35	41	36	47		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGGAAGTTGACAGCCACTTTAGCAGGGGCCAACGTCCTGACTTTCGGGGCC	CASRKLTATLAGANVLTF	In	VDJ	1	30	2.730897372876727E-4	3.2971018474760685E-4	54	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	2	5	4	6	11	22	33	44	39	55		TCRBV12-03,TCRBV12-04												CASRKLTATLAGANVLTF+TCRBV12-X+TCRBJ02-06	TCRBV12	TCRBD01-01*01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGAGGTTCGGGACATGAATACGAGCAGTACTTCGGGCCG		Out	VDJ	1	30	2.730897372876727E-4		49				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	6	4	7	4	18	35	48	42	52	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												X+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTCTCGACTAGACGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSSRLDGTGELFF	In	VDJ	1	30	2.730897372876727E-4	3.2971018474760685E-4	45	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	2	8	4	3	4	19	32	41	35	45		TCRBV05-06,TCRBV05-07				01,02								CASSSRLDGTGELFF+TCRBV05-X+TCRBJ02-02	TCRBV05	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTTACACTCAAGAGACCCAGTACTTCGGGCCA	CASSYTQETQYF	In	VDJ	1	31	2.8219272853059513E-4	3.4070052423919376E-4	36	TCRBV06			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	3	10	2	0	0	24	-1	-1	39	42		TCRBV06-05,TCRBV06-06				01,02								CASSYTQETQYF+TCRBV06-X+TCRBJ02-05	TCRBV06	TCRBD02-01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTCGGGACAGGGAAAAACTATGGCTACACCTTCGGTTCG	CASSQVGTGKNYGYTF	In	VDJ	1	31	2.8219272853059513E-4	3.4070052423919376E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	3	2	2	3	26	42	53	44	56		TCRBV03-01,TCRBV03-02												CASSQVGTGKNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGAACTAAAGAAATTCGAGCAGTACTTCGGGCCG	CSAELKKFEQYF	In	VDJ	1	31	2.8219272853059513E-4	3.4070052423919376E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	3	9	6	3	8	26	34	41	37	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSAELKKFEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCAGGGACTAGCGGGAGGGGTGAGCAGTTCTTCGGGCCA	CSARPGTSGRGEQFF	In	VDJ	1	31	2.8219272853059513E-4	3.4070052423919376E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	0	0	9	3	1	26	38	57	41	58		TCRBV20-01,TCRBV20-or09_02												CSARPGTSGRGEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGCCCGTGCTAGCAATCCTCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	31	2.8219272853059513E-4		53	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	4	7	0	8	8	26	37	50	45	58		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAGGGGGGCAACCTTCTAGGGACTGCCTACGAGCAGTACTTCGGGCCG	CSAEGGNLLGTAYEQYF	In	VDJ	1	31	2.8219272853059513E-4	3.4070052423919376E-4	51	TCRBV20						TCRBJ02	TCRBJ02-07	01	5	5	1	2	1	18	26	35	42	36	60		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAEGGNLLGTAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTCAGGGGCCGGGCAATCAGCCCCAGCATTTTGGTGAT	CATSQGPGNQPQHF	In	VDJ	1	31	2.8219272853059513E-4	3.4070052423919376E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	2	2	0	4	24	-1	42	36	46		TCRBV24-01,TCRBV24-or09_02												CATSQGPGNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACCAAAGACAGAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	31	2.8219272853059513E-4		43	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	5	5	8	1	24	36	49	44	50		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCGGCYGTGTATSTCTGTGCCAGCAGCTTGGTTCGTCTCCGGTTAAGCTTAACAGGGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSLVRLRLSLTGGSGNTIYF	In	VDJ	1	31	2.8219272853059513E-4	3.4070052423919376E-4	66				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	1	0	23	0	15	28	-1	51	59	TCRBV07,TCRBV11	TCRBV07-01,TCRBV07-02,TCRBV07-04,TCRBV07-05,TCRBV11-02,TCRBV11-03												CASSLVRLRLSLTGGSGNTIYF+X+TCRBJ01-03		TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCCGACAGGGGAGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	32	2.912957197735176E-4		41	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	2	3	4	2	26	37	49	41	51		TCRBV12-03,TCRBV12-04,TCRBV12-05												X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCAAGGACAGGGGTGTTGGCAGAGACCCAGTACTTCGGGCCA	CASSPRTGVLAETQYF	In	VDJ	1	32	2.912957197735176E-4	3.516908637307806E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	2	4	4	7	26	38	51	42	58		TCRBV12-03,TCRBV12-04												CASSPRTGVLAETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGGCTACTAGCGACACCCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	32	2.912957197735176E-4		38	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	9	3	6	2	3	6	26	31	41	34	47		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGTACAGAGCCTACGAGCAGTACTTCGGGCCG	CSARGYRAYEQYF	In	VDJ	1	32	2.912957197735176E-4	3.516908637307806E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	3	5	2	3	2	26	39	46	42	48		TCRBV20-01,TCRBV20-or09_02												CSARGYRAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCTTACGGGACTAGCGGGGGACATGAGCAGTTCTTCGGGCCA	CSARSYGTSGGHEQFF	In	VDJ	1	32	2.912957197735176E-4	3.516908637307806E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	0	2	8	6	2	26	38	58	44	60		TCRBV20-01,TCRBV20-or09_02												CSARSYGTSGGHEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCACCGACAGAAATAATCAGCCCCAGCATTTTGGTGAT	CSASTDRNNQPQHF	In	VDJ	1	32	2.912957197735176E-4	3.516908637307806E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	5	4	4	4	26	37	46	41	50		TCRBV20-01,TCRBV20-or09_02												CSASTDRNNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGCACCACTCGGATATCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSARGTTRISGANVLTF	In	VDJ	1	32	2.912957197735176E-4	3.516908637307806E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	8	0	1	0	12	26	-1	41	37	53		TCRBV20-01,TCRBV20-or09_02												CSARGTTRISGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD01-01*01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATGTCGGACTAGCGGGAGGTGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	32	2.912957197735176E-4		47	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	1	1	4	4	3	26	36	54	40	57		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGAGTCAACAGGGATCAGCCCCAGCATTTTGGTGAT	CASRVNRDQPQHF	In	VDJ	1	32	2.912957197735176E-4	3.516908637307806E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	3	5	5	0	23	34	-1	39	45	TCRBV06,TCRBV10													CASRVNRDQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCTAGCGGGGGCTCGACGCAGTATTTTGGCCCA	CASSLASGGSTQYF	In	VDJ	1	32	2.912957197735176E-4	3.516908637307806E-4	42				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	5	2	9	0	4	18	-1	44	35	48	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLASGGSTQYF+X+TCRBJ02-03		TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGTATTTCTGTGCCAGCAGCCAAGCCCCAGGACTAGCGGGGGGGCCAAAAGATCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	32	2.912957197735176E-4		65	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	0	1	0	2	4	9	2	19	38	23	47	TCRBV03,TCRBV21													X+X+TCRBJ02-04	unresolved	TCRBD02-01*01	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCTGGAGGGACGAGAGACCCAGTACTTCGGGCCA	CASSLEGRETQYF	In	VDJ	1	33	3.0039871101644E-4	3.6268120322236754E-4	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	10	0	4	3	3	26	37	46	40	49		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSLEGRETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*02	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTACACAAGAGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSTQESNQPQHF	In	VDJ	1	33	3.0039871101644E-4	3.6268120322236754E-4	42	TCRBV12						TCRBJ01	TCRBJ01-05	01	5	3	6	1	0	6	26	-1	41	38	47		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTQESNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAACCTACGAGCAGTACTTCGGGCCG	CASSQTYEQYF	In	VJ	1	33	3.0039871101644E-4	3.6268120322236754E-4	33	TCRBV03						TCRBJ02	TCRBJ02-07	01	2	0	0	2	0	1	26	-1	41	-1	42		TCRBV03-01,TCRBV03-02												CASSQTYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGACAGGGCAAGGGGCTACACCTTCGGTTCG	CASSPDRARGYTF	In	VDJ	1	33	3.0039871101644E-4	3.6268120322236754E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	3	8	1	5	26	39	48	40	53		TCRBV03-01,TCRBV03-02												CASSPDRARGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAGGACTCCAGGAGCAGTTCTTCGGGCCA	CASSLGLQEQFF	In	VDJ	1	33	3.0039871101644E-4	3.6268120322236754E-4	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	10	10	3	4	26	38	46	41	50		TCRBV03-01,TCRBV03-02				01,02								CASSLGLQEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCAGGGAGATGGCAATCAGCCCCAGCATTTTGGTGAT	CASSQGDGNQPQHF	In	VDJ	1	33	3.0039871101644E-4	3.6268120322236754E-4	42	TCRBV03						TCRBJ01	TCRBJ01-05	01	6	4	3	2	1	5	26	37	43	38	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGDGNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACCAAGGGAGCCCTCTCCTACAATGAGCAGTTCTTCGGGCCA	CSATKGALSYNEQFF	In	VDJ	1	33	3.0039871101644E-4	3.6268120322236754E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	9	2	0	6	4	26	34	45	40	49		TCRBV20-01,TCRBV20-or09_02												CSATKGALSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTCGGGGACACCTCATACAATGAGCAGTTCTTCGGGCCA	CSALGDTSYNEQFF	In	VDJ	1	33	3.0039871101644E-4	3.6268120322236754E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	6	4	5	5	26	34	45	39	50		TCRBV20-01,TCRBV20-or09_02												CSALGDTSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGTGGGACTAGCTTCCGACTACGAGCAGTACTTCGGGCCG	CSAVGLASDYEQYF	In	VDJ	1	33	3.0039871101644E-4	3.6268120322236754E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	7	3	2	6	26	35	46	37	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSAVGLASDYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACTCCGGGGCCTACAATCAGCCCCAGCATTTTGGTGAT	CATSDSGAYNQPQHF	In	VDJ	1	33	3.0039871101644E-4	3.6268120322236754E-4	45	TCRBV24						TCRBJ01	TCRBJ01-05	01	4	7	0	3	4	3	24	38	47	42	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDSGAYNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGGACGGCTACGAGCAGTACTTCGGGCCG	CATSDLDGYEQYF	In	VDJ	1	33	3.0039871101644E-4	3.6268120322236754E-4	39	TCRBV24						TCRBJ02	TCRBJ02-07	01	0	2	7	3	0	2	24	-1	45	42	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDLDGYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGGAGGGACCCAAGAGACCCAGTACTTCGGGCCA	CASSLAGGTQETQYF	In	VDJ	1	33	3.0039871101644E-4	3.6268120322236754E-4	45				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	9	0	1	0	2	18	-1	42	35	44	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAGGTQETQYF+X+TCRBJ02-05		TCRBD02-01*02	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCRGCCMTSTATCKCTGTGCCAGAAGCTTGGCGTAGGCGGGCCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	33	3.0039871101644E-4		50	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	7	4	0	5	1	19	35	45	40	46	TCRBV05,TCRBV07					01,02								X+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TTTATCTYTGCGCCAGCCTCCATTGGTAGGGCGAGCCGGGACTAGCGGGAGGAGAGGCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	33	3.0039871101644E-4		67	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	8	0	1	2	20	5	4	13	48	33	53	TCRBV01,TCRBV05													X+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCGGCGATTTACAGATGAACACTGAAGCTTTCTTTGGACAA	CASGDLQMNTEAFF	In	VDJ	1	34	3.0950170225936243E-4	3.7367154271395446E-4	42	unresolved			unresolved			TCRBJ01	TCRBJ01-01	01	10	3	5	0	10	1	24	31	45	41	46	TCRBV06,TCRBV10			TCRBD01,TCRBD02										CASGDLQMNTEAFF+X+TCRBJ01-01	unresolved	unresolved	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGTAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVNTGELFF	In	VDJ	1	34	3.0950170225936243E-4	3.7367154271395446E-4	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	5	9	2	1	0	26	38	-1	39	41		TCRBV03-01,TCRBV03-02				01,02								CASSVNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTTATTGTTCCATTTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	34	3.0950170225936243E-4		50	TCRBV03						TCRBJ01	TCRBJ01-02	01	5	2	7	4	19	0	26	38	-1	57	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAGCCTCTCGGGACGCTATACAATGAGCAGTTCTTCGGGCCA	CSAKPLGTLYNEQFF	In	VDJ	1	34	3.0950170225936243E-4	3.7367154271395446E-4	45	TCRBV20						TCRBJ02	TCRBJ02-01	01	6	0	7	4	10	4	26	34	49	44	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKPLGTLYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGAAGCCGAGAAGGAAACACCATATATTTTGGAGAG	CSAGSREGNTIYF	In	VDJ	1	34	3.0950170225936243E-4	3.7367154271395446E-4	39	TCRBV20						TCRBJ01	TCRBJ01-03	01	6	1	8	4	1	9	26	34	38	35	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAGSREGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAATTACCAAGAGACCCAGTACTTCGGGCCA	CSARDNYQETQYF	In	VDJ	1	34	3.0950170225936243E-4	3.7367154271395446E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	5	9	0	0	3	26	-1	42	40	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDNYQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGTGACAGGGAACACTGAAGCTTTCTTTGGACAA	CASSVTGNTEAFF	In	VDJ	1	34	3.0950170225936243E-4	3.7367154271395446E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	4	1	2	0	23	35	-1	37	43	TCRBV06,TCRBV10													CASSVTGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCTGCAGTGCCGCTCCCGGACTAGCGGGAGAAATTAGTCTCACCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	34	3.0950170225936243E-4		67	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	6	1	2	0	7	14	2	10	30	17	44		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD02-01*02	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGACCCGACAGGGACCACAGATACGCAGTATTTTGGCCCA	CASSDPTGTTDTQYF	In	VDJ	1	35	3.1860469350228484E-4	3.846618822055413E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	3	2	6	2	26	37	50	43	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSDPTGTTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCTTCTAGCACAGATACGCAGTATTTTGGCCCA	CASSLASSTDTQYF	In	VDJ	1	35	3.1860469350228484E-4	3.846618822055413E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	4	10	0	2	0	26	43	-1	45	47		TCRBV12-03,TCRBV12-04				01,02								CASSLASSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGCAGGTCCGAAAAACATTCAGTACTTCGGCGCC	CASSQGAGPKNIQYF	In	VDJ	1	35	3.1860469350228484E-4	3.846618822055413E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	4	4	4	3	4	26	42	49	45	53		TCRBV03-01,TCRBV03-02												CASSQGAGPKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD01-01*01	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAGGACCCTAGATACGCAGTATTTTGGCCCA	CSARTLDTQYF	In	VDJ	1	35	3.1860469350228484E-4	3.846618822055413E-4	33	TCRBV20						TCRBJ02	TCRBJ02-03	01	6	1	7	5	2	3	26	34	40	36	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARTLDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGGGGGACTAATGAAAAACTGTTTTTTGGCAGT	CSARGTNEKLFF	In	VDJ	1	35	3.1860469350228484E-4	3.846618822055413E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	6	8	2	2	1	0	26	34	-1	35	41		TCRBV20-01,TCRBV20-or09_02												CSARGTNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCGGGACACACTGAAGCTTTCTTTGGACAA	CSARPGHTEAFF	In	VDJ	1	35	3.1860469350228484E-4	3.846618822055413E-4	36	TCRBV20						TCRBJ01	TCRBJ01-01	01	2	0	7	3	2	0	26	38	-1	40	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARPGHTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAACAGGGGGACTTCAATCAGCCCCAGCATTTTGGTGAT	CSAREQGDFNQPQHF	In	VDJ	1	35	3.1860469350228484E-4	3.846618822055413E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	1	3	0	4	26	-1	48	40	52		TCRBV20-01,TCRBV20-or09_02												CSAREQGDFNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTAGCGGGGGGGTCTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSARDLAGGSSSYNEQFF	In	VDJ	1	35	3.1860469350228484E-4	3.846618822055413E-4	54	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	4	0	0	1	5	26	40	53	41	58		TCRBV20-01,TCRBV20-or09_02												CSARDLAGGSSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCCAGGACAGGGGGTAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	35	3.1860469350228484E-4		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	1	1	2	3	1	19	31	44	34	45	TCRBV07,TCRBV11													X+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCAGGGGGCGCGGAATGAAAAACTGTTTTTTGGCAGT	CASSQGARNEKLFF	In	VDJ	1	35	3.1860469350228484E-4	3.846618822055413E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	0	5	0	4	18	-1	38	30	42	TCRBV07,TCRBV11													CASSQGARNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCCGACAGGGGGCTTTACGATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	36	3.2770768474520726E-4		44	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	0	5	3	6	26	34	47	37	53		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGCGGGGACTCAAGATACGCAGTATTTTGGCCCA	CSAAGTQDTQYF	In	VDJ	1	36	3.2770768474520726E-4	3.9565222169712824E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	10	5	4	2	26	34	44	38	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSAAGTQDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACACAGGGGGCATCACTGAAGCTTTCTTTGGACAA	CSANTGGITEAFF	In	VDJ	1	36	3.2770768474520726E-4	3.9565222169712824E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	0	4	2	2	26	36	47	38	49		TCRBV20-01,TCRBV20-or09_02												CSANTGGITEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGACAGTCCAGGGCGGGAACACCATATATTTTGGAGAG	CSARGTVQGGNTIYF	In	VDJ	1	36	3.2770768474520726E-4	3.9565222169712824E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	1	5	7	0	11	26	-1	45	39	56		TCRBV20-01,TCRBV20-or09_02												CSARGTVQGGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGGTGATTAGAATTCACCCCTCCACTTTGGGAAC	CSARGGD*NSPLHF	Stop	VDJ	1	36	3.2770768474520726E-4		42	TCRBV20						TCRBJ01	TCRBJ01-06	01	1	6	2	7	0	7	26	-1	43	39	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGGD*NSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCGTGGCGGGGGCCTCCTACGAGCAGTACTTCGGGCCG	CSASVAGASYEQYF	In	VDJ	1	36	3.2770768474520726E-4	3.9565222169712824E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	7	2	0	6	1	26	35	48	41	49		TCRBV20-01,TCRBV20-or09_02												CSASVAGASYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCTAGGGTGCCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	36	3.2770768474520726E-4		41	TCRBV24						TCRBJ02	TCRBJ02-02	01	3	5	3	6	2	3	24	39	45	41	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGCCATGGGTGGTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSAMGGSYNEQFF	In	VDJ	1	36	3.2770768474520726E-4	3.9565222169712824E-4	45	unresolved						TCRBJ02	TCRBJ02-01	01	4	0	9	1	4	4	23	36	43	40	47	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAMGGSYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACTGGGGTCCTGGGAACATTCAGTACTTCGGCGCC	CASSHWGPGNIQYF	In	VDJ	1	37	3.368106759881297E-4	4.066425611887151E-4	42	TCRBV03						TCRBJ02	TCRBJ02-04	01	3	6	2	7	2	7	26	40	46	42	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHWGPGNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03		TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGCGGGGGAGGAGATACGCAGTATTTTGGCCCA	CSARRGGGDTQYF	In	VDJ	1	37	3.368106759881297E-4	4.066425611887151E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	7	2	5	1	3	26	38	46	39	49		TCRBV20-01,TCRBV20-or09_02												CSARRGGGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGTTACTGATCATGGCTACACCTTCGGTTCG	CSARVTDHGYTF	In	VDJ	1	37	3.368106759881297E-4	4.066425611887151E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	3	10	6	4	4	26	37	44	41	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSARVTDHGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGACCGACGAACATCTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	37	3.368106759881297E-4		41	TCRBV24						TCRBJ02	TCRBJ02-07	01	7	2	7	3	3	8	24	35	41	38	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCACAGGGGCAGTCATCTACTACGAGCAGTACTTCGGGCCG	CASSTGAVIYYEQYF	In	VDJ	1	38	3.4591366723105214E-4	4.17632900680302E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	2	3	0	10	26	-1	45	38	55		TCRBV03-01,TCRBV03-02												CASSTGAVIYYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGACCAAGACAGGACTATGGCTACACCTTCGGTTCG	CRPRQDYGYTF	In	VDJ	1	38	3.4591366723105214E-4	4.17632900680302E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	2	4	3	5	0	26	31	-1	36	42		TCRBV20-01,TCRBV20-or09_02												CRPRQDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTTGGGGTCTATGGGGATGAGCAGTTCTTCGGGCCA	CASSFGVYGDEQFF	In	VDJ	1	38	3.4591366723105214E-4	4.17632900680302E-4	42	unresolved						TCRBJ02	TCRBJ02-01	01	6	6	2	8	3	9	24	36	43	39	52	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGVYGDEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCAGGGGTCTCCCAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	38	3.4591366723105214E-4		49				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	5	2	0	0	6	18	-1	40	35	46	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												X+X+TCRBJ02-03		TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAACCCCAGGGGGCGGGTGAAAAACTGTTTTTTGGCAGT	CASSQPQGAGEKLFF	In	VDJ	1	39	3.5501665847397456E-4	4.2862324017188893E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	0	7	3	3	23	38	49	41	52	TCRBV01,TCRBV04													CASSQPQGAGEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCGGGGCTATGGCTACACCTTCGGTTCG	CSARDRGYGYTF	In	VDJ	1	39	3.5501665847397456E-4	4.2862324017188893E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	8	3	4	1	0	26	40	-1	41	46		TCRBV20-01,TCRBV20-or09_02												CSARDRGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGCTAGCGCGTCCTACGACGAGCAGTACTTCGGGCCG	CSAREASASYDEQYF	In	VDJ	1	39	3.5501665847397456E-4	4.2862324017188893E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	4	6	5	2	9	26	40	48	42	57		TCRBV20-01,TCRBV20-or09_02				01,02								CSAREASASYDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCSTGTATSTCTGTGCCAGCAGCTCCTTGGACAGGGGAGACTACGAGCAGTACTTCGGGCCG	CASSSLDRGDYEQYF	In	VDJ	1	39	3.5501665847397456E-4	4.2862324017188893E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	2	3	4	3	18	31	44	35	47	TCRBV05,TCRBV11													CASSSLDRGDYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTCTGACTAGCGGGAGTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	39	3.5501665847397456E-4		44	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	2	2	4	2	1	18	32	46	34	47	TCRBV05,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAAGGAGCGGGGTAACCGGGGAGCTGTTTTTTGGAGAA	CASSLRSGVTGELFF	In	VDJ	1	39	3.5501665847397456E-4	4.2862324017188893E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	6	3	5	4	2	19	33	44	37	46	TCRBV05,TCRBV11													CASSLRSGVTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGYYWGGWGACWCWGCWSKGTATTTCTGTGCCAGCAGCCCACAGGGAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	40	3.6411964971689697E-4		41	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	3	3	0	1	0	26	39	-1	40	46	TCRBV03,TCRBV21													X+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCTGGGCAAAGGGTGAAAAACTGTTTTTTGGCAGT	CASSRWAKGEKLFF	In	VDJ	1	40	3.6411964971689697E-4	4.396135796634758E-4	42	TCRBV03						TCRBJ01	TCRBJ01-04	01	4	5	3	7	9	0	26	39	-1	48	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRWAKGEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCCGGATCCAAAACAATGAGCAGTTCTTCGGGCCA	CSARDPRIQNNEQFF	In	VDJ	1	40	3.6411964971689697E-4	4.396135796634758E-4	45	TCRBV20						TCRBJ02	TCRBJ02-01	01	0	1	8	5	5	6	26	40	48	45	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDPRIQNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCGGGACTCCTACAATGAGCAGTTCTTCGGGCCA	CSAPRDSYNEQFF	In	VDJ	1	40	3.6411964971689697E-4	4.396135796634758E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	8	3	0	3	0	26	35	-1	38	43		TCRBV20-01,TCRBV20-or09_02												CSAPRDSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCATGGACTATTCGCCCCCACATAGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	40	3.6411964971689697E-4		52	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	1	9	5	3	16	22	33	42	36	58		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCCTCCCGGGGTCGGGGACTGAAGCTTTCTTTGGACAA	CASSLPGSGTEAFF	In	VDJ	1	40	3.6411964971689697E-4	4.396135796634758E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	3	5	4	6	24	36	45	40	51	TCRBV12,TCRBV21													CASSLPGSGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGATGGACTTTCAAGAGACCCAGTACTTCGGGCCA	CASRMDFQETQYF	In	VDJ	1	41	3.732226409598194E-4	4.506039191550627E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	1	10	2	3	2	26	37	45	40	47		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASRMDFQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATATCGCAAGACAGAAAAACATTCAGTACTTCGGCGCC	CASSQDIARQKNIQYF	In	VDJ	1	41	3.732226409598194E-4	4.506039191550627E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	2	5	4	8	0	26	43	-1	51	56		TCRBV03-01,TCRBV03-02												CASSQDIARQKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD01-01*01	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGACAGGGGGAATTCACCCCTCCACTTTGGGAAC	CSASDRGNSPLHF	In	VDJ	1	41	3.732226409598194E-4	4.506039191550627E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	2	1	7	1	0	26	37	-1	38	47		TCRBV20-01,TCRBV20-or09_02												CSASDRGNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTCCCTGGACGGGATACGCAGTATTTTGGCCCA	CATSDFPGRDTQYF	In	VDJ	1	41	3.732226409598194E-4	4.506039191550627E-4	42	TCRBV24						TCRBJ02	TCRBJ02-03	01	1	1	7	6	4	2	24	41	49	45	51		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDFPGRDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGGGGACAGGGCTCTCCGAGCAGTACTTCGGGCCG	CASSLGTGLSEQYF	In	VDJ	1	41	3.732226409598194E-4	4.506039191550627E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	6	3	5	24	36	48	39	53		TCRBV24-01,TCRBV24-or09_02												CASSLGTGLSEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GAGRGACWCRGCMSTGTATCTCTRCGCCAGCAGCCAAGATGGGTCTAGCGGCTCCTACAATGAGCAGTTCTTCGGGCCA	XASSQDGSSGSYNEQFF	In	VDJ	1	41	3.732226409598194E-4	4.506039191550627E-4	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	5	0	5	0	22	39	-1	44	51	TCRBV04,TCRBV23					01,02								XASSQDGSSGSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCCAAGATGGAACAGGGGACAATGAAAAACTGTTTTTTGGCAGT	CASSQDGTGDNEKLFF	In	VDJ	1	41	3.732226409598194E-4	4.506039191550627E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	2	5	9	2	19	31	47	40	49	TCRBV05,TCRBV11													CASSQDGTGDNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGGGACAGACCGGGGACTATGGCTACACCTTCGGTTCG	CASSQAGQTGDYGYTF	In	VDJ	1	42	3.823256322027418E-4	4.615942586466496E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	5	3	1	7	26	42	50	43	57		TCRBV03-01,TCRBV03-02												CASSQAGQTGDYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTCGAGGTGACACTGAAGCTTTCTTTGGACAA	CASSPRGDTEAFF	In	VDJ	1	42	3.823256322027418E-4	4.615942586466496E-4	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	11	1	3	3	2	26	39	46	42	48		TCRBV03-01,TCRBV03-02												CASSPRGDTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*02	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGGAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	42	3.823256322027418E-4		37	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	10	2	0	1	0	26	39	-1	40	44		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTACAGGACAGCCCGGAGAGCAGTACTTCGGGCCG	CSASTGQPGEQYF	In	VDJ	1	42	3.823256322027418E-4	4.615942586466496E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	5	7	4	6	26	37	47	41	53		TCRBV20-01,TCRBV20-or09_02												CSASTGQPGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGGAAACCACTAGACCCGGGGAGCTGTTTTTTGGAGAA	CASSQETTRPGELFF	In	VDJ	1	42	3.823256322027418E-4	4.615942586466496E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	3	8	6	7	2	23	37	49	44	51	TCRBV01,TCRBV04					01,02								CASSQETTRPGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACKCRGCCRTGTAYSTSTGTGCCAGCAGCTCTTCCCGGACAGAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSSRTENTGELFF	In	VDJ	1	42	3.823256322027418E-4	4.615942586466496E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	1	5	1	6	1	18	31	43	37	44	TCRBV11,TCRBV15													CASSSSRTENTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCGACGTTACAATGAGCAGTTCTTCGGGCCA	CASSPRRYNEQFF	In	VDJ	1	43	3.9142862344566427E-4	4.725845981382365E-4	39	TCRBV03						TCRBJ02	TCRBJ02-01	01	4	2	7	4	3	2	26	39	45	42	47		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRRYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTTACAGGAACTAATGAGCAGTTCTTCGGGCCA	CSALTGTNEQFF	In	VDJ	1	43	3.9142862344566427E-4	4.725845981382365E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	4	7	4	4	26	34	43	38	47		TCRBV20-01,TCRBV20-or09_02												CSALTGTNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCGGGACCCCAAGCTTTCTTTGGACAA	CSARPGPQAFF	In	VDJ	1	43	3.9142862344566427E-4	4.725845981382365E-4	33	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	0	7	9	3	3	26	37	45	40	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARPGPQAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAGCCACGTTTGSYSMMMSMSASASCTCTKTACYTCTGTGCCAGCAGTCTTCGACTAGCCCCCTCCTACGAGCAGTACTTCGGGCCG	CASSLRLAPSYEQYF	In	VDJ	1	43	3.9142862344566427E-4	4.725845981382365E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	2	7	0	4	3	24	36	47	40	50	TCRBV24,TCRBV25,TCRBV27,TCRBV28					01,02								CASSLRLAPSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCAGAGGGGGCCTACGAGCAGTACTTCGGGCCG	CASSLAEGAYEQYF	In	VDJ	1	43	3.9142862344566427E-4	4.725845981382365E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	5	1	2	2	0	18	35	-1	37	43	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAEGAYEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCGGGGCGCCTCAAGAGACCCAGTACTTCGGGCCA	CSARVGAPQETQYF	In	VDJ	1	44	4.005316146885867E-4	4.835749376298234E-4	42	TCRBV20						TCRBJ02	TCRBJ02-05	01	1	7	0	2	2	4	26	39	46	41	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVGAPQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCTTTCCGGGACAGGGATCCTCTGGAAACACCATATATTTTGGAGAG	CATFPGQGSSGNTIYF	In	VDJ	1	44	4.005316146885867E-4	4.835749376298234E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	9	0	3	0	5	3	24	33	47	38	50		TCRBV24-01,TCRBV24-or09_02												CATFPGQGSSGNTIYF+TCRBV24-X+TCRBJ01-03	TCRBV24	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
RRGACWCSGCMSTGTATCTCTGYGCCAGCAGCTCCACCTAGGACAGGGAATTTCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	44	4.005316146885867E-4		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	3	6	9	5	20	31	48	40	53	TCRBV07,TCRBV23													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCGTCCGGGACAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSRPGQGNTEAFF	In	VDJ	1	45	4.096346059315091E-4	4.945652771214103E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	1	5	0	26	38	-1	43	52		TCRBV12-03,TCRBV12-04												CASSRPGQGNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGACGGGACGGGCACAGATACGCAGTATTTTGGCCCA	CASSLDGTGTDTQYF	In	VDJ	1	45	4.096346059315091E-4	4.945652771214103E-4	45	TCRBV12						TCRBJ02	TCRBJ02-03	01	1	0	7	1	2	2	26	42	49	44	51		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDGTGTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGTAGCCTTGGCACGGGGGGTGAAGTAACACTGAAGCTTTCTTTGGACAA	CASR*PWHGG*SNTEAFF	Stop	VDJ	1	45	4.096346059315091E-4		54	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	8	1	2	12	6	24	35	54	47	60		TCRBV24-01,TCRBV24-or09_02												CASR*PWHGG*SNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCGACAGGGGGCGTTCACTGAAGCTTTCTTTGGACAA	CASSRQGAFTEAFF	In	VDJ	1	46	4.187375971744315E-4	5.055556166129972E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	0	4	1	3	24	36	47	37	50	TCRBV06,TCRBV10													CASSRQGAFTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGTCACTAGCGGCCTGGGGAAACGAGCAGTACTTCGGGCCG	CASSQESLAAWGNEQYF	In	VDJ	1	46	4.187375971744315E-4	5.055556166129972E-4	51	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	3	5	5	3	9	26	43	54	46	63		TCRBV03-01,TCRBV03-02				01,02								CASSQESLAAWGNEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATACGGGCATGGGTTTGGTATCCTCAAGATGAACACTGAAGCTTTCTTTGGACAA	CASSLYGHGFGILKMNTEAFF	In	VDJ	1	46	4.187375971744315E-4	5.055556166129972E-4	63							TCRBJ01	TCRBJ01-01	01	2	8	0	0	3	21	18	33	40	36	61	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLYGHGFGILKMNTEAFF+X+TCRBJ01-01			TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGGACCGCTGTGTCAGGGGAGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	46	4.187375971744315E-4		41							TCRBJ02	TCRBJ02-07	01	9	4	2	6	11	3	18	26	43	37	46	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-07			TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGGGGACTYGGCYSTSTATCTCTGTGCCAGCAGCTTAGGAACCCCTGGAAACACCATATATTTTGGAGAG	CASSLGTPGNTIYF	In	VDJ	1	46	4.187375971744315E-4	5.055556166129972E-4	42	unresolved						TCRBJ01	TCRBJ01-03	01	2	1	8	2	1	4	19	33	37	34	41	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGTPGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAACGACAGGGGGCTATGGCTACACCTTCGGTTCG	CASSQTTGGYGYTF	In	VDJ	1	47	4.2784058841735393E-4	5.16545956104584E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	1	4	2	0	26	41	-1	43	52		TCRBV03-01,TCRBV03-02												CASSQTTGGYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCATTCAGACAGACCCAGAACACTGAAGCTTTCTTTGGACAA	CSAFRQTQNTEAFF	In	VDJ	1	47	4.2784058841735393E-4	5.16545956104584E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	5	1	5	5	26	34	44	39	49		TCRBV20-01,TCRBV20-or09_02												CSAFRQTQNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAGGGGACTAGCGGGAGCCGGGCCAAAAACATTCAGTACTTCGGCGCC	CSAQGTSGSRAKNIQYF	In	VDJ	1	47	4.2784058841735393E-4	5.16545956104584E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	6	0	2	1	4	4	26	34	52	38	56		TCRBV20-01,TCRBV20-or09_02												CSAQGTSGSRAKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*02	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCTCCGGACAGTTGGATTCACCCCTCCACTTTGGGAAC	CSAPSGQLDSPLHF	In	VDJ	1	47	4.2784058841735393E-4	5.16545956104584E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	5	8	6	4	26	35	47	41	51		TCRBV20-01,TCRBV20-or09_02												CSAPSGQLDSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCTCACGAAAGGGGGGCTCCGTCCCATACGCAGTATTTTGGCCCA	CSASHERGAPSHTQYF	In	VDJ	1	47	4.2784058841735393E-4	5.16545956104584E-4	48	TCRBV20						TCRBJ02	TCRBJ02-03	01	5	5	1	7	9	10	26	35	50	44	60		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASHERGAPSHTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCCCAGGACTAGCGGGAGTAGAGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPGLAGVEANTGELFF	In	VDJ	1	47	4.2784058841735393E-4	5.16545956104584E-4	57	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	1	2	0	3	6	18	30	46	33	52	TCRBV05,TCRBV07													CASSPGLAGVEANTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCACTCGGCCGGGACAGGGGGTCACTGAAGCTTTCTTTGGACAA	CASTRPGQGVTEAFF	In	VDJ	1	48	4.3694357966027634E-4	5.275362955961709E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	12	0	1	4	12	1	26	31	54	43	55	TCRBV12,TCRBV21													CASTRPGQGVTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAAAGACCGATACGAGCAGTACTTCGGGCCG	CASSQKDRYEQYF	In	VDJ	1	48	4.3694357966027634E-4	5.275362955961709E-4	39	TCRBV03						TCRBJ02	TCRBJ02-07	01	2	2	7	4	3	3	26	41	47	44	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQKDRYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAAACAGCGCATATGAGCAGTTCTTCGGGCCA	CASSQENSAYEQFF	In	VDJ	1	48	4.3694357966027634E-4	5.275362955961709E-4	42	TCRBV03						TCRBJ02	TCRBJ02-01	01	0	3	5	8	2	5	26	43	49	45	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQENSAYEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCAGTTCGGGACGGCTGAAACTTTCTTTGGACAA	CASSQDQFGTAETFF	In	VDJ	1	48	4.3694357966027634E-4	5.275362955961709E-4	45	TCRBV03						TCRBJ01	TCRBJ01-01	01	0	0	7	12	7	8	26	43	55	50	63		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDQFGTAETFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACGACAGGGGTTAGGAGAGACCCAGTACTTCGGGCCA	CASSPRQGLGETQYF	In	VDJ	1	48	4.3694357966027634E-4	5.275362955961709E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	2	2	4	3	5	26	39	50	42	55		TCRBV03-01,TCRBV03-02												CASSPRQGLGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTGGACAGGGAAACTACGAGCAGTACTTCGGGCCG	CASSLGQGNYEQYF	In	VDJ	1	48	4.3694357966027634E-4	5.275362955961709E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	3	3	2	3	26	39	49	41	52		TCRBV03-01,TCRBV03-02												CASSLGQGNYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGTGGAGTTTCAGGCTTGACCGGGGAGCTGTTTTTTGGAGAA	CASSGGVSGLTGELFF	In	VDJ	1	48	4.3694357966027634E-4	5.275362955961709E-4	48	TCRBV03						TCRBJ02	TCRBJ02-02	01	5	4	4	5	10	4	26	38	52	48	56		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGGVSGLTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTCGGACAGGGAACAGATACGCAGTATTTTGGCCCA	CATSDFGQGTDTQYF	In	VDJ	1	48	4.3694357966027634E-4	5.275362955961709E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	1	3	3	1	1	24	41	50	42	51		TCRBV24-01,TCRBV24-or09_02												CATSDFGQGTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAAGAAGGTAGCGTGTACGAGCAGTACTTCGGGCCG	CASSQEEGSVYEQYF	In	VDJ	1	48	4.3694357966027634E-4	5.275362955961709E-4	45				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	5	6	4	6	2	18	35	46	41	48	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03				01,02								CASSQEEGSVYEQYF+X+TCRBJ02-07		TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTACTTGGACCGCGAAGCTTTCTTTGGACAA		Out	VDJ	1	49	4.460465709031988E-4		37	TCRBV24						TCRBJ01	TCRBJ01-01	01	5	1	7	8	5	3	24	37	46	42	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGACCCCCGGACTGCCCTACAATGAGCAGTTCTTCGGGCCA	CSARTPGLPYNEQFF	In	VDJ	1	50	4.551495621461212E-4	5.495169745793447E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	1	10	2	7	2	26	37	49	44	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSARTPGLPYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCGTTTCTGGGGGGCTGGACTGAAGCTTTCTTTGGACAA	CSARPFLGGWTEAFF	In	VDJ	1	50	4.551495621461212E-4	5.495169745793447E-4	45	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	6	0	5	10	3	26	37	53	47	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARPFLGGWTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCAAGATGAGACTAGCGCCGCCTACGAGCAGTACTTCGGGCCG	CASSQDETSAAYEQYF	In	VDJ	1	50	4.551495621461212E-4	5.495169745793447E-4	48				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	2	6	2	3	3	18	35	46	38	49	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03				01,02								CASSQDETSAAYEQYF+X+TCRBJ02-07		TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCGGGACGAGGACCCTACAATGAGCAGTTCTTCGGGCCA	CASSPGRGPYNEQFF	In	VDJ	1	51	4.6425255338904364E-4	5.605073140709316E-4	45	TCRBV12						TCRBJ02	TCRBJ02-01	01	5	0	7	2	2	6	26	38	45	40	51		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGRGPYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACCCAGATATGGCAGGCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	51	4.6425255338904364E-4		50	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	4	1	11	1	26	41	56	52	57		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCGGGGGGTTGGACAATGAGCAGTTCTTCGGGCCA	CASSLGGLDNEQFF	In	VDJ	1	52	4.7335554463196606E-4	5.714976535625186E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	8	1	5	1	4	26	39	47	40	51		TCRBV03-01,TCRBV03-02												CASSLGGLDNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAACCCCCCGGGGGAGCAGTACTTCGGGCCG	CSARDNPPGEQYF	In	VDJ	1	52	4.7335554463196606E-4	5.714976535625186E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	3	7	8	0	26	40	-1	48	53		TCRBV20-01,TCRBV20-or09_02												CSARDNPPGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTACAGGGGGAGCTCTATACGAGCAGTACTTCGGGCCG	CASSLTGGALYEQYF	In	VDJ	1	53	4.8245853587488847E-4	5.824879930541054E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	1	4	2	7	26	39	49	41	56		TCRBV03-01,TCRBV03-02												CASSLTGGALYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACAACTCTGGAAACACCATATATTTTGGAGAG	CSARDNSGNTIYF	In	VDJ	1	53	4.8245853587488847E-4	5.824879930541054E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	4	6	0	0	1	26	-1	42	40	43		TCRBV20-01,TCRBV20-or09_02												CSARDNSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCCGGGACTAGCGGGAGTTGAGCAGTTCTTCGGGCCA	CSARDPGLAGVEQFF	In	VDJ	1	53	4.8245853587488847E-4	5.824879930541054E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	0	2	9	3	1	26	40	57	43	58		TCRBV20-01,TCRBV20-or09_02												CSARDPGLAGVEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCACGGGTCCTGGTGCGGCTTCCAAATTACAATGAGCAGTTCTTCGGGCCA	CSAPRVLVRLPNYNEQFF	In	VDJ	1	53	4.8245853587488847E-4	5.824879930541054E-4	54	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	7	5	4	14	9	26	35	53	49	62		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPRVLVRLPNYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCGAGGGGGAGATACGCAGTATTTTGGCCCA	CASSRGGDTQYF	In	VDJ	1	54	4.915615271178109E-4	5.934783325456923E-4	36	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	5	1	5	3	0	26	37	-1	40	46		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSRGGDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCTCATTGGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	54	4.915615271178109E-4		41	TCRBV24						TCRBJ02	TCRBJ02-01	01	3	0	9	6	7	0	24	39	-1	46	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGCCGGGACACAGAATGAGCAGTTCTTCGGGCCA	CASSLAGTQNEQFF	In	VDJ	1	54	4.915615271178109E-4	5.934783325456923E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	6	7	1	3	18	35	42	36	45	TCRBV07,TCRBV11													CASSLAGTQNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGCGGAATTGGGTCAAAAACATTCAGTACTTCGGCGCC	CASSQRNWVKNIQYF	In	VDJ	1	55	5.006645183607333E-4	6.044686720372793E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	3	7	5	3	0	8	26	-1	44	40	52		TCRBV03-01,TCRBV03-02				01,02								CASSQRNWVKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD02-01	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCGGGGAGAGAGACACCGGGGAGCTGTTTTTTGGAGAA	CSARGGERDTGELFF	In	VDJ	1	56	5.097675096036558E-4	6.154590115288661E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	7	3	3	0	6	26	-1	45	39	51		TCRBV20-01,TCRBV20-or09_02												CSARGGERDTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGGGCTAGCGGGGACTGACGAGCAGTACTTCGGGCCG	CASSQDGLAGTDEQYF	In	VDJ	1	57	5.188705008465782E-4	6.26449351020453E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	5	4	4	26	43	56	47	60		TCRBV03-01,TCRBV03-02												CASSQDGLAGTDEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCAGGGGACGGGGCACAGATACGCAGTATTTTGGCCCA	CSASRGRGTDTQYF	In	VDJ	1	57	5.188705008465782E-4	6.26449351020453E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	2	1	0	5	26	-1	43	37	48		TCRBV20-01,TCRBV20-or09_02												CSASRGRGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCTCAATAATTGGAGATACGCAGTATTTTGGCCCA	CASSIIGDTQYF	In	VDJ	1	57	5.188705008465782E-4	6.26449351020453E-4	36	TCRBV24						TCRBJ02	TCRBJ02-03	01	11	0	10	5	11	0	24	31	-1	42	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSIIGDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAGGGTCCGGGGAGCTGTTTTTTGGAGAA	CASSPGSGELFF	In	VDJ	1	58	5.279734920895006E-4	6.3743969051204E-4	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	3	6	0	1	26	-1	44	39	45		TCRBV03-01,TCRBV03-02												CASSPGSGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGCAGGGTAGTGAAAAACTGTTTTTTGGCAGT	CSARRQGSEKLFF	In	VDJ	1	58	5.279734920895006E-4	6.3743969051204E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	3	7	3	3	26	38	46	41	49		TCRBV20-01,TCRBV20-or09_02												CSARRQGSEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAAGGGCCTTCGGGGAGGACCGGGAACTATGGCTACACCTTCGGTTCG	CASSQEGPSGRTGNYGYTF	In	VDJ	1	58	5.279734920895006E-4	6.3743969051204E-4	57				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	9	1	2	10	6	18	35	51	45	57	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQEGPSGRTGNYGYTF+X+TCRBJ01-02		TCRBD02-01*02	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGGGGACAGGGATGTGTGGTCCAATGAGCAGTTCTTCGGGCCA	CASSGDRDVWSNEQFF	In	VDJ	1	60	5.461794745753454E-4	6.594203694952137E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	6	2	10	26	37	48	39	58		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSGDRDVWSNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTCCCGGGGGGACAGCCACCTACGAGCAGTACTTCGGGCCG	CASSPGGTATYEQYF	In	VDJ	1	60	5.461794745753454E-4	6.594203694952137E-4	45							TCRBJ02	TCRBJ02-07	01	5	0	5	2	6	3	36	48	61	54	64	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGGTATYEQYF+X+TCRBJ02-07			TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGACCCGGGACTAGAGAAGCAATGAGCAGTTCTTCGGGCCA	CASSQTRD*RSNEQFF	Stop	VDJ	1	61	5.552824658182679E-4		48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	8	6	5	5	26	40	53	45	58		TCRBV03-01,TCRBV03-02				01,02								CASSQTRD*RSNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGGCGACCGGGGACAGAAAACATTCAGTACTTCGGCGCC	CASRRPGTENIQYF	In	VDJ	1	61	5.552824658182679E-4	6.704107089868006E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	0	5	5	7	0	23	34	-1	41	48	TCRBV06,TCRBV10													CASRRPGTENIQYF+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCCTCGGTGGACTAGCGGGTTACAATGAGCAGTTCTTCGGGCCA	CASSFLGGLAGYNEQFF	In	VDJ	1	62	5.643854570611903E-4	6.814010484783875E-4	51	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	1	4	4	7	1	26	40	58	47	59		TCRBV12-03,TCRBV12-04				01,02								CASSFLGGLAGYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCGGGACAACCTAACACTGAAGCTTTCTTTGGACAA	CATSDPGQPNTEAFF	In	VDJ	1	62	5.643854570611903E-4	6.814010484783875E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	6	2	2	4	24	39	47	41	51		TCRBV24-01,TCRBV24-or09_02												CATSDPGQPNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCCCCGGGTGGTTTGGGTTACGAGCAGTACTTCGGGCCG	CASSSPGGLGYEQYF	In	VDJ	1	62	5.643854570611903E-4	6.814010484783875E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	8	4	4	3	10	18	31	38	34	48	TCRBV07,TCRBV11					01,02								CASSSPGGLGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGTTCCTACGGCCGGGGACAGGACCAAGAGACCCAGTACTTCGGGCCA	CASSSYGRGQDQETQYF	In	VDJ	1	64	5.825914395470352E-4	7.033817274615613E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	4	0	12	0	18	29	-1	41	49	TCRBV07,TCRBV11													CASSSYGRGQDQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAGTATGGGGGTAGCACAGATACGCAGTATTTTGGCCCA	CASSQEYGGSTDTQYF	In	VDJ	2	66	6.0079742203288E-4	7.253624064447351E-4	48							TCRBJ02	TCRBJ02-03	01	0	6	1	0	4	1	18	35	44	39	45	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEYGGSTDTQYF+X+TCRBJ02-03			TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCTGGGACAGGGGGACACTGAAGCTTTCTTTGGACAA	CASSLGQGDTEAFF	In	VDJ	2	67	6.099004132758024E-4	7.36352745936322E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	1	3	1	0	23	36	-1	37	48	TCRBV01,TCRBV23													CASSLGQGDTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCACGGGGAGGACCGCTATGGCTACACCTTCGGTTCG	CASSHGEDRYGYTF	In	VDJ	2	67	6.099004132758024E-4	7.36352745936322E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	9	1	4	4	4	19	31	41	35	45	TCRBV07,TCRBV11													CASSHGEDRYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGTTCTACTCCATTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	2	68	6.190034045187249E-4		49	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	3	10	5	6	14	26	38	47	44	61		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCACGACTCCATTTCCATTCCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	70	6.372093870045697E-4		52	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	10	5	4	14	26	39	47	43	61		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTGGGACAGGGGGGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	70	6.372093870045697E-4		41	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	1	0	2	1	26	34	47	36	48		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACTCTCTCGGCATTTCGTGTTAGACGAACAGTACTTCGGGCCG		Out	VDJ	2	71	6.463123782474922E-4		46	TCRBV03						TCRBJ02	TCRBJ02-07	01	7	2	7	10	21	3	26	36	60	57	63		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGAGGATTCTGCGTCCCCCGGCCGGGAGCTGTTTTTTGGAGAA	CSAEDSASPGRELFF	In	VDJ	2	72	6.554153694904145E-4	7.913044433942565E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	11	1	9	1	18	26	34	39	35	57		TCRBV20-01,TCRBV20-or09_02												CSAEDSASPGRELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATCTAGCGGGAGGGAGGAACACAGATACGCAGTATTTTGGCCCA	CASSQDLAGGRNTDTQYF	In	VDJ	2	72	6.554153694904145E-4	7.913044433942565E-4	54				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	4	0	2	1	5	18	35	48	36	53	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDLAGGRNTDTQYF+X+TCRBJ02-03		TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGACGACAGGGGTGGTCAGCCCCAGCATTTTGGTGAT	CASSQDDRGGQPQHF	In	VDJ	2	73	6.64518360733337E-4	8.022947828858433E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	2	6	4	3	26	40	52	44	55		TCRBV03-01,TCRBV03-02												CASSQDDRGGQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACCGAGACAGGGCTTGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASTETGLGNTGELFF	In	VDJ	2	73	6.64518360733337E-4	8.022947828858433E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	11	2	3	1	7	5	24	31	45	38	50		TCRBV24-01,TCRBV24-or09_02												CASTETGLGNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAAGATGTTACAGCCTCTGGAAACACCATATATTTTGGAGAG	CASSQDVTASGNTIYF	In	VDJ	2	74	6.736213519762595E-4	8.132851223774302E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	3	5	0	4	1	23	40	48	44	49	TCRBV01,TCRBV23													CASSQDVTASGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGTCGCTAGCGGGGGTATTTTCTACGAGCAGTACTTCGGGCCG	CASSLVASGGIFYEQYF	In	VDJ	2	75	6.827243432191818E-4	8.242754618690172E-4	51	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	4	2	3	7	6	24	36	53	43	59		TCRBV24-01,TCRBV24-or09_02												CASSLVASGGIFYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCCCGCAAGCGGGGGCACAGATACGCAGTATTTTGGCCCA	CSAPASGGTDTQYF	In	VDJ	2	76	6.918273344621043E-4	8.35265801360604E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	6	3	1	7	0	26	34	-1	41	48		TCRBV20-01,TCRBV20-or09_02												CSAPASGGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATCCTCTGCCTCTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSESSASSNQPQHF	In	VDJ	2	77	7.009303257050266E-4	8.462561408521909E-4	48	TCRBV06						TCRBJ01	TCRBJ01-05	01	2	10	0	0	6	3	23	38	46	44	49		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSESSASSNQPQHF+TCRBV06-X+TCRBJ01-05	TCRBV06		TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCAAACGGGAGCAAACATTCAGTACTTCGGCGCC	CASSQDQTGANIQYF	In	VDJ	2	78	7.100333169479491E-4	8.572464803437779E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	0	8	2	6	5	1	26	43	54	48	55		TCRBV03-01,TCRBV03-02												CASSQDQTGANIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD02-01*02	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCATCTGATTGGAGGGACAGGAGAACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	78	7.100333169479491E-4		49	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	0	4	3	12	3	19	27	47	39	50	TCRBV07,TCRBV11													X+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGCAATCAGGGTCTGGGGACAGATACGCAGTATTTTGGCCCA	CASSNQGLGTDTQYF	In	VDJ	2	81	7.373422906767164E-4	8.902174988185385E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	3	3	4	7	23	34	43	38	50	TCRBV02,TCRBV21													CASSNQGLGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCACCCGACTAGCCGATTACCAAGAGACCCAGTACTTCGGGCCA	CASSTRLADYQETQYF	In	VDJ	2	84	7.646512644054836E-4	9.231885172932991E-4	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	2	7	0	4	5	26	38	49	42	54		TCRBV03-01,TCRBV03-02				01,02								CASSTRLADYQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCAGAGCGGACTACTCTCACTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	84	7.646512644054836E-4		47	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	1	9	3	6	6	26	39	51	45	57		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCATTTAGGTGCATAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	85	7.737542556484061E-4		44	TCRBV03						TCRBJ01	TCRBJ01-04	01	5	5	4	4	6	4	26	38	47	44	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAGGGGAGTGAATACGAGCAGTACTTCGGGCCG	CSARDQGSEYEQYF	In	VDJ	2	85	7.737542556484061E-4	9.341788567848861E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	2	4	1	6	26	40	47	41	53		TCRBV20-01,TCRBV20-or09_02												CSARDQGSEYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAGGAGCTTACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	86	7.828572468913285E-4		47				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	0	10	2	0	0	4	18	-1	39	35	43	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												X+X+TCRBJ01-03		TCRBD02-01*02	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAGTTTCAGATGGCTACACCTTCGGTTCG	CASSLVSDGYTF	In	VDJ	2	88	8.010632293771734E-4	9.671498752596468E-4	36	TCRBV03						TCRBJ01	TCRBJ01-02	01	5	4	5	6	7	0	26	38	-1	45	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVSDGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCGGGACAGGTGTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSATGTGVSGANVLTF	In	VDJ	2	89	8.101662206200957E-4	9.781402147512337E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	0	4	0	2	3	26	36	46	38	49		TCRBV20-01,TCRBV20-or09_02												CSATGTGVSGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD01-01*01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAATAGTATTGCACGAAACACCATATATTTTGGAGAG	CASSNSIARNTIYF	In	VDJ	2	90	8.192692118630182E-4	9.891305542428206E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	5	8	5	2	8	26	38	43	40	51		TCRBV03-01,TCRBV03-02				01,02								CASSNSIARNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD02-01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTAGGGGGTGGAGAAAACACCATATATTTTGGAGAG	CSARDLGGGENTIYF	In	VDJ	2	92	8.37475194348863E-4	0.0010111112332259944	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	5	1	6	3	6	26	40	49	43	55		TCRBV20-01,TCRBV20-or09_02												CSARDLGGGENTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCTCTAGCGGGAGATAGCATTGAGCAGTTCTTCGGGCCA	CSASLAGDSIEQFF	In	VDJ	2	95	8.647841680776303E-4	0.001044082251700755	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	2	9	4	7	26	34	48	38	55		TCRBV20-01,TCRBV20-or09_02												CSASLAGDSIEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGTGGGGGGGCTGGGAACTGAAGCTTTCTTTGGACAA	XASSQVGGLGTEAFF	In	VDJ	2	97	8.829901505634752E-4	0.0010660629306839288	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	9	0	5	1	6	23	39	47	40	53	TCRBV01,TCRBV04													XASSQVGGLGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCSRGGGACTYRGCTGTGTATYTYTGTGCCAGCAGCTTAAAATTCGCCAGGGTTTACGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	97	8.829901505634752E-4		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	3	4	10	6	22	35	50	45	56	TCRBV07,TCRBV12													X+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCGGATTACGGGAAAGCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSGLRESNTGELFF	In	VDJ	2	103	9.376080980210098E-4	0.0011320049676334502	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	8	3	2	6	4	18	30	41	36	45	TCRBV07,TCRBV11													CASSGLRESNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGACTAGCGGGAGTTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	112	0.0010195350192073115		37	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	2	2	4	0	1	26	-1	47	35	48		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCCCCGGGCTCGGCCAGCCCCAGCATTTTGGTGAT	CASSFPGLGQPQHF	In	VDJ	3	118	0.0010741529666648461	0.0012968600600072537	42	TCRBV12						TCRBJ01	TCRBJ01-05	01	3	8	0	7	4	5	26	40	48	44	53		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFPGLGQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGACGGGGGAGGGGGATACGCAGTATTTTGGCCCA	CASSQTGEGDTQYF	In	VDJ	3	120	0.0010923589491506909	0.0013188407389904274	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	9	0	6	5	1	26	40	52	45	53		TCRBV03-01,TCRBV03-02												CASSQTGEGDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGGAAGAAGCACAGATACGCAGTATTTTGGCCCA	CASSGRSTDTQYF	In	VDJ	3	120	0.0010923589491506909	0.0013188407389904274	39	unresolved						TCRBJ02	TCRBJ02-03	01	5	1	8	0	0	3	24	-1	39	36	42	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGRSTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCCGGACTAGCTTTAGAGACCCAGTACTTCGGGCCA	CASSPGLALETQYF	In	VDJ	3	123	0.0011196679228794582	0.001351811757465188	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	1	7	4	3	3	18	30	41	33	44	TCRBV07,TCRBV11					01,02								CASSPGLALETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCGGTGCTAGCGTCTCTGGCGGGCAGTACTTCGGGCCG	CASSLAGASVSGGQYF	In	VDJ	3	126	0.0011469768966082255	0.0013847827759399488	48				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	4	6	9	5	10	18	35	46	40	56	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLAGASVSGGQYF+X+TCRBJ02-07		TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTATCCGGGCCAGCGGATACGCAGTATTTTGGCCCA	CASSVSGPADTQYF	In	VDJ	3	130	0.0011833888615799151	0.0014287441339062964	42	unresolved						TCRBJ02	TCRBJ02-03	01	1	8	0	6	3	5	23	38	45	41	50	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVSGPADTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGGAGGCCTCTGGCGGGTGAGATCCTACGAGCAGTACTTCGGGCCG	CASSLGGLWRVRSYEQYF	In	VDJ	3	131	0.0011924918528228377	0.0014397344733978832	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	9	1	1	0	16	18	-1	38	32	54	TCRBV07,TCRBV11													CASSLGGLWRVRSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCAGCTGTGTATTTTTGTGCCAGCAGTGCTGGGACAGCCTTCGGACTAGCGGGAGATACCGGGGAGCTGTTTTTTGGAGAA	CASSAGTAFGLAGDTGELFF	In	VDJ	3	139	0.001265315782766217	0.0015276571893305783	60	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	1	2	5	15	2	15	27	55	42	57		TCRBV12-03,TCRBV12-04												CASSAGTAFGLAGDTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*02	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTAGCAGGGGGCGAAAACACCATATATTTTGGAGAG	CSARDLAGGENTIYF	In	VDJ	3	144	0.001310830738980829	0.001582608886788513	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	4	0	6	5	2	26	40	53	45	55		TCRBV20-01,TCRBV20-or09_02												CSARDLAGGENTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTGGGGACAGGAAAGGGATTCACCCCTCCACTTTGGGAAC	CASSWGQERDSPLHF	In	VDJ	4	161	0.0014655815901105102	0.0017694446581454902	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	0	4	8	1	6	18	31	40	32	46	TCRBV07,TCRBV11													CASSWGQERDSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCGGCGGGCCCTACGAGCAGTACTTCGGGCCG	CASSFGGPYEQYF	In	VDJ	4	162	0.0014746845813534328	0.001780434997637077	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	7	4	2	4	1	24	36	45	40	46		TCRBV24-01,TCRBV24-or09_02				01,02								CASSFGGPYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGACAGGGGGAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	4	164	0.0014928905638392775		41	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	1	1	1	0	26	36	-1	37	46		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGAGGGGGCAGGGGGTAAGGTCTGAAGCTTTCTTTGGACAA	CASSLRGQGVRSEAFF	In	VDJ	4	166	0.0015110965463251225	0.0018243963556034246	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	1	6	7	6	18	32	46	39	52	TCRBV05,TCRBV11													CASSLRGQGVRSEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAACCTTCAGGGGGCGCAAGAGACCCAGTACTTCGGGCCA	CASNLQGAQETQYF	In	VDJ	4	168	0.0015293025288109672	0.0018463770345865983	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	4	0	2	5	1	26	36	49	41	50		TCRBV03-01,TCRBV03-02												CASNLQGAQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCGCGGGACTAGCGGGGGAATACGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSAGLAGEYANTGELFF	In	VDJ	4	168	0.0015293025288109672	0.0018463770345865983	57	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	0	2	0	2	6	19	31	47	33	53	TCRBV07,TCRBV11													CASSAGLAGEYANTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAACCTTCCGGGGGGGGCCGGGTAGATACGCAGTATTTTGGCCCA	CASSQEPSGGGRVDTQYF	In	VDJ	4	171	0.0015566115025397345	0.001879348053061359	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	8	0	5	6	7	23	40	54	46	61	TCRBV01,TCRBV04													CASSQEPSGGGRVDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAGTCTGACAACTCCTACGAGCAGTACTTCGGGCCG	CASSQESDNSYEQYF	In	VDJ	4	178	0.0016203324412401915	0.0019562804295024674	45				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	6	0	4	1	18	35	43	39	44	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQESDNSYEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCGATTTGGGACAGAGCACAGATACGCAGTATTTTGGCCCA	CASSDLGQSTDTQYF	In	VDJ	4	182	0.0016567444062118813	0.002000241787468815	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	5	0	5	0	23	35	-1	40	47	TCRBV01,TCRBV04													CASSDLGQSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAATAGGGATTCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	4	182	0.0016567444062118813		47	TCRBV06						TCRBJ01	TCRBJ01-04	01	2	0	8	0	3	2	23	38	45	41	47		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ01-04	TCRBV06		TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGACAGGGATCTTTGGCTACACCTTCGGTTCG	CASRTGIFGYTF	In	VDJ	4	188	0.0017113623536694157	0.002066183824418336	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	2	3	7	0	5	24	-1	42	35	47		TCRBV24-01,TCRBV24-or09_02												CASRTGIFGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGAGATATAGCGGGAACCCTCACAGATACGCAGTATTTTGGCCCA	CAIRDIAGTLTDTQYF	In	VDJ	4	191	0.001738671327398183	0.002099154842893097	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	5	3	2	5	5	23	34	47	39	52	TCRBV06,TCRBV10													CAIRDIAGTLTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCGCGGGACTAGCGGGGCCGACGGAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSAGLAGPTENTGELFF	In	VDJ	4	192	0.0017477743186411054	0.0021101451823846836	57	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	0	3	1	2	8	18	30	45	32	53	TCRBV07,TCRBV11													CASSAGLAGPTENTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGAGACTAGCGACGCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	5	195	0.0017750832923698727		47	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	2	6	0	2	3	26	37	47	39	50		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								X+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TTCTGTGCCAGCAGTCCCCTACGGACAGGGGGCCTTAGCGGGGCCGGGAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSPLRTGGLSGAGSTGELFF	In	VDJ	5	196	0.0017841862836127952	0.0021541065403510315	66	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	0	4	7	17	3	15	33	22	50		TCRBV24-01,TCRBV24-or09_02												CASSPLRTGGLSGAGSTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGACTTAAGGACTCACTAGCGCATTTACAATGAGCAGTTCTTCGGGCCA	CASSDLRTH*RIYNEQFF	Stop	VDJ	5	200	0.001820598248584485		54	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	3	6	4	9	4	23	39	55	48	59	TCRBV06,TCRBV10					01,02								CASSDLRTH*RIYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATACTTCGGACCTACCGGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CATSDTSDLPGDTGELFF	In	VDJ	5	202	0.0018388042310703296	0.002220048577300553	54	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	8	2	3	13	0	24	39	-1	52	58		TCRBV24-01,TCRBV24-or09_02												CATSDTSDLPGDTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGTAGCGGGGGTGGGACCCGAAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	5	203	0.0018479072223132522		55	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	0	5	2	7	0	10	24	-1	51	42	61		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD02-01*01	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGTTTCTAGCGGGAGTGGGGCCAATGAGCAGTTCTTCGGGCCA	CASSLVSSGSGANEQFF	In	VDJ	5	208	0.0018934221785278642	0.0022859906142500743	51	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	2	6	7	6	24	36	53	43	59		TCRBV24-01,TCRBV24-or09_02												CASSLVSSGSGANEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCCGGACAGGGGGGACTGAAGCTTTCTTTGGACAA	CSARDPRTGGTEAFF	In	VDJ	5	209	0.0019025251697707866	0.0022969809537416613	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	1	5	5	1	26	40	55	45	56		TCRBV20-01,TCRBV20-or09_02												CSARDPRTGGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGTATCGACCACAGATACGCAGTATTTTGGCCCA	CASSVSTTDTQYF	In	VDJ	5	227	0.00206637901214339	0.002494807064590225	39	unresolved						TCRBJ02	TCRBJ02-03	01	5	2	7	2	5	0	22	34	-1	39	42	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVSTTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAATGAAGGTCACAGGGTCGAAGGTCGAGGACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	6	242	0.002202923880787227		62				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	3	3	2	9	14	18	33	48	42	62	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02,TCRBV11-03												X+X+TCRBJ02-05		TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGCCGGGACAGGGTGGTACAATGAGCAGTTCTTCGGGCCA	CASSQAGTGWYNEQFF	In	VDJ	6	244	0.0022211298632730716	0.0026816428359472022	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	3	4	4	3	26	40	53	44	56		TCRBV03-01,TCRBV03-02												CASSQAGTGWYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTCAGGCGAGCGGAGGCTCGTGGTACGAGCAGTACTTCGGGCCG	CASSFQASGGSWYEQYF	In	VDJ	6	245	0.002230232854515994	0.002692633175438789	51	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	6	5	4	9	10	24	36	50	45	60		TCRBV24-01,TCRBV24-or09_02				01,02								CASSFQASGGSWYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACAAGGCCTGGGCGATACTATGGCTACACCTTCGGTTCG		Out	VDJ	6	251	0.0022848508019735285		46	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	8	0	3	8	3	26	40	52	48	55		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCCCGGCTAGGGGTGGACACCCCATGGGGATACGCAGTATTTTGGCCCA		Out	VDJ	6	256	0.0023303657581881408		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	11	1	6	6	12	9	22	28	45	40	54	TCRBV02,TCRBV12													X+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCGGTCGGGGTGTGGGCTATGGCTACACCTTCGGTTCG	CASGRGVGYGYTF	In	VDJ	6	271	0.002466910626831977	0.0029783820022200487	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	8	8	3	4	3	6	22	31	39	34	45	TCRBV12,TCRBV21													CASGRGVGYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGCGAGGGACAGGGGACGGCCGGGGAGCTGTTTTTTGGAGAA	CASSEGQGTAGELFF	In	VDJ	7	280	0.0025488375480182787	0.0030772950576443306	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	2	6	3	4	22	33	46	36	50	TCRBV02,TCRBV12													CASSEGQGTAGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATGCGAGTTAAGGTACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	7	316	0.002876545232763486		50	unresolved						TCRBJ02	TCRBJ02-05	01	0	5	4	0	9	1	23	40	52	49	53	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATGGCAGGGAAACAATGAGCAGTTCTTCGGGCCA	CASSLWQGNNEQFF	In	VDJ	8	339	0.003085914031350702	0.0037257250876479575	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	3	5	6	2	24	36	47	42	49		TCRBV24-01,TCRBV24-or09_02												CASSLWQGNNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCCACGGCGGTCTCTGGAAACACCATATATTTTGGAGAG	CASSPTAVSGNTIYF	In	VDJ	9	367	0.0033407977861525297	0.00403345459341239	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	4	7	5	0	5	1	23	36	45	41	46	TCRBV01,TCRBV04					01,02								CASSPTAVSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGTCCTTTCCTACGAGCAGTACTTCGGGCCG	CASSQVLSYEQYF	In	VDJ	9	385	0.0035046516285251335	0.004231280704260955	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	4	10	1	2	1	23	39	43	41	44	TCRBV01,TCRBV04					01,02								CASSQVLSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGGGTACGAGCAGTACTTCGGGCCG	CASSFGYEQYF	In	VDJ	10	408	0.003714020427112349	0.004484058512567453	33	TCRBV12						TCRBJ02	TCRBJ02-07	01	3	0	9	4	1	0	26	40	-1	41	44		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCCATCAGCCCCCCCGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	10	419	0.003814153330784496		44	TCRBV24						TCRBJ02	TCRBJ02-01	01	6	4	5	8	6	9	24	36	45	42	54		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCGGGACAGCCTAGCACAGATACGCAGTATTTTGGCCCA	CASSPGQPSTDTQYF	In	VDJ	10	425	0.00386877127824203	0.00467089428392443	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	5	0	1	3	23	36	44	37	47	TCRBV01,TCRBV04													CASSPGQPSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGTGTCACAGGGGCGGCGAACTGTTTTTTGGCAGT		Out	VDJ	11	459	0.004178272980501393		43	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	3	2	12	4	5	26	42	53	46	58		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTTGGAGGGAGGGGAACAATGAGCAGTTCTTCGGGCCA	CSARVWREGNNEQFF	In	VDJ	15	657	0.0059806652466000325	0.00722065304597259	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	9	0	5	6	2	26	39	52	45	54		TCRBV20-01,TCRBV20-or09_02												CSARVWREGNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCGGGAGGACTTTATGAACACTGAAGCTTTCTTTGGACAA	CASSQDREDFMNTEAFF	In	VDJ	19	826	0.007519070766653923	0.009078020420050775	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	8	1	0	1	6	23	40	48	41	54	TCRBV01,TCRBV04													CASSQDREDFMNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCATGGACCCCATAACCCCCGGGGCGGATACGCAGTATTTTGGCCCA	CASMDPITPGADTQYF	In	VDJ	23	989	0.009002858339250278	0.010869445757179439	48	unresolved						TCRBJ02	TCRBJ02-03	01	6	7	0	6	17	1	23	33	55	50	56	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASMDPITPGADTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCGGGGGGACAGCCACCTACGAGCAGTACTTCGGGCCG	CASSPGGTATYEQYF	In	VDJ	30	1278	0.011633622808454858	0.014045653870248052	45	TCRBV24						TCRBJ02	TCRBJ02-07	01	6	0	5	2	6	3	24	36	49	42	52		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGGTATYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTGGACTATTTACAATGAGCAGTTCTTCGGGCCA	CASSWTIYNEQFF	In	VDJ	36	1525	0.013882061645456698	0.016760267724670014	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	1	9	4	2	2	26	37	45	39	47		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSWTIYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGCAGGCAGCACAGATACGCAGTATTTTGGCCCA	CSARDAGSTDTQYF	In	VDJ	60	2574	0.02343109945928232	0.02828913385134467	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	4	0	2	1	26	40	46	42	47		TCRBV20-01,TCRBV20-or09_02												CSARDAGSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGGGGCGGGAAAGCACAGATACGCAGTATTTTGGCCCA	CSARDGGRESTDTQYF	In	VDJ	69	2956	0.026908442114078685	0.032487443537130865	48	TCRBV20						TCRBJ02	TCRBJ02-03	01	0	6	0	0	2	5	26	40	48	42	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDGGRESTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCAAGTTGCGGACTCTGGAAACACCATATATTTTGGAGAG	CASSQVADSGNTIYF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	45	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	7	5	0	6	1	18	30	40	36	41						01,02								CASSQVADSGNTIYF+TCRBV07-02+TCRBJ01-03	TCRBV07-02*01	TCRBD02-01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTATCCCTACGTGAAAAACTGTTTTTTGGCAGT	CASSLSLREKLFF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	2	4	9	7	3	2	18	33	39	36	41						01,02								CASSLSLREKLFF+TCRBV07-02+TCRBJ01-04	TCRBV07-02*01	TCRBD02-01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTGCTGCTAGACCAAAATACGCAGTATTTTGGCCCA	CASSLLLDQNTQYF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	42	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	4	8	7	4	6	18	32	40	36	46						01,02								CASSLLLDQNTQYF+TCRBV07-02+TCRBJ02-03	TCRBV07-02*01	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAAACTCGAGAGGGTCTGAAGCTTTCTTTGGACAA	CASSLNSRGSEAFF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	42	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	11	0	6	7	1	18	33	45	40	46														CASSLNSRGSEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD02-01*02	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATCTCTGTGCCAGCGGTGCGGGAGCTCCCACCGGGGAGCTGTTTTTTGGAGAA	CASGAGAPTGELFF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	42	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	8	7	2	4	3	4	18	27	37	30	41														CASGAGAPTGELFF+TCRBV07-02+TCRBJ02-02	TCRBV07-02*01	TCRBD02-01*02	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAACGGAGAACTATGGCTACACCTTCGGTTCG	CASSLTENYGYTF	In	VDJ	1	44	4.005316146885867E-4	4.835749376298234E-4	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	10	2	2	2	0	18	33	-1	35	39														CASSLTENYGYTF+TCRBV07-02+TCRBJ01-02	TCRBV07-02*01	TCRBD02-01*02	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGATGGTCGGGCGGGGAGAACGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLDGRAGRTSGANVLTF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	60	TCRBV11	TCRBV11-02	02	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	0	7	3	1	7	6	18	35	48	42	54													Vb 21.3	CASSLDGRAGRTSGANVLTF+TCRBV11-02+TCRBJ02-06	TCRBV11-02*02	TCRBD02-01*01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCCCACGACAGACCTGAACACTGAAGCTTTCTTTGGACAA	CASSPTTDLNTEAFF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	5	0	5	3	18	30	40	35	43														CASSPTTDLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGGACAACTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSWDNSYNSPLHF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	0	6	0	0	1	18	-1	37	31	38														CASSWDNSYNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACACAGGGAATCTCCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	12	1.0923589491506909E-4		43	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	3	5	1	7	18	33	40	34	47														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACAGGGGGCGCGGACTGAAGCTTTCTTTGGACAA	CASSLQGARTEAFF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	0	5	0	4	18	-1	41	33	45														CASSLQGARTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGACCCAGCTGGGCCAACGTCCTGACTTTCGGGGCC	CASSPGPSWANVLTF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	5	0	7	5	2	6	18	30	37	32	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGPSWANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCCGGGGGGAGCTTAGAGACCCAGTACTTCGGGCCA	CASSLSGGSLETQYF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	8	1	4	2	5	18	33	42	35	47														CASSLSGGSLETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGGGAAAACAGTAACTATGGCTACACCTTCGGTTCG	CASSFGENSNYGYTF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	8	3	1	0	7	18	-1	37	32	44														CASSFGENSNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTGATGCCGGGACAACGGGCGAGCAGTACTTCGGGCCG	CASSDAGTTGEQYF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	6	6	7	5	18	29	42	36	47														CASSDAGTTGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCGAGGGACAGGGGTATAATACGCAGTATTTTGGCCCA	CASTEGQGYNTQYF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	0	2	7	4	4	18	28	42	32	46														CASTEGQGYNTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGACCGGGACACGTCCTACGAGCAGTACTTCGGGCCG	CASSDRDTSYEQYF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	6	1	4	2	18	30	40	34	42														CASSDRDTSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTTACCCTAGGGCTTCTGATGAAAAACTGTTTTTTGGCAGT	CASSSYPRASDEKLFF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	4	5	3	6	8	6	18	31	43	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSYPRASDEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGGCCAGGACTAGCGGGGGGCTCCCTATTAGGAGCAGTTCTTCGGGCCA		Out	VDJ	1	17	1.5475085112968121E-4		56	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	1	1	10	7	11	18	30	51	37	62														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGGGGACAGATGTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSWGTDVSGANVLTF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	0	5	0	2	4	18	31	40	33	44														CASSWGTDVSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCAAGCTGGGACTAGCGGAGGGACCTACAATGAGCAGTTCTTCGGGCCA	CASSQAGTSGGTYNEQFF	In	VDJ	1	17	1.5475085112968121E-4	1.8683577135697723E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	5	2	7	5	18	29	47	36	52						01,02								CASSQAGTSGGTYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGGGGTTCCGACACTGAAGCTTTCTTTGGACAA	CASSPGGSDTEAFF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	2	3	2	5	18	30	38	32	43														CASSPGGSDTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGCGACAGGACCCATTGGCCCCAGCATTTTGGTGAT	CASSRDRTHWPQHF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	4	9	3	8	18	30	39	33	47														CASSRDRTHWPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGGTTCTGACAGGGGGCCCCTACAATGAGCAGTTCTTCGGGCCA	CASRVLTGGPYNEQFF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	0	2	6	1	18	29	45	35	46														CASRVLTGGPYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTGAGGGACAACCGGGAGATACGCAGTATTTTGGCCCA	CASSPEGQPGDTQYF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	6	5	5	6	18	30	41	35	47														CASSPEGQPGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTTGTACCACGACAGGGGGCCGGCGGGGAGCTGTTTTTTGGAGAA	CASSLVPRQGAGGELFF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	0	7	10	3	18	30	50	40	53														CASSLVPRQGAGGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGACAGCTTCAATGAAAAACTGTTTTTTGGCAGT	CASSSDSFNEKLFF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	1	5	5	1	4	18	31	38	32	42														CASSSDSFNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTTGAGTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLLSSSYNEQFF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	5	8	0	6	0	18	32	-1	38	41						01,02								CASSLLSSSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTAGGGCGGGGGCCGGGGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	20	1.8205982485844849E-4		47	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	7	2	5	1	7	18	34	42	35	49														X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGACTAGCGGGGGGCGGTATTTCCCCCTACGAGCAGTACTTCGGGCCG	CASS*LAGGGISPYEQYF	Stop	VDJ	1	20	1.8205982485844849E-4		54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	2	1	2	0	11	18	-1	44	31	55														CASS*LAGGGISPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTAGGACGGTTACAGATACGCAGTATTTTGGCCCA	CASSLVRTVTDTQYF	In	VDJ	1	20	1.8205982485844849E-4	2.198067898317379E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	1	1	7	3	3	4	18	34	41	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVRTVTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAGTTGTCGGCCGAGGGAGTGTGGCTTTCTTTGGACAA	CASSLVVGRGSVAFF	In	VDJ	1	20	1.8205982485844849E-4	2.198067898317379E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	9	2	11	11	4	18	34	50	45	54														CASSLVVGRGSVAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGACAGGTAACAGATACGCAGTATTTTGGCCCA	CASSPGQVTDTQYF	In	VDJ	1	21	1.911628161013709E-4	2.307971293233248E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	4	3	2	2	18	30	40	32	42														CASSPGQVTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCAGGGGGCCACAGATACGCAGTATTTTGGCCCA	CASSLQGATDTQYF	In	VDJ	1	21	1.911628161013709E-4	2.307971293233248E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	0	2	1	0	18	32	-1	33	41														CASSLQGATDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTACAGGCTACGTCCTACGAGCAGTACTTCGGGCCG	CASSLQATSYEQYF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	4	1	2	5	18	30	37	32	42														CASSLQATSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGGACAGCCCCACAATGAGCAGTTCTTCGGGCCA	CASSLEGQPHNEQFF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	5	5	0	4	18	-1	42	35	46														CASSLEGQPHNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCGGGACAGGGGGCCCTCTATGGCTACACCTTCGGTTCG	CASSAGQGALYGYTF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	0	4	2	3	18	30	44	32	47														CASSAGQGALYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATTCTGGGGGGCGCAATGAGCAGTTCTTCGGGCCA	CASSLDSGGRNEQFF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	0	6	0	6	5	1	18	35	46	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDSGGRNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCGGGGGTCGGTGAAAAACTGTTTTTTGGCAGT	CASSLAGVGEKLFF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	7	2	7	1	4	18	32	40	33	44														CASSLAGVGEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCACAGGGGGCTCGATCACCGGGGAGCTGTTTTTTGGAGAA	CASTTGGSITGELFF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	3	0	4	2	5	18	28	39	30	44														CASTTGGSITGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGTGACCCCCCCGACAGGGGGGCGATCAGCCCCAGCATTTTGGTGAT	CASR*PPRQGGDQPQHF	Stop	VDJ	1	24	2.1847178983013817E-4		51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	1	5	11	3	18	29	49	40	52														CASR*PPRQGGDQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTACAGTTCTCTGGAAACACCATATATTTTGGAGAG	CASSVQFSGNTIYF	In	VDJ	1	25	2.275747810730606E-4	2.7475848728967237E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	5	0	2	2	18	30	36	32	38														CASSVQFSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGACTAGCATCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	25	2.275747810730606E-4		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	2	7	3	0	2	18	-1	41	34	43						01,02								X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTCCCATGCGGGTCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	26	2.3667777231598303E-4		43	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	7	4	4	8	1	18	30	43	38	44						01,02								X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGCGGGAGGACGGGGGAGACCCAGTACTTCGGGCCA	CASSLSGRTGETQYF	In	VDJ	1	26	2.3667777231598303E-4	2.857488267812593E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	6	1	5	0	6	18	-1	42	33	48														CASSLSGRTGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTTATCATCCCTGGGACAGGGGGCGACTAATGAAAAACTGTTTTTTGGCAGT	CARSLSSLGQGATNEKLFF	In	VDJ	1	27	2.4578076355890547E-4	2.9673916627284615E-4	57	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	0	0	2	8	1	18	33	53	41	54														CARSLSSLGQGATNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCCCAGGGGGAGCCTACTATGGCTACACCTTCGGTTCG	CASSTPGGAYYGYTF	In	VDJ	1	27	2.4578076355890547E-4	2.9673916627284615E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	1	3	4	5	18	30	41	34	46														CASSTPGGAYYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCACCCGGACTAGCCTACGAGCAGTACTTCGGGCCG	CASSPPGLAYEQYF	In	VDJ	1	28	2.548837548018279E-4	3.0772950576443307E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	8	2	6	0	18	30	-1	36	43						01,02								CASSPPGLAYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCAAAGTACGAGCGGGGGGCTCATACGAGCAGTACTTCGGGCCG	CASTKVRAGGSYEQYF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	6	1	4	10	4	18	28	47	38	51														CASTKVRAGGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCGACAGGGACTAGCGGGGGGGGGAGCCAAAAACATTCAGTACTTCGGCGCC	CASSPRQGLAGGGAKNIQYF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	60	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	5	0	0	0	8	2	18	30	54	38	56														CASSPRQGLAGGGAKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCACCCGGACTAGCGGGAGTAATGAATGAGCAGTTCTTCGGGCCA	CASSPPGLAGVMNEQFF	In	VDJ	1	30	2.730897372876727E-4	3.2971018474760685E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	1	2	7	6	5	18	30	49	36	54														CASSPPGLAGVMNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAATGGGCAGACAAGAGACCCAGTACTTCGGGCCA	CASSPMGRQETQYF	In	VDJ	1	31	2.8219272853059513E-4	3.4070052423919376E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	8	0	2	5	3	18	30	39	35	42														CASSPMGRQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGACGCGGAGGTCCCATGAGCAGTACTTCGGGCCG		Out	VDJ	1	31	2.8219272853059513E-4		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	10	1	7	5	6	18	34	44	39	50														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTATAGCGTAGGAGTCTCGTGGACTATAACAGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	32	2.912957197735176E-4		59	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	1	9	4	18	6	18	31	55	49	61						01,02								X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACCGGACAGGCCTCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	32	2.912957197735176E-4		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	1	4	2	2	3	18	35	44	37	47														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCAGACAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFRQNTGELFF	In	VDJ	1	33	3.0039871101644E-4	3.6268120322236754E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	2	6	1	2	0	18	32	-1	34	38														CASSFRQNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGACGGGAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPTGTNTGELFF	In	VDJ	1	34	3.0950170225936243E-4	3.7367154271395446E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	8	3	0	4	1	18	30	39	34	40														CASSPTGTNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTTGAGGTGCCTTAGAACACTGAAGCTTTCTTTGGACAA	CASSVEVP*NTEAFF	Stop	VDJ	1	36	3.2770768474520726E-4		45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	1	1	3	7	18	30	37	33	44														CASSVEVP*NTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCTGGGACAGAGTAATTCACCCCTCCACTTTGGGAAC	CASSFLGQSNSPLHF	In	VDJ	1	36	3.2770768474520726E-4	3.9565222169712824E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	0	5	6	3	2	18	32	42	35	44														CASSFLGQSNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGATTAACGTCAGCGTCCGTTTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	39	3.5501665847397456E-4		52	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	2	6	6	3	5	6	18	33	42	38	48						01,02								X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD02-01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGACAGGCCGCGACAGATACGCAGTATTTTGGCCCA	CASSLGQAATDTQYF	In	VDJ	1	40	3.6411964971689697E-4	4.396135796634758E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	2	4	3	0	5	18	-1	40	34	45														CASSLGQAATDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATGGCCTTACGGGGAATACGCAGTATTTTGGCCCA	CASSLDGLTGNTQYF	In	VDJ	1	44	4.005316146885867E-4	4.835749376298234E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	8	3	7	8	1	18	35	48	43	49														CASSLDGLTGNTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTGGACTAGTCAGGGCCACAGATACGCAGTATTTTGGCCCA	CASSSGLVRATDTQYF	In	VDJ	1	49	4.460465709031988E-4	5.385266350877579E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	1	8	2	2	7	18	31	40	33	47						01,02								CASSSGLVRATDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGTGACGTGCAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	52	4.7335554463196606E-4		43	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	4	2	7	0	2	6	18	31	36	33	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATCGGACAGGGGGCATTAGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	53	4.8245853587488847E-4		59	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	1	0	0	3	7	18	33	47	36	54														X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTTAGCCGCCCTCGGGACGAGCAGTACTTCGGGCCG	CASSLFSRPRDEQYF	In	VDJ	1	59	5.370764833324231E-4	6.484300300036268E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	5	7	5	2	10	18	33	39	35	49						01,02								CASSLFSRPRDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAATTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLNSNTGELFF	In	VJ	1	63	5.734884483041127E-4	6.923913879699744E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	2	0	0	0	0	4	18	-1	33	-1	37														CASSLNSNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGGGGTGGCTATGAAAAACTGTTTTTTGGCAGT	CASSPGGGYEKLFF	In	VDJ	1	64	5.825914395470352E-4	7.033817274615613E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	8	2	6	2	5	18	30	38	32	43														CASSPGGGYEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCTGCTAGTAGGCTGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	64	5.825914395470352E-4		55	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	5	2	6	5	14	5	18	30	48	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCGCTGAGCGGGACAGGCCTTTCTGGGGCTACACCTTCGGTTCG	CASAERDRPFWGYTF	In	VDJ	2	70	6.372093870045697E-4	7.693237644110826E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	0	4	8	7	9	18	27	42	34	51														CASAERDRPFWGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGGACAGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSPGTGDTGELFF	In	VDJ	2	84	7.646512644054836E-4	9.231885172932991E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	2	3	3	0	18	30	-1	33	43														CASSPGTGDTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAAAACGGGACTAGCGGTCGACGAGCAGTACTTCGGGCCG	CASSKTGLAVDEQYF	In	VDJ	2	87	7.919602381342509E-4	9.561595357680598E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	5	5	5	3	18	30	46	35	49						01,02								CASSKTGLAVDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAACAGGGGGGATGAACACTGAAGCTTTCTTTGGACAA	CASSPTGGMNTEAFF	In	VDJ	2	89	8.101662206200957E-4	9.781402147512337E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	1	0	3	2	18	30	41	33	43														CASSPTGGMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATGGCAGGGGGCGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	115	0.0010468439929360788		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	0	4	3	2	18	35	46	38	48														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCACAGATGGGGACAGGGGGCGAGGTGAGCAGTTCTTCGGGCCA	CASSLTDGDRGRGEQFF	In	VDJ	3	121	0.0011014619403936134	0.0013298310784820144	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	0	9	10	4	18	30	52	40	56														CASSLTDGDRGRGEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGAAAGACTAGCGGGGGAACTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	126	0.0011469768966082255		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	2	2	3	3	2	18	29	44	32	46														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATGACAGACTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSMTDYSNQPQHF	In	VDJ	6	266	0.002421395670617365	0.0029234303047621143	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	5	2	5	0	2	4	18	30	37	32	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSMTDYSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCGGACTAGCGGGGGCCCTCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSAGLAGALANTGELFF	In	VDJ	7	297	0.00270358839914796	0.0032641308290013078	57	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	1	2	0	3	6	18	30	46	33	52														CASSAGLAGALANTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCTCTAGCGGGGCGCTACCAGGTTCGGGATACGCAGTATTTTGGCCCA	CASSALAGRYQVRDTQYF	In	VDJ	9	399	0.0036320935059260475	0.004385145457143171	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	3	6	3	15	18	30	42	33	57														CASSALAGRYQVRDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGACCGGGCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSLGTGLAKNIQYF	In	VDJ	12	519	0.004724452455076738	0.005703986196133598	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-04	01	3	0	7	0	1	6	18	32	38	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGTGLAKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01		TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACTGGGAGGCCAAGATACGCAGTATTTTGGCCCA	CASSLLGGQDTQYF	In	VDJ	13	562	0.005115881078522402	0.006176570794271835	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	9	1	5	2	3	18	33	41	35	44														CASSLLGGQDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTACGACTAGCGGGGTTGACTACAATGAGCAGTTCTTCGGGCCA	CASSFTTSGVDYNEQFF	In	VDJ	15	648	0.005898738325413731	0.007121739990548308	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	2	3	3	3	4	18	32	46	35	50														CASSFTTSGVDYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTATGTTCGGGGGGGCAAGTGAGCAGTTCTTCGGGCCA	CASSPMFGGASEQFF	In	VDJ	17	711	0.0064722267737178435	0.007814131378518283	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	0	9	8	4	18	30	46	38	50														CASSPMFGGASEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCATTATTGGGACCCGGGGAGCTGTTTTTTGGAGAA	CASSLSLLGPGELFF	In	VDJ	132	5670	0.05161396034737015	0.0623152249172977	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	2	0	7	6	8	0	18	33	-1	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSLLGPGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTACGGGACAGGTCCCTGGAAACACCATATATTTTGGAGAG	CASSSTGQVPGNTIYF	In	VDJ	282	12117	0.11030094489049101	0.13316994361955842	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	0	4	2	4	3	18	31	43	35	46														CASSSTGQVPGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAAGGTGGAGAGGGAGCTGTTTTTTGGAGAA	CASKVERELFF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	33	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	12	10	2	9	9	1	26	31	44	40	45														CASKVERELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACTACAGGGGTCTCTCCCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	12	1.0923589491506909E-4		43	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	12	3	2	6	7	7	26	31	45	38	52														X+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCCAACAGGAGAACACTGAAGCTTTCTTTGGACAA	CASTQQENTEAFF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	12	3	4	1	9	1	26	31	45	40	46														CASTQQENTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGACCGGATCAGCCCCAGCATTTTGGTGAT	CASGLGPDQPQHF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	39	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-05	01	1	2	7	5	0	3	26	-1	45	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLGPDQPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01		TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTACGGGACAGTAAGCGGGGATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	43	3.9142862344566427E-4		58	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-05	01	0	0	5	0	2	10	23	40	49	42	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01		TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCCCTCACACCGGGGAGCTGTTTTTTGGAGAA	CASGPHTGELFF	In	VDJ	1	59	5.370764833324231E-4	6.484300300036268E-4	36	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	4	10	3	2	1	26	37	41	39	42						01,02								CASGPHTGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTCCATAGGGGCGCTTGGTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	72	6.554153694904145E-4		49	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	5	2	7	4	7	26	43	52	47	59														X+TCRBV12-05+TCRBJ01-04	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTTGGAGTGAACACTGAAGCTTTCTTTGGACAA	CASSFGVNTEAFF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	39	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	10	2	0	4	0	20	31	-1	35	39														CASSFGVNTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD02-01*02	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GAGACACGGCACTGTATCTCTGCGCCAGCGGCTGGGTCTGTAGGGTTTCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	13	1.1833888615799151E-4		46	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-05	01	8	5	3	2	12	3	20	29	45	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01		TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGAAAGACAGGGTTCGGCGACAGACAAAAACATTCAGTACTTCGGCGCC	CASSQERQGSATDKNIQYF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	57	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	2	2	3	3	4	12	20	35	46	39	58														CASSQERQGSATDKNIQYF+TCRBV23-01+TCRBJ02-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGGCCCTACCGGGCTTTCCTCCTACGAGCAGTACTTCGGGCCG	CASSQGPTGLSSYEQYF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	51	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-07	01	2	8	0	0	9	4	20	35	48	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGPTGLSSYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGCGGGGGGACAGGGACGATTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQSRGDRDDYSNQPQHF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	60	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	0	3	0	5	7	20	37	51	42	58														CASSQSRGDRDDYSNQPQHF+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGATCTCGGCCACCCAATGAAGCAGTTCTTCGGGCCA	CASSQDLGHPMKQFF	In	VDJ	1	38	3.4591366723105214E-4	4.17632900680302E-4	45	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-01	01	2	9	0	11	6	10	20	35	44	41	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDLGHPMKQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01		TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGACCTAGGTTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQDLGSGANVLTF	In	VDJ	1	39	3.5501665847397456E-4	4.2862324017188893E-4	48	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	2	4	8	1	3	2	20	35	42	38	44						01,02								CASSQDLGSGANVLTF+TCRBV23-01+TCRBJ02-06	TCRBV23-01*01	TCRBD02-01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAGACCCGGGACAGGTGTTATATGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	46	4.187375971744315E-4		53	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	4	2	5	9	20	34	47	39	56														X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAACGGGGTGTGGTCAATGAGCAGTTCTTCGGGCCA	CASSQRGVVNEQFF	In	VDJ	1	52	4.7335554463196606E-4	5.714976535625186E-4	42	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	8	3	6	0	6	20	-1	40	35	46														CASSQRGVVNEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGTGCGGTCCCCCTAGCACAGATACGCAGTATTTTGGCCCA	CASSQSCGPPSTDTQYF	In	VDJ	1	56	5.097675096036558E-4	6.154590115288661E-4	51	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	7	5	0	2	7	20	37	43	39	50						01,02								CASSQSCGPPSTDTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGACTCCAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQDSSSGANVLTF	In	VDJ	2	70	6.372093870045697E-4	7.693237644110826E-4	48	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	2	2	10	0	0	4	20	-1	39	35	43						01,02								CASSQDSSSGANVLTF+TCRBV23-01+TCRBJ02-06	TCRBV23-01*01	TCRBD02-01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCGCACCATAGGCCACCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	110	0.0010013290367214666		46	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-05	01	6	5	4	1	9	4	20	31	43	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01		TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCACGACAGGGATGGTACATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	122	0.0011105649316365358		43	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	3	8	4	7	20	31	42	35	49														X+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGGGAGCGAGCTATGAGCAGTTCTTCGGGCCA	CASSDSGASYEQFF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	9	2	8	0	6	23	-1	45	40	51														CASSDSGASYEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCTCCATCGGACTAGCGGGAAGGTAGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	12	1.0923589491506909E-4		53	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	1	3	4	7	6	23	36	55	43	61														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGGAAACTAGCGGGGGCGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CAIRKLAGAANTGELFF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	3	2	0	3	3	23	34	48	37	51														CAIRKLAGAANTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGACTACGGACAAAACGAAGCTTTCTTTGGACAA	CAISDYGQNEAFF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	6	8	2	4	23	39	46	41	50														CAISDYGQNEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAATGGAGCAGGGACTGAAGCTTTCTTTGGACAA	CASNGAGTEAFF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	4	3	5	6	0	23	33	-1	39	44														CASNGAGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAGACTTGACCCATCCTATGGCTACACCTTCGGTTCG	CASSRLDPSYGYTF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	2	10	4	2	9	23	34	40	36	49						01,02								CASSRLDPSYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGGTTCCGCTAGCGAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSEVPLASTGELFF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	4	6	4	9	2	23	35	50	44	52						01,02								CASSEVPLASTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGACTAGCGGGAGCAGATACGCAGTATTTTGGCCCA	CASSYSGLAGADTQYF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	0	2	4	0	0	23	-1	-1	40	54														CASSYSGLAGADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGCGCGCCCGGGACAGCCACCTACACCTTCGGTTCG		Out	VDJ	1	13	1.1833888615799151E-4		43	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	5	10	9	4	23	36	52	45	56														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTCGCGAATCAGACGAGCAGTTCTTCGGGCCA	CAISRESDEQFF	In	VDJ	1	13	1.1833888615799151E-4	1.4287441339062964E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	5	2	7	10	9	0	23	35	-1	44	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISRESDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGACAGAAGAGACCCAGTACTTCGGGCCA	CASSPTEETQYF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	5	3	2	0	23	35	-1	37	42														CASSPTEETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGTTGTCATGCTCTAGAAAGACCTATGGCTACACCTTCGGTTCG	CASSWLSCSRKTYGYTF	In	VDJ	1	14	1.2744187740091394E-4	1.5386475288221653E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	4	8	4	12	6	23	36	52	48	58						01,02								CASSWLSCSRKTYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGATTAGACAGGGGGCAGGGTGGAAACTATGGCTACACCTTCGGTTCG	CASRLDRGQGGNYGYTF	In	VDJ	1	15	1.3654486864383636E-4	1.6485509237380342E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	0	2	4	8	23	34	48	38	56														CASRLDRGQGGNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTCTTAGCGGGTAAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	15	1.3654486864383636E-4		41	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	9	5	4	0	3	4	23	31	41	34	45						01,02								X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAATAGCGGGGGAACCTACGAGCAGTACTTCGGGCCG	CASNSGGTYEQYF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	5	2	2	1	2	23	33	43	34	45														CASNSGGTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGGGACAAACTACGAGCAGTACTTCGGGCCG	CASSYGGTNYEQYF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	2	0	6	3	3	2	23	38	47	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGGTNYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGCGGGAAGCCAAAAACATTCAGTACTTCGGCGCC	CASSWREAKNIQYF	In	VDJ	1	16	1.456478598867588E-4	1.758454318653903E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	4	7	3	0	1	0	23	36	-1	37	43														CASSWREAKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCCCGCCGGACAGTACATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	16	1.456478598867588E-4		50	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	5	0	7	4	23	36	49	43	53														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCGAGCCCTACAGGGGTAAGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	18	1.6385384237260363E-4		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	3	2	3	9	4	23	30	46	39	50														X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAATGATAGACAGGGGGCATTCTATGAGCAGTTCTTCGGGCCA	CASNDRQGAFYEQFF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	2	0	8	6	5	23	33	49	39	54														CASNDRQGAFYEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGTTCTTGGGACGAGCAGTACTTCGGGCCG	CASSYSGSWDEQYF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	0	0	9	5	0	8	23	-1	43	40	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGSWDEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTAGCGGAAGCCCTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSYLAEALSYNEQFF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	5	5	0	0	7	23	-1	45	39	52						01,02								CASSYLAEALSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCGAAGGCCCCGGGAGCGGCTACACCTTCGGTTCG	CAISEGPGSGYTF	In	VDJ	1	18	1.6385384237260363E-4	1.9782611084856412E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	8	2	8	9	1	23	34	49	43	50														CAISEGPGSGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGAGATAACTATGGCTACACCTTCGGTTCG	CASSRDNYGYTF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	11	2	1	2	1	23	34	39	36	40														CASSRDNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGATCAGGGAATTTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	19	1.7295683361552607E-4		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	3	0	4	4	23	34	43	38	47														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
TGTGCCAGCATCAACCGGGGCTCCCCAAAGTGGTGGTAGCGGGAGTCCGGCACAGATACGCAGTATTTTGGCCCA	CASINRGSPKWW*RESGTDTQYF	Stop	VDJ	1	19	1.7295683361552607E-4		69	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	5	2	1	26	4	0	10	45	36	49														CASINRGSPKWW*RESGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGGGCAGGGGGGCGGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	20	1.8205982485844849E-4		49	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	1	2	3	4	23	40	50	43	54														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACGGGGGGCCCAGATACGCAGTATTTTGGCCCA	CASSYSTGGPDTQYF	In	VDJ	1	20	1.8205982485844849E-4	2.198067898317379E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	8	1	4	2	2	23	40	49	42	51														CASSYSTGGPDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGGACACCCTAGCTACAATGAGCAGTTTTTCGGGCCA	CASSGHPSYNEQFF	In	VDJ	1	21	1.911628161013709E-4	2.307971293233248E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02			6	1	6	19	1	22	23	34	40	35	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01			TCRBJ02-01,TCRBJ02-05						CASSGHPSYNEQFF+TCRBV06-08+TCRBJ02-X	TCRBV06-08*01		TCRBJ02	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCAGTTTACGAGTCGGGCAGGGGGCCACAGATACGCAGTATTTTGGCCCA	CATSLRVGQGATDTQYF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	0	2	11	0	23	36	-1	47	55														CATSLRVGQGATDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCGGRACTAGCGGGGGCACAGATACGCAGTATTTTGGCCCA	CASTGTSGGTDTQYF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	0	3	1	2	0	23	33	-1	35	48														CASTGTSGGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCGGACAGGGGTGGCCTACGAGCAGTACTTCGGGCCG	CASRRTGVAYEQYF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	2	2	2	3	23	34	45	36	48														CASRRTGVAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTAACCTCGGGACTCTCTGGAAACACCATATATTTTGGAGAG	CASSVTSGLSGNTIYF	In	VDJ	1	22	2.0026580734429334E-4	2.417874688149117E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	0	10	0	8	0	23	35	-1	43	49						01,02								CASSVTSGLSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCAACCCGCCACTAGCGAGTACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	23	2.0936879858721576E-4		52	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	3	6	3	9	3	23	36	52	45	55						01,02								X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGTGGCTAGCTCTGTCGGCAGTACTTCGGGCCG		Out	VDJ	1	23	2.0936879858721576E-4		40	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	4	7	9	5	7	23	36	46	41	53						01,02								X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCGATCCGGGAGGAAGCGCTTTCTTTGGACAA	CASSFDPGGSAFF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	8	1	11	6	4	23	36	49	42	53														CASSFDPGGSAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTGCGTAGTAGAACTCATACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLRSRTHTNTGELFF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	3	10	0	11	4	23	36	50	47	54						01,02								CASSLRSRTHTNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCTGGAGACTATGGCTACACCTTCGGTTCG	CASSPGDYGYTF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	10	2	3	4	0	23	34	-1	38	42														CASSPGDYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGACTAGCGGGACAGATACGCAGTATTTTGGCCCA	CASSGTSGTDTQYF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	4	3	0	0	23	-1	-1	35	47						01,02								CASSGTSGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCCGACTAGCGGGAGAAGATACGCAGTATTTTGGCCCA	CAIRLAGEDTQYF	In	VDJ	1	24	2.1847178983013817E-4	2.6376814779808546E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	10	2	2	5	3	1	23	30	45	33	46														CAIRLAGEDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAAGAGGGACAAAGGGAGAAAGAGCAGTTCTTCGGGCCA	CASKEGQREKEQFF	In	VDJ	1	26	2.3667777231598303E-4	2.857488267812593E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	0	6	10	4	10	23	33	43	37	53														CASKEGQREKEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAATGATCCGGGACAGACCTACGAGCAGTACTTCGGGCCG	CASNDPGQTYEQYF	In	VDJ	1	26	2.3667777231598303E-4	2.857488267812593E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	5	2	7	1	23	33	47	40	48														CASNDPGQTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCTGGTACAAATGAGCAGTTCTTCGGGCCA	CASSDSGTNEQFF	In	VDJ	1	26	2.3667777231598303E-4	2.857488267812593E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	3	6	7	4	0	23	40	-1	44	47														CASSDSGTNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGTCAGACGTACGAGCAGTACTTCGGGCCG	CASSYSSQTYEQYF	In	VDJ	1	26	2.3667777231598303E-4	2.857488267812593E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	0	2	7	4	6	1	23	40	49	46	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSSQTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTGACAGGGGTTTAGCAATCAGCCCCAGCATTTTGGTGAT	CAS*QGFSNQPQHF	Stop	VDJ	1	26	2.3667777231598303E-4		42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	2	2	0	1	2	23	32	41	33	43														CAS*QGFSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGAGTATTCGGGTAATTCACCCCTCCACTTTGGGAAC	CASREYSGNSPLHF	In	VDJ	1	28	2.548837548018279E-4	3.0772950576443307E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	6	8	4	6	8	0	23	34	-1	42	46						01,02								CASREYSGNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTATCTCCGGGGGGGTGGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	28	2.548837548018279E-4		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	0	1	5	3	23	35	48	40	51														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCACATGGGACAGCCCGACTATGGCTACACCTTCGGTTCG	CASRHMGQPDYGYTF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	3	6	4	23	34	47	40	51														CASRHMGQPDYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCAGAGTAGGGCCAACGTCCTGACTTTCGGGGCC	CASSQSRANVLTF	In	VDJ	1	30	2.730897372876727E-4	3.2971018474760685E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	6	4	5	5	1	4	23	34	38	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQSRANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACAGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSDRDTGELFF	In	VDJ	1	30	2.730897372876727E-4	3.2971018474760685E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	3	3	0	0	23	-1	-1	35	42														CASSDRDTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGCGGCGGGGGAACAGATACGCAGTATTTTGGCCCA	CASSGGGGTDTQYF	In	VDJ	1	31	2.8219272853059513E-4	3.4070052423919376E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	7	2	3	4	1	23	35	46	39	47														CASSGGGGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGTCTAGCGGGATGACCGGGGAGCTGTTTTTTGGAGAA	CASRSSGMTGELFF	In	VDJ	1	33	3.0039871101644E-4	3.6268120322236754E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	4	3	5	2	2	23	34	45	36	47														CASRSSGMTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGACAGGGATTGCTGGCTACACCTTCGGTTCG		Out	VDJ	1	34	3.0950170225936243E-4		37	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	7	1	5	23	34	42	35	47														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGACTCGAGGACAGCTCCTACGAGCAGTACTTCGGGCCG	CASSRLEDSSYEQYF	In	VDJ	1	35	3.1860469350228484E-4	3.846618822055413E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	5	0	9	0	23	34	-1	43	49														CASSRLEDSSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCCGACAGGGAGAAGGCTACGAGCAGTACTTCGGGCCG	CASSFRQGEGYEQYF	In	VDJ	1	36	3.2770768474520726E-4	3.9565222169712824E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	3	3	3	6	23	36	46	39	52														CASSFRQGEGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACCGACCGGGAGGCGGGGAGCTGTTTTTTGGAGAA	CASNRPGGGELFF	In	VDJ	1	37	3.368106759881297E-4	4.066425611887151E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	8	1	7	6	0	23	33	-1	39	46														CASNRPGGGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGCCGGGACTGTATACGAGCAGTACTTCGGGCCG	CASRAGTVYEQYF	In	VDJ	1	37	3.368106759881297E-4	4.066425611887151E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	10	4	4	3	23	34	44	38	47						01,02								CASRAGTVYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACTTCGCTAGCGGGAGGGCGGGATGAGCAGTTCTTCGGGCCA	CASSTSLAGGRDEQFF	In	VDJ	1	37	3.368106759881297E-4	4.066425611887151E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	0	8	6	4	23	35	53	41	57														CASSTSLAGGRDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGCGGGAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSSGSTGELFF	In	VDJ	1	37	3.368106759881297E-4	4.066425611887151E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	6	2	4	0	0	23	-1	-1	35	43														CASSSGSTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGACAGGGGGACGTCAGCCCCAGCATTTTGGTGAT	CASSGTGGRQPQHF	In	VDJ	1	38	3.4591366723105214E-4	4.17632900680302E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	1	6	0	3	23	-1	46	35	49														CASSGTGGRQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGGGAGGCTAATGAAAAACTGTTTTTTGGCAGT	CASSYSGEANEKLFF	In	VDJ	1	38	3.4591366723105214E-4	4.17632900680302E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	0	9	1	3	2	0	23	40	-1	42	48														CASSYSGEANEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCGATCGCGGGGGTTCCTACGAGCAGTACTTCGGGCCG	CASTDRGGSYEQYF	In	VDJ	1	39	3.5501665847397456E-4	4.2862324017188893E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	7	2	1	6	1	23	33	46	39	47														CASTDRGGSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGGGACTAGCGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSDGTSGNTGELFF	In	VDJ	1	40	3.6411964971689697E-4	4.396135796634758E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	5	1	3	0	23	35	-1	38	49						01,02								CASSDGTSGNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCCCCCACCGGGGGGGCCAACGTCCTGACTTTCGGGGCC	CASSYPPTGGANVLTF	In	VDJ	1	40	3.6411964971689697E-4	4.396135796634758E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	2	8	4	4	8	0	23	38	-1	46	50						01,02								CASSYPPTGGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCGGGGCCCAAGGGGCAGATACGCAGTATTTTGGCCCA	CASSPGAQGADTQYF	In	VDJ	1	41	3.732226409598194E-4	4.506039191550627E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	6	5	2	4	12	0	23	34	-1	46	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGAQGADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGACGACAGGGCTTGCCTACGAGCAGTACTTCGGGCCG	CASRTTGLAYEQYF	In	VDJ	1	41	3.732226409598194E-4	4.506039191550627E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	3	2	3	4	23	34	44	37	48														CASRTTGLAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCGACGGATGGGATGGGGCCGGGGAGCTGTTTTTTGGAGAA	CAISDGWDGAGELFF	In	VDJ	1	42	3.823256322027418E-4	4.615942586466496E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	6	0	8	6	8	5	23	34	46	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISDGWDGAGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGCGTGGGGGGCTACGAGCAGTACTTCGGGCCG	CASSYSSVGGYEQYF	In	VDJ	1	43	3.9142862344566427E-4	4.725845981382365E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	9	1	3	6	0	23	40	-1	46	52														CASSYSSVGGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCTAGCACAGATACGCAGTATTTTGGCCCA	CASSDSSTDTQYF	In	VJ	1	44	4.005316146885867E-4	4.835749376298234E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	0	0	0	0	0	1	23	-1	40	-1	41														CASSDSSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCAGGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSDSGGSYNEQFF	In	VDJ	1	45	4.096346059315091E-4	4.945652771214103E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	5	1	0	0	0	23	-1	-1	40	46														CASSDSGGSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAACAGGATCAGATACGCAGTATTTTGGCCCA	CASRTGSDTQYF	In	VDJ	1	46	4.187375971744315E-4	5.055556166129972E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	4	4	1	2	23	34	40	35	42														CASRTGSDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTGGTGCGGGAAACTTACAATGAGCAGTTCTTCGGGCCA	CASSLVRETYNEQFF	In	VDJ	1	47	4.2784058841735393E-4	5.16545956104584E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	7	3	4	4	4	23	36	46	40	50														CASSLVRETYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCGAGACAGGGGCAGATACGCAGTATTTTGGCCCA	CASSAETGADTQYF	In	VDJ	1	51	4.6425255338904364E-4	5.605073140709316E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	2	4	5	0	23	35	-1	40	48														CASSAETGADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACTAGCGGGGGGAATGAGCAGTTCTTCGGGCCA	CASSYSTSGGNEQFF	In	VDJ	1	52	4.7335554463196606E-4	5.714976535625186E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	2	1	7	0	0	23	-1	-1	40	53														CASSYSTSGGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTACCCGACGACAGGGGGGGTCACTGAAGCTTTCTTTGGACAA	CASSYPTTGGVTEAFF	In	VDJ	1	53	4.8245853587488847E-4	5.824879930541054E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	1	4	5	3	23	38	52	43	55														CASSYPTTGGVTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGACCGGTCTACTAACACTGAAGCTTTCTTTGGACAA	CASRDRSTNTEAFF	In	VDJ	1	54	4.915615271178109E-4	5.934783325456923E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	6	1	7	2	0	9	23	-1	38	34	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRDRSTNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCACGGCCGGGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSTAGGSSYNEQFF	In	VDJ	1	55	5.006645183607333E-4	6.044686720372793E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	8	1	0	7	2	23	36	50	43	52														CASSSTAGGSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATGCGGGGTCCGGAAACACCATATATTTTGGAGAG	CASSDAGSGNTIYF	In	VDJ	1	57	5.188705008465782E-4	6.26449351020453E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	5	7	3	4	3	3	23	35	44	38	47														CASSDAGSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGAGCGGGGGCCCAGATACGCAGTATTTTGGCCCA	CASSDSSGGPDTQYF	In	VDJ	1	59	5.370764833324231E-4	6.484300300036268E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	6	2	4	1	2	23	40	49	41	51														CASSDSSGGPDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAGGGGGCGTCGGTAATGAAAAACTGTTTTTTGGCAGT	CASSLGGVGNEKLFF	In	VDJ	2	70	6.372093870045697E-4	7.693237644110826E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	5	0	4	1	5	23	36	44	37	49														CASSLGGVGNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGACAGGGGAATGACATTCAGTACTTCGGCGCC	CASSRQGNDIQYF	In	VDJ	2	71	6.463123782474922E-4	7.803141039026695E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	2	2	8	1	4	23	35	44	36	48														CASSRQGNDIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGGACAACACTGAAGCTTTCTTTGGACAA	CASSDSDNTEAFF	In	VDJ	2	82	7.464452819196388E-4	9.012078383101254E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	0	1	7	2	0	0	23	-1	-1	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSDNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGACTAGCGGGGGGGCCAGATACGCAGTATTTTGGCCCA	CASSGLAGGPDTQYF	In	VDJ	2	87	7.919602381342509E-4	9.561595357680598E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	1	0	4	0	1	23	-1	50	35	51														CASSGLAGGPDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTATTCCGGGGAGCTGTTTTTTGGAGAA	CASSYYSGELFF	In	VJ	2	92	8.37475194348863E-4	0.0010111112332259944	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	1	0	0	6	0	3	23	-1	39	-1	42														CASSYYSGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCATAACGGGGGAGGTGGAGACCCAGTACTTCGGGCCA	CASSITGEVETQYF	In	VDJ	2	95	8.647841680776303E-4	0.001044082251700755	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	8	2	5	5	5	23	34	45	39	50						01,02								CASSITGEVETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTCAACACCGGGACAGGGGGCGACGCGGAGACCCAGTACTTCGGGCCA	CASSLNTGTGGDAETQYF	In	VDJ	2	98	8.920931418063976E-4	0.0010770532701755158	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	0	5	10	6	23	34	56	44	62														CASSLNTGTGGDAETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATAGGGTGGACTTCGCCGAGCTGTTTTTTGGAGAA	CASSYRVDFAELFF	In	VDJ	3	139	0.001265315782766217	0.0015276571893305783	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	1	10	11	6	5	23	37	48	43	53						01,02								CASSYRVDFAELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCGAGGGAGGCGGGGAAGCCGGGGAGCTGTTTTTTGGAGAA	CASTEGGGEAGELFF	In	VDJ	3	145	0.0013199337302237516	0.0015935992262800997	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	7	3	6	9	3	23	33	48	42	51						01,02								CASTEGGGEAGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACAACAATTGAACACTGAAGCTTTCTTTGGACAA	CASRQQLNTEAFF	In	VDJ	3	149	0.0013563456951954413	0.0016375605842464474	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	6	0	0	5	23	-1	37	34	42														CASRQQLNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACTCGGGAGGGCCCCAGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	4	154	0.0014018606514100533		43	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	8	0	8	3	5	23	35	46	38	51														X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGGAGAGCGGGGGGGGCTATGGCTACACCTTCGGTTCG	CASSDSESGGGYGYTF	In	VDJ	4	176	0.0016021264587543467	0.0019342997505192936	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	6	0	4	4	1	23	40	54	44	55														CASSDSESGGGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGTAGAAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	4	187	0.0017022593624264934		41	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	2	6	2	5	0	4	23	-1	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCATTCCCGACAGGGGGCGTGGTGAAGCTTTCTTTGGACAA	CAIIPDRGRGEAFF	In	VDJ	5	226	0.002057276020900468	0.0024838167250986385	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	2	0	7	8	4	23	30	48	38	52														CAIIPDRGRGEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGGGTATGAGGACACAGATACGCAGTATTTTGGCCCA	CASSYGYEDTDTQYF	In	VDJ	6	242	0.002202923880787227	0.0026596621569640287	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	11	1	2	7	1	23	37	48	44	49														CASSYGYEDTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGGGAGGGCGCAACACAGATACGCAGTATTTTGGCCCA	CASSPGGRNTDTQYF	In	VDJ	7	319	0.0029038542064922534	0.0035059182978162194	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	8	0	2	1	5	23	35	44	36	49														CASSPGGRNTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGACGTACAGGGGACAGATACGCAGTATTTTGGCCCA	CASSDDVQGTDTQYF	In	VDJ	8	332	0.003022193092650245	0.003648792711206849	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	2	3	8	0	23	35	-1	43	50														CASSDDVQGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCAGGTGACAGCGGAGCCTTAAAAAACATTCAGTACTTCGGCGCC	CASSYPGDSGALKNIQYF	In	VDJ	18	777	0.007073024195750724	0.008539493784963017	54	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-04	01	2	2	5	4	6	10	23	38	49	44	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYPGDSGALKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01		TCRBJ02-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCGGGGGGCGGACCAACACCGGGGAGCTGTTTTTTGGAGAA	CAIGGRTNTGELFF	In	VDJ	22	965	0.00878438654942014	0.010605677609381354	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	10	8	1	2	1	6	23	30	38	31	44														CAIGGRTNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCCCAGGCACAGATACGCAGTATTTTGGCCCA	CASSLPGTDTQYF	In	VDJ	1	12	1.0923589491506909E-4	1.3188407389904273E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	5	1	3	0	24	37	-1	40	43													Vb 18	CASSLPGTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAGCCACGTTTGGTGGCGAGGAGATTCGGCAGCTTATTCTGTGCCAGCTCACTCGGGGTTGGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	15	1.3654486864383636E-4		41	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	19	8	3	0	15	4	40	38	58	53	62													Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCTCAACAGGGGCGGACACTGAAGCTTTCTTTGGACAA	CASSPSTGADTEAFF	In	VDJ	1	19	1.7295683361552607E-4	2.08816450340151E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	2	3	4	3	24	38	49	42	52													Vb 18	CASSPSTGADTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACTAGCGGGGGGGCCAGTTGGGAGCAGTACTTCGGGCCG	CASSPTSGGASWEQYF	In	VDJ	1	20	1.8205982485844849E-4	2.198067898317379E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	3	0	7	0	8	24	-1	52	39	60													Vb 18	CASSPTSGGASWEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGTGTGGGAGAGACCCAGTACTTCGGGCCA	CASSPGVGETQYF	In	VDJ	1	20	1.8205982485844849E-4	2.198067898317379E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	3	0	9	4	0	6	24	-1	41	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGVGETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCAGGACACAAAACACTGAAGCTTTCTTTGGACAA	CASSRTQNTEAFF	In	VDJ	1	20	1.8205982485844849E-4	2.198067898317379E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	6	2	2	3	24	35	42	37	45													Vb 18	CASSRTQNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCGAAATTCGGGGGTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSRNSGVSGANVLTF	In	VDJ	1	20	1.8205982485844849E-4	2.198067898317379E-4	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	6	8	2	0	8	1	24	35	49	43	50													Vb 18	CASSRNSGVSGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCTTACAGGGGCGGGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSLTGAGSYNSPLHF	In	VDJ	1	20	1.8205982485844849E-4	2.198067898317379E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	3	2	0	4	4	24	35	46	39	50													Vb 18	CASSLTGAGSYNSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
AAGCCACGTTTGGTGGCGAGGAGATTCGGCAGCTATTTCTGTGCCAGCTCACTCGGGGTTGGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	21	1.911628161013709E-4		41	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	23	8	3	0	19	4	40	34	58	53	62													Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCGGTTATACGGGCTTTCTCCAGGGGACAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	21	1.911628161013709E-4		50	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	11	4	2	3	18	1	24	30	54	48	55													Vb 18	X+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGACCGGAATCAGCCCCAGCATTTTGGTGAT	CASSPDRNQPQHF	In	VDJ	1	23	2.0936879858721576E-4	2.527778083064986E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	2	2	7	4	0	3	24	-1	42	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPDRNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAGGGACAGGGGGATCCTGGAAACACCATATATTTTGGAGAG	CASSQGQGDPGNTIYF	In	VDJ	1	25	2.275747810730606E-4	2.7475848728967237E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	0	1	2	1	3	24	37	49	38	52													Vb 18	CASSQGQGDPGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGACAGAGAGCTCTGGAAACACCATATATTTTGGAGAG	CASSPTESSGNTIYF	In	VDJ	1	25	2.275747810730606E-4	2.7475848728967237E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	2	5	0	0	4	24	-1	43	38	47													Vb 18	CASSPTESSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCTCACAGAGCACCATGGGGGGCTACACCTTCGGTTCG	CASSLSQSTMGGYTF	In	VDJ	1	25	2.275747810730606E-4	2.7475848728967237E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	4	3	5	8	4	12	24	37	45	41	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSLSQSTMGGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGAGTTCTACGAGCAGTACTTCGGGCCG	CASSPEFYEQYF	In	VDJ	1	26	2.3667777231598303E-4	2.857488267812593E-4	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	10	2	3	0	2	24	-1	42	38	44													Vb 18	CASSPEFYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCCGGGACAGGCAGGCTCGAGCAGTACTTCGGGCCG	CASSPGTGRLEQYF	In	VDJ	1	28	2.548837548018279E-4	3.0772950576443307E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	4	6	4	6	24	35	47	39	53													Vb 18	CASSPGTGRLEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTCCGGGACAGGGGGCTCGCCGGGGAGCTGTTTTTTGGAGAA	CASSPLRDRGLAGELFF	In	VDJ	1	29	2.639867460447503E-4	3.1871984525602E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	0	0	6	3	3	24	40	55	43	58													Vb 18	CASSPLRDRGLAGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGACCTGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPDLYSNQPQHF	In	VDJ	1	32	2.912957197735176E-4	3.516908637307806E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	3	1	7	0	0	5	24	-1	42	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPDLYSNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGGGATTCTAGCACAGATACGCAGTATTTTGGCCCA	CASSPRDSSTDTQYF	In	VDJ	1	33	3.0039871101644E-4	3.6268120322236754E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	2	0	8	0	1	4	24	39	44	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPRDSSTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGAGGGATGGGGCACTGAAGCTTTCTTTGGACAA	CASSPPEGWGTEAFF	In	VDJ	1	33	3.0039871101644E-4	3.6268120322236754E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	10	0	4	0	6	24	-1	47	41	53													Vb 18	CASSPPEGWGTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCCATAACAGGGGTCGCGAGCTTTCTTTGGACAA		Out	VDJ	1	35	3.1860469350228484E-4		35	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	3	2	10	4	5	24	33	44	37	49													Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGAGGCAGGGGGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	36	3.2770768474520726E-4		41	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	1	6	4	1	24	40	51	44	52													Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCTGAGAGAACTGAAGCTTTCTTTGGACAA	CASSPERTEAFF	In	VDJ	1	37	3.368106759881297E-4	4.066425611887151E-4	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	11	2	5	4	3	24	35	42	39	45													Vb 18	CASSPERTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGACAGGAATCAGCCCCAGCATTTTGGTGAT	CASSPDRNQPQHF	In	VDJ	1	39	3.5501665847397456E-4	4.2862324017188893E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	4	4	0	0	24	-1	-1	38	45													Vb 18	CASSPDRNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCACCTCGGATTTACGCGAAAAACTGTTTTTTGGCAGT	CATSDLREKLFF	In	VDJ	1	42	3.823256322027418E-4	4.615942586466496E-4	36	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-04	01	6	1	8	8	0	7	24	-1	38	35	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CATSDLREKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01		TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGCGGGTCCCTACAATGAGCAGTTCTTCGGGCCA	CASSPPAGPYNEQFF	In	VDJ	1	42	3.823256322027418E-4	4.615942586466496E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	7	4	2	1	2	24	41	47	42	49						01,02							Vb 18	CASSPPAGPYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGGGACAGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSGTGNTGELFF	In	VDJ	1	42	3.823256322027418E-4	4.615942586466496E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	4	1	0	0	24	-1	-1	36	44													Vb 18	CASSGTGNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAAGGGGACCGCTATGGCTACACCTTCGGTTCG	CASSQGDRYGYTF	In	VDJ	1	45	4.096346059315091E-4	4.945652771214103E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	4	0	7	4	3	2	24	37	45	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSQGDRYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAGGAGTCTCTGGGGCAAACTGAAGCTTTCTTTGGACAA	CASSQESLGQTEAFF	In	VDJ	1	49	4.460465709031988E-4	5.385266350877579E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	7	0	5	10	2	24	37	52	47	54													Vb 18	CASSQESLGQTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCGGGACAGGGGGCTGGGGAACACTGAAGCTTTCTTTGGACAA	CASSRDRGLGNTEAFF	In	VDJ	1	52	4.7335554463196606E-4	5.714976535625186E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	0	1	2	4	24	35	49	37	53													Vb 18	CASSRDRGLGNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGATTTTGGGGGTGAGACCCAGTACTTCGGGCCA	CASSPDFGGETQYF	In	VDJ	1	54	4.915615271178109E-4	5.934783325456923E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	3	6	1	5	7	1	24	38	50	45	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPDFGGETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTTGGTCAAACAGGGCGGCAGCCCCAGCATTTTGGTGAT	CASSPLGQTGRQPQHF	In	VDJ	1	56	5.097675096036558E-4	6.154590115288661E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	3	3	7	8	3	24	40	54	48	57													Vb 18	CASSPLGQTGRQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCAGCGACAGGAGAGGGCCTGAAGCTTTCTTTGGACAA	CASSPSDRRGPEAFF	In	VDJ	1	60	5.461794745753454E-4	6.594203694952137E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	4	6	4	7	24	38	48	42	55													Vb 18	CASSPSDRRGPEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGACAGAGAGAGGGGACCCAGTACTTCGGGCCA	CASSPGQREGTQYF	In	VDJ	1	60	5.461794745753454E-4	6.594203694952137E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	5	7	0	8	24	-1	45	38	53													Vb 18	CASSPGQREGTQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCGTACGGGGGACTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	70	6.372093870045697E-4		49	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	3	8	2	2	5	1	24	38	49	43	50													Vb 18	X+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGCGAGGTCGGGGAAAAACTGTTTTTTGGCAGT	CASSREVGEKLFF	In	VDJ	2	76	6.918273344621043E-4	8.35265801360604E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	8	4	8	7	0	24	37	-1	44	48						01,02							Vb 18	CASSREVGEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD02-01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCAGGGATTCCGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	80	7.282392994337939E-4		49	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-06	01	2	0	8	0	0	5	24	-1	43	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01		TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATGTTAAGCGGACATTTACAAAGCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	91	8.283722031059407E-4		55	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-06	01	5	1	6	5	8	10	24	36	49	44	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01		TCRBJ02-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCCACTCGGACTGAAGCTTTCTTTGGACAA	CASSPPTRTEAFF	In	VDJ	2	92	8.37475194348863E-4	0.0010111112332259944	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	3	10	5	1	3	24	41	45	42	48						01,02							Vb 18	CASSPPTRTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGACCGGGACCACTGACGGAAACACCATATATTTTGGAGAG	CASSPTGTTDGNTIYF	In	VDJ	2	100	9.102991242922425E-4	0.0010990339491586895	48	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	3	0	7	4	4	7	24	38	47	42	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPTGTTDGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCGGCGGGGGGATACGCAGTATTTTGGCCCA	CASSPRRGDTQYF	In	VDJ	2	100	9.102991242922425E-4	0.0010990339491586895	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	7	2	6	3	0	24	38	-1	41	48													Vb 18	CASSPRRGDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCGGGACAGTCACACACCATATATTTTGGAGAG	CASSPPGQSHTIYF	In	VDJ	2	103	9.376080980210098E-4	0.0011320049676334502	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	5	8	3	4	24	38	48	41	52													Vb 18	CASSPPGQSHTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATACGGACAGACCAACTACGAGCAGTACTTCGGGCCG	CASSYGQTNYEQYF	In	VDJ	3	110	0.0010013290367214666	0.0012089373440745585	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	5	3	3	5	24	36	45	39	50													Vb 18	CASSYGQTNYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGTTAACCCCCCAGGGGGCGGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	3	147	0.0013381397127095963		52	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	4	0	8	11	2	24	40	59	51	61													Vb 18	X+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGACACCGGATAATTCACCCCTCCACTTTGGGAAC	CASSPGTPDNSPLHF	In	VDJ	6	255	0.002321262766945218	0.0028025365703546585	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	0	6	5	0	4	24	-1	45	39	49													Vb 18	CASSPGTPDNSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-06*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGGGGTGGGGGGCTACGAGCAGTACTTCGGGCCG	CASSPGVGGYEQYF	In	VDJ	20	862	0.00784677845139913	0.009473672641747904	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	9	1	3	6	0	24	38	-1	44	50													Vb 18	CASSPGVGGYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCGGGGTTGGCTCCTACGAGCAGTACTTCGGGCCG	CASSLGVGSYEQYF	In	VDJ	113	4845	0.04410399257195915	0.053248194836738504	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	8	3	0	1	4	24	37	43	38	47													Vb 18	CASSLGVGSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-07*01	6229A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2951	2444	408	97	0	1305	1044	244	17	0	109854	90989	15219	3646	0	0.238573059	7.6355176	0.217761397	8.09603977				145614	0.0164964292	0.133169949	0.110300943	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:36	Age (Range):45-65 Years (Late Adulthood),Age:58 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1187,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 397,type of chemo:carbo/taxol	0.8281938100255186	MSKCC- Snyder- P01-02		2402.0	
